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1.1 Introduction  
 
Modern drug discovery is facing with the challenge of designing chemical 
reactions that are capable of providing most of different structural molecules with a 
minimum number of synthetic steps.1–5 
Classical chemical reactions correspond to equilibria between one or two 
reagents and their products.  
In theory, the perfect chemical reactions form their products irreversibly, 
without the competing formation of by-products, affording the desired products in 
quantitative yield. This ideal situation is anyway very far from the reality. Finally, 
using the two-component chemistry to form complex products, requires usually 
sequences of chemical reactions leading to reduced overall yield.6 
On the contrary, in the multicomponent reactions (MCRs) three or more 
different starting materials are combined, in one step, to give a product that 
incorporates substantial portions of all the components, reducing the number of 
synthetic steps necessary to form the desired molecules.7,8 
Indeed, over the last decades, multicomponent reactions have demonstrated their 
ability and efficiency in the generation of chemical diversity, being an extremely 
powerful synthetic tool for medicinal chemists and pharmaceutical industry.9–12 
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1.2 Multicomponent reactions (MCRs) 
 
Reaction in which more than two starting compounds react to form a product in 
such a way that the majority of the atoms of the starting materials can be found in 
the product are called multicomponent reactions.8  
To note that MCRs do not directly convert their educts into the products, but 
they are sequences of subreactions that proceed stepwise. Ideally, all reaction 
equilibria in the MCR mixture are reversible, except one, thus providing the 
driving force to shift all intermediates and starting materials towards a single final 
product. 
 
Figure 1. Schematic presentation of a one component reaction, a two component 
reaction, and a three and four component (adapted from reference 5). 
 
Compared to conventional multistep organic syntheses, MCRs are advantageous 
due to their greater efficiency and the accessibility to a large number of molecules 
with broad structural diversity. The experimental simplicity of one-pot procedures 
is also a major benefit, they are easier to carry out than multistep syntheses and 
require a single final purification. Finally, the structure of the reaction product can 
be modified by systematic variation of each input.5 
A selection of the most important named MCR discovered starting from 1850 
are reported herein (Figure 2).  
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Name of the 
reaction 
Year of 
discovery Example 
Strecker synthesis13 1850 
 
Hantzsch 
dihydropyridine 
synthesis14 
1882 
 
Radziszewski 
imidazole 
synthesis15  
 
1882 
 
Willgerodt-Kindler 
reaction16,17 
 
1887 
 
Döebner 
reaction18,19 
 
1887 
 
Hantzsch pirrole 
synthesis20,21 1890 
 
  
Figure 2. Named MCRs. 
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Name of the 
reaction 
Year of 
discovery Example 
 
 
Biginelli  
reaction22–25 
 
 
 
 
1891 
 
 
 
Guareschi 
reaction26,27 
 
 
 
 
1896 
 
Betti reaction28,29 1900 
 
Reissert reaction30  1905 
 
Bargellini 
reaction31 
 
1906 
 
  
Figure 2. Named MCRs (continued). 
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Name of the 
reaction 
Year of 
discovery Example 
Mannich reaction32 
 
1912 
 
Bucherer-Bergs 
hydantoin 
synthesis33,34 
 
1929 
 
Kabachnik-Fields 
synthesis35,36 
 
1952 
 
Asinger reaction37  
 
 
1956 
 
 
 
Povarov reaction38  
 
 
 
1963 
 
  
Figure 2. Named MCRs (continued). 
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Name of the 
reaction 
Year of 
discovery Example 
 
 
 
 
Gewald reaction39  
 
 
 
 
1966 
 
Pauson-Khand 
reaction40 
 
1977 
 
Yonemitsu 
synthesis41 
 
1978 
 
Petasis reaction42 
 
1993 
 
Figure 2. Named MCRs (continued). 
 
As shows in Figure 2, a vast number of MCRs have been reported in the 
literature, but special subclasses isocyanide based MCRs (IMCRs) are probably the 
most documented ones.1,5,10,43–46 
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1.3 Isocyanides  
 
Isocyanides (or isonitriles or carbylamine) represent a class of stable organic 
compounds with the functional group -N≡C.47 
Isocyanides are considered as highly “unpleasant” compounds, due to their vile 
odor. However, higher molecular weight isocyanides are often solid and odorless.  
Isocyanides are considered resonance forms between divalent carbon forms 1a 
and zwitterions 1b (Scheme 1). The carbon atom of the isocyano group can exhibit 
a carbene-like reactivity that is reflected in the resonance structure 1a, conversely, 
the linear structure of isocyanides is well represented by the dipolar resonance 
structure 1b, which has a nucleophilic character.48,49  
 
Scheme 1. Resonance structures of isocyanides. 
Isocyanides are stable under basic treatment (they are often made under basic 
conditions), but they are quite sensitive to acids. In the presence of aqueous acidic 
solutions, isocyanides react to give the corresponding formamides by an acidic 
hydrolysis and this is a generally convenient method for removing the horrible 
smell of isocyanides.50,51 
The chemistry of isocyanide is characterized by three properties: the α-acidity, 
the easy formation of radicals and the α-addition. 
The α-acidity of the isocyanides is further increased by electron-withdrawing 
substituents in the α-position such as carboxylic ester, nitriles and phosphonic ester 
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or sulfonyl group. In certain cases, a weak base is sufficient to alkylate the 
isonitrile. This property has been widely studied for the synthesis of oxazoles 51,52 
pyrroles,53 triazoles. 30 For instant, Van Leusen reported an oxazole synthesis to 
oxazoles from toluenesulfonylmethyl isocyanide (TosMIC) and an aldehyde 
(Scheme 2).53  
 
Scheme 2. Synthesis of oxazole starting from TosMIC. 
In the radical reaction of isocyanides, radicals are able to add on isonitriles to 
form an imidoyl radical species, which can then fragment into a nitrile and an alkyl 
radical55 or can react intramolecularly with an unsaturated system to give cyclic 
compounds56 (Scheme 3).  
 
Scheme 3. Addition of a radical on an isonitrile. 
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Finally, isocyanides are able to react with nucleophiles and electrophiles at the 
same isocyanide carbon-atom through an “α-addition”, to give an “α-adducts”5 
(Scheme 4).  
 
Scheme 4. Formation of α-adducts. 
This characteristic is unique in organic chemistry, both nucleophile and 
electrophile attacks will occur on the terminal carbon atom. After the attack of the 
isocyanide on an electrophile, the divalent carbon becomes electrophilic and can be 
attacked by a nucleophile, and conversely although rarer it can react first with a 
nucleophile and then with an electrophile.  
Only a few isocyanides are commercially available, but they can be easily 
prepared in one or two steps. 
The first isocyanide compound, allyl isocyanide, was obtained by Lieke in 1859, 
from the reaction of allyl iodide and silver cyanide.57 
In 1867, Hofman described a new approach via the condensation of a primary 
amine with a dichlorocarbene, generated in situ by reacting chloroform with 
potassium hydroxide58 (Scheme 5). However this method suffers from a lack of 
reproducibility, low yield and difficulties of separation of isocyanides from 
amines.59 
 
Scheme 5. Hofman synthesis of isocyanide (carbylamine method). 
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In 1958, Ivar Ugi optimized the formation of isocyanide using the dehydration 
of N-monosubstituted formamide, prepared from condensation of primary amines 
with methyl or ethyl formate or formic acid (Scheme 6).60 
 
Scheme 6. Synthesis of isocyanide by dehydration of formamide. 
Various dehydrating agents can be used (for example phosgene, P2O5, POCl3, 
(CO)2Cl2, SOCl2, PBr3) in the presence of a base like pyridine, triethylamine, 
diisopropyl ethylamine. This method is compatible with a larger number of 
substrates, so it is the most used. 
 
Scheme 7. Synthesis of isocyanide by dehydration of formamide (using POCl3 or phosgene as a 
dehydrating agent). 
 
In 1972, Weber, Gokel and Ugi improved the Hofman method of carbylamine 
by carrying it out in a biphasic medium: a mixture of dichloromethane and water in 
the presence of a phase transfer catalyst (Scheme 8).61,62 
In this method, the attack of the primary amine on dichlorocarbene is more 
selective and the method is high yielding (up to 70% after purification) and more 
reproducible.63 In this case dichlorocarbene may be generated efficiently from 
chloroform and aqueous NaOH in a heterogeneous system by use of the phase 
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transfer catalyst benzyltriethylammonium chloride. This method improves the 
selectivity of the addition of the dichlorocarbene to the primary amine, and limits 
the formation of side products. For this reason, it is utilized still today for the 
preparation of a great number of isocyanides. 
 
Scheme 8. Synthesis of isocyanides improved by Ugi. 
Other synthesis have been reported, but they are less general and more substrate 
specific (Figure 3).8  
Gassman et al, 
198264 
 
Baldwin et al, 
199065 
 
Kitano et al, 
199866 
 
 
Figure 3. Other synthesis of isocyanides. 
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El Kaïm et al, 
200967 
(method in 
situ) 
 
Dömling et al, 
201568 
(method in 
situ) 
 
 
Figure 3. Other synthesis of isocyanides (Continued). 
 
 
1.4 Isocyanide based multicomponent 
reactions (IMCRs) 
 
The Passerini reaction was the first reported isocyanide based multi-component 
reaction. It was discovered by Mario Passerini in 1921. This three-component 
reaction (which is abbreviated as P-3CR) involves a carboxylic acid as a 
nucleophile, an oxo component (aldehyde or ketone) and an isocyanide to give an 
α-hydroxy carboxamide (Schema 9).  
 
Scheme 9. Passerini reaction P-3CR. 
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The exact mechanism was subject of some uncertainty. The most accepted 
mechanism involves the formation of the adduct between the carboxylic acid and 
the carbonyl compound; the isocyanide then inserts into this intermediate followed 
by nucleophilic addition of the isocyanide to give the nitrilium ion. The carbonyl 
carbon acts as electropile and the oxygen of the carboxylic acid as nucleophile, and 
their addition into the isocyanide carbon atom is simoultaneous. The final, non-
reversible step is a Mumm type rearrangement: the intramolecular transfert of the 
acyl. This is the driving force of the reaction, where an unstable iminoanhydride 
intermediate converts into a stable adduct (Scheme 10).49,69,70  
 
Scheme 10. Mechanism of the Passerini 3-component reaction. 
In 1959, Ivar Karl Ugi extended the scope of the Passerini reactions by adding 
an amine. The Ugi reaction (U-4CR) is defined as the reaction of a carboxylic acid 
(as a nucleophile), a ketone or aldehyde, an amine, and an isocyanide.7,71,72 The 
reaction is typically carried out in methanol or 2,2,2-trifluoroethanol in high 
reactant concentrations (Scheme 11). 
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Scheme 11. Ugi reaction U-4CR. 
The initial step is the formation of an imine from the amine and the carbonyl 
compound, followed by protonation with carboxylic acid. Subsequently the 
nucleophilic attack of the isocyanide to the iminium ion, produces the formation of 
the highly reactive nitrilium intermediate. The nitrilium is then attacked by the 
carboxylate ion, and as a result of intramolecular Mumm rearrangement, the 
reaction yields a bis-amide (Scheme 12).70  
 
Scheme 12. Mechanism of the Ugi 4-component reaction. 
Interestingly, Ugi, compared to Passerini reaction, is much more versatile, not 
only in terms of library size, but also in terms of scaffolds. This can be attributed to 
the many different nucleophiles and amine components that have been described to 
date for the Ugi reaction.5  
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The nature of the components may vary widely; for example, the acid 
component may be hydrazoic acid, hydrogen thiosulfate, isocyanic and 
isothiocyanic acids, hydrogen selenide, a thiocarboxylic acid or water (Scheme 
13).73  
 
 
Scheme 13. Selected acid surrogates in Ugi-type couplings. 
Pioneering work by El Kaïm and Grimaud led to the discovery of a new Ugi-
Smiles reaction. In this case an electron deficient phenol such as 2-nitrophenol 
replaces the carboxylic acid. The mechanism is believed to involve activation of 
the aldehyde by the weakly acidic phenol (pKa ~ 4.2) which makes the carbonyl 
electrophilic vulnerable to attack by the isocyanide. The incipient nitrilium ion 
formed is attacked by the phenol followed by an SNAr leading to an α-aryloxy 
amide. The key step is believed to be the irreversible Smiles rearrangement of the 
intermediate phenoxyimidate adduct, instead of the classical Mumm acyl transfer 
rearrangement (Scheme 14).74,75  
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Scheme 14. Ugi-Smiles reaction. 
Depending upon the R groups, post Ugi reactions have been reported. For 
example Ugi-Heck76, Ugi-Diels-Alder77, Ugi-click78,79 and Ugi-Buchwald-
Hartwig80 reactions, whereby the Ugi bis-amide with reactive functional groups 
undergoes secondary reactions to form a ring (Scheme 15) . Linear bis-amides on 
the other hand are useful in the synthesis of peptides (linear and cyclic) and 
peptidomimetics.81 
 
 
Scheme 15. Examples of Ugi-Heck, Ugi-Diels-Alder, Ugi-click and 
Ugi-Buchwald-Hartwig reactions. 
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Scheme 15. Examples of Ugi-Heck, Ugi-Diels-Alder, Ugi-click and 
Ugi-Buchwald-Hartwig reactions (continued). 
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One well known example of utilizing the Ugi reaction in medicianal chemistry 
is the one-pot synthesis of the local anesthetic xylocaine (Scheme 16).7  
 
Scheme 16. Ugi’s synthesis of xylocaine. 
A more recent pharmaceutical application using MCR is the synthesis of 
fentanyl and carfentanil, two potent analgesics acting primarily on μ opiod receptor 
(Scheme 17).82  
Scheme 17. Synthesis of carfentanil by the U-4CR. 
Three more examples of the potential use of MCRs in the field of generic drug 
production, is the two-step synthesis of clopidogrel (Plavix®), an antiplatelet agent, 
telaprevir (Incivek®), used in HCV treatment, and praziquantel (Biltricide®), an 
anthelmintic (Scheme 18).83–86  
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Scheme 18. Examples of application of Ugi reaction. 
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Scheme18. Examples of application of Ugi reaction (continued). 
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2.1 Outline of the thesis 
 
The rapid and easy access to biologically relevant compounds, associated with the 
scaffold diversity, obtainable via multicomponent reactions, it has been recognized 
in our laboratory as a preferred method to design and discover biologically active 
compounds.1–11 
In this context is inserted the idea of this thesis. The major objective is related to 
the discovery of new multicomponent reactions, which can rapidly lead to the 
synthesis of important scaffold in medicinal chemistry either not easily accessible 
via the classical two-component chemistry or never reported in literature. 
 
Our research was focused on searching for neglected electrophilic groups that 
could replace the carbonyl component in the Passerini reaction. 
We have investigated, in particular, the role of two species: Z-chlorooximes and 
hydrazonoyl chlorides, able to generate 1,3-dipolar species, respectively, nitrile N-
oxides and nitrile imines which can be attacked by the isocyanide. The ephemeral 
nitrilium ion created can then be intercepted by a third component. 
 
In Chapters 3 and 9 an overview of the chemical features and the existing 
literature on Z-chlorooximes and hydrazonoyl chlorides, with particular attention to 
their reactivity with isocyanide, is reported. 
In Chapter 4, the discovery of a novel multicomponent reaction between Z-
chlorooximes, isocyanides and amines to obtain C-oximinoamidines is described. 
In Chapter 5, the use of an α‑isocyanoacetamides for the synthesis of aryl-α-
ketoamide amides is disclosed. In this reaction the nitrilium ion can be 
intramolecularly intercepted by an internal nucleophile to produce 1,3-oxazol-2-
oxime, which undergoes opening of the oxazole ring and deoximation reaction.  
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In Chapter 6, a new methodology for synthesis of aryloxyimino amides via Smiles 
rearrangement of the MCR product among aromatic Z‑chlorooximes, isocyanides, 
and electron-deficient phenols is presented. 
In Chapter 7, a multicomponent reaction using hydroxylamines as 
hypernucleophilic traps, to form aminodioximes and 5‑amino-1,2,4-oxadiazoles by 
Mitsunobu−Beckmann rearrangement is reported. 
In Chapter 8, the details of general mechanism of the reaction between nitrile N-
oxides, isocyanide and a third component is treated. 
In Chapter 10, the synthesis of aminocarbonyl N‑acylhydrazones by a three- 
component reaction among isocyanides, hydrazonoyl chlorides, and carboxylic acids 
is discussed. 
Chapter 11 shows the one-pot three-component synthesis of furo[2,3‑d]pyridazin-
4(5H)‑ones, while in a Chapter 12 an efficient synthesis of 1-arylindazole-3-
carboxamides followed by a chemoselective Buchwald–Hartwig intramolecular 
cyclization is presented. 
Finally, in Chapter 13 all the multicomponent reactions discovered along with the 
molecular scaffolds obtained, are summarized.  
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3.1 Introduction 
 
Z-chlorooximes (also known as Z-hydroximoyl chlorides) are organic 
compounds that contain the functional group RC(NOH)Cl with a double bond 
between the nitrogen and the carbon atom.  
Usually, they can be easily prepared starting from an aldehyde and 
hydroxylamine hydrochloride, in presence of base, to give a Z/E mixture of 
aldoxime. The aldoximes then react with N-chlorosuccinimide in DMF at room 
temperature to produce Z-chlorooximes (Scheme 1).1,2  
 
Scheme 1. Synthesis of Z-chlorooximes. 
The method of chlorination using NCS in DMF is quite general and is 
applicable both on alkyl and aromatic aldoximes. The only disadvantage is in case 
of electron rich aromatic aldoximes. For example, when applied to 2-
furancarbaldehyde oxime the chlorination of the ring cannot be suppressed.3 
Other methods for the preparations of hydroximoyl chlorides, have been 
reported in literature and they are listed in Table 1. 
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Chiang in 19714 Chiarino et al in 1988
5 
Lee in 19826 Kim et al. in 19907 
 
Hassner et al. in 19898 Halling et al in 19919 
Kumara et al. in 199610,11 
(Reported also the substitution of diethyl 
malonate by propargyl alcohol, ethanethiol, 
diethyl phosphite). 
Kuo-His Kao et al. in 199812 
Kanemasa et al. in 20003 Yan et al. in 200213 
Ye et al. in 200314 Kumar et al. in 200615 
Table 1. Main methods for the synthesis of Z-chlorooximes. 
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Aromatic chlorooximes are sufficiently stable to be purified by column 
chromatography and they can be stored at 0 °C without decomposing. On the other 
hand, aliphatic chlorooximes are much more delicate, decomposing during 
isolation and purification procedures. For this reason it is better to use the crude 
reaction mixture after their preparation. 
Independently from the stereochemistry of the starting oxime, chlorooximes are 
always obtained in the Z formand never as mixture of Z and E isomers.16 Although 
the reason for the observed formation of Z-chlorooximes is not completely clear, 
it is possible to speculate that the formation of an intramolecular Cl·· ·H hydrogen 
bond preferentially stabilizes this geometrical isomer over the opposite one.17,18 
E-chlorooxime can only be formed by introduction of an acyl group to the Z 
form. This allows for the photoequilibration of isomers and subsequently removal 
of the acyl group.  
Z-chlorooximes are able to generate the electrophilic species nitrile N-oxides 
under very mild reaction conditions of base-mediated dehydrochlorination 
(Scheme 2).19  
 
Scheme 2. Formation of nitrile N-oxides. 
It is interesting to highlight that E isomers react 107 fold more slowly than the 
corresponding Z isomers, and this discrepancy can be rationalized by the fact that 
Z-chlorooximes have the lone pair of nitrogen atom antiperiplanar to the chlorine 
atom, facilitating its expulsion after deprotonation of the hydroxyl group.18,20 
Before 2011 there were only three papers about the two-component reaction 
between nitrile N-oxides and isocyanides. The first one was reported in 1964 by 
Chapter 3 
40 
R. Olofson (Harvard University). Studying the decomposition of N-alkyl 
furazanium salts, he envisaged that nitrile N-oxides could react with isocyanides 
to give cyanides and isocyanides via oxygen transfer or 1,3-dipolar 
cycloaddition.21  
The second paper was by Paola Vita Finzi (University of Pavia) and dated 
1965.22 She reported that isocyanides reacted with benzonitrile N-oxide in diethyl 
ether under refluxing conditions to form benzonitrile and isocyanates. However, 
the reaction did not appear to be clean and the authors recovered several 
byproducts: diphenylfuroxan, the product of benzonitrile oxide dimerization, 3,5-
diphenyl-1,2,4-oxadiazole, formed by condensation of benzonitrile oxide with 
benzonitrile, and unreacted isocyanide (Scheme 3).  
 
Scheme 3. The products in the reaction between nitrile N-oxides and isocyanides. 
In 1980 a paper by Derek Barton and co-workers (Imperial College, London)23 
reconsidered this reaction with the aim to find a novel methodology to convert an 
isocyanide into an amine.They chose the sterically hindered and more stable 2,4,6-
trimethylbenzonitrile N-oxide, in order to prevent self-dimerization to furoxans. 
When the reaction was attempted between 2,4,5-trimethybenzonitrile N-oxide, 
cyclohexyl isocyanide, and aniline, N-cyclohexyl-N′-phenylurea was obtained in 
80% yield (Scheme 4).18 
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Scheme 4. One-pot synthesis of unsymmetrical urea. 
 
 
3.2 Reaction between Z-chlorooximes, 
isocyanides and carboxylic acids 
 
In 2011 in the laboratory where I carried out my Ph.D., it was reported a novel 
multicomponent reaction among Z-chlorooximes, isocyanides, and carboxylic 
acids to afford syn-α-oximinoamides with a high level of stereospecificity 
(Scheme 5).24  
 
Scheme 5. General reaction with carboxylic acid. 
 
In detail, the reaction between Z-phenylchlorooxime, cyclohexyl isocyanide 
and phenylacetic acid in dichloromethane, in the presence of 1 eq. of triethylamine, 
at room temperature allows to obtain the desired syn-oximinoamide in 70% yield 
(Scheme 6).  
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Scheme 6. Three-component reaction between cyclohexylisocyanide, phenylacetic acid and 
benzylchloroxime. 
Mechanistically speaking, the nitrile N-oxide, generated from Z-chlorooximes, 
reacts with isocyanide to form the nitrilium intermediate that is then intercepted 
by the carboxylate ion. The intermediate so obtained undergoes an irreversible 
Mumm-type rearrangement mediated by the syn-oxime driving all the equilibria 
to the final syn-α-oximinoamide (Scheme 7).  
 
Scheme 7. General mechanism between Z-chlorooximes, isocyanide 
and carboxylic acid. 
 
The reaction was general in scope as a wide range of both chlorooximes 
(aliphatic, aromatic, heteroaromatic) and isocyanides (primary, secondary, tertiary 
isocyanide) proved to react smoothly in the aforementioned reaction conditions. 
Only aromatic isocyanides did not react. The reaction was tolerant to primary, 
secondary, and tertiary isocyanides but failed with aromatic isocyanides. Both 
aliphatic and aromatic carboxylic acids participated well in the reaction. The 
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presence of electron-withdrawing or electron-releasing groups on the benzoic acid 
did not affect the course of the reaction (Figure 1).  
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Figure 1. Selected examples of syn-oximinoamides synthesized. 
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4.1 Results and discussion 
 
Starting from the multicomponent reaction with Z-chlorooximes, isocyanides, 
and carboxylic acids discussed in Chapter 3,1 we hypothesized we could introduce 
a novel level of complexity by using an amine as a third component.  
In principle, in this case several scenarios are possible as reactions between 
chlorooximes and amines, via nitrile N-oxide, are well known in literature for 
giving amidoximes.2–5 
However, initial experiments, reveled to us that the reaction between one 
equivalent of Z-phenylchlorooxime 1 and two equivalents of N,N-dibenzylamine 
2 was slugghish and not clean requiring at least 10 hours to go to completeness to 
give 3 in 60% yield (Scheme 1).  
 
Scheme 1. Synthesis of amidoxime 3. 
 
On the other hand, when pentylisocyanide 4 was reacted with the Z-
phenylchlorooxime 1 in dichloromethane at room temperature, after six hours, the 
TLC analysis revealed a complex mixture and it was not possible to isolate an 
established product (Scheme 2).  
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Scheme 2. Reaction between Z-phenylchlorooxime and isocyanide. 
However, this disappointing scenario dramatically changed when in the third 
experiment an amine (2 equivalents) was present in the flask. Indeed, we could 
observe, after three hours, the neat formation of a novel product (5) which 
incorporated all the reactants. Spectroscopic analyses determined the formation of 
an α-oximinoamidine in 71% yield, a novel chemical moiety never reported before 
to the best of our knowledge (Scheme 3).  
 
Scheme 3. Three component synthesis of C-oximinoamidines. 
The proposed mechanism for this new multicomponent transformation is 
depicted in Scheme 4. The Z-phenylchlorooxime 1 reacts with a base 2, forming 
the corresponding nitrile N-oxide 6, rapidly intercepted by pentylisocyanide 4 to 
give a nitrilium ion intermediate 7, eventually stereospecifically trapped by the 
amine, to afford the final product 5. Indeed, it was well established by Professor 
Hegarty that nitriulium species react with nucleophiles is a stereospecific way with 
the entering nucleophile and the lone pair trans from each other.6 
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Scheme 4. Proposed mechanism. 
 
Unlike those of most amidines,7,8 the 1H and 13C spectra of the final adducts 
recorded at 80 °C reveal, in most cases, the lack of geometrical isomerism pointing 
to a fast equilibrium between the two geometrical isomers.  
This novel multicomponent reaction was examined using different Z-
chlorooximes (1, 8-12), isocyanides (4, 13-16), and amines (2, 17-23) (Figure 1). 
Z-Chlorooximes were readily prepared by reacting oximes with N-
chlorosuccinimide in DMF.9–13 
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Isocyanides
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Figure 1. Building blocks. 
As shown in Figure 2, the reaction was quite general. Yields varied from 80% 
to 26%; this result depends on the purification step, since these compounds are 
extremely polar. The reaction was tolerant to primary, secondary and tertiary 
isocyanides, but failed with aromatic isocyanides. Indeed, reaction of 
phenylchlorooxime 1 with phenylisocyanide 16 and morpholine 20 only gave the 
adduct between the chlorooxime and the morpholine in 61% yield. This result was 
not surprising in the light of the reduced nucleophilicity of aromatic isocyanides.14 
Both primary and secondary amines were good partners for the reaction, and even 
aniline reacted, although in low yield. The presence of electron-withdrawing or 
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electron-donating groups on the phenyl ring of arylchlorooximes does not seem to 
alter the course of the reaction. 
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Figure 2. Synthesized C-oximinoamidines. 
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The structure and the stereochemistry of 24 was unambiguously established by 
a single crystal X-ray diffraction analysis. 
Figure 3 shows the molecular structure of 24, disordered at C14 and C16 of the 
morpholine moiety. The two alternate conformations of the ring show a site 
occupancy of 75% and 25% for the labeled atoms, respectively. 
 
Figure 3: ORTEP15 view of 24 and the relative arbitrary atom-
numbering scheme (thermal ellipsoids at 40% probability). 
 
Both imino groups show a Z-conformation in the solid state. The two rings are 
almost perpendicularly oriented, as shown by the N3-C8-C7-C4 are linked through 
strong hydrogen bond interactions between O1-H1a…N2, forming chains running 
in the a axis direction.  
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4.2 Conclusions 
 
In conclusion, we developed a novel multicomponent reaction that generates to 
C-oximinoamidines, a class of previously unreported compounds which could be 
used as starting materials for further elaborations taking advantage of the presence 
of the oxime.16–18 
Remarkably, the use of Z-chlorooximes makes it possible to overcome the lack 
of reactivity of the isocyanide-Nef adduct19 with amines, owing to a higher 
reactivity of the carbonyl. Indeed, C-acylamidines have never been synthesized 
starting from α-keto imidoyl chlorides and amines.20,21 The Z-chlorooximes can 
therefore be considered excellent surrogates for acyl chlorides in the reaction with 
isocyanides (Scheme 5).  
 
Scheme 5. Isocyanide Nef reaction and reaction between imidoyl 
chlorides and amines. 
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4.3 Experimental section 
 
Solvents and Reagents. Commercially available solvents and reagents were 
used without further purification. Dichloromethane was dried by distillation over 
P2O5 and stored over activated molecular sieves (4 Å). When needed, the reactions 
were performed in ovendried glassware under a positive pressure of dry nitrogen. 
Chromatography. Column chromatography was performed on silica gel 60 
(Merck Kieselgel 230-400 mesh ASTM) using the indicated eluents. Thin layer 
chromatography (TLC) was carried out on 5 x 20 cm plates with a layer thickness 
of 0.25 mm (Merck Silica gel 60 F254). When necessary they were visualized using 
Dragendorff's reagent.  
Spectra. Infrared spectra were recorded on a FT-IR Thermo-Nicolet Avatar 
spectrometer with absorption maxima (νmax) recorded in wavenumbers (cm-1). 
NMR spectra were recorded using a JEOL ECP 300 MHz spectrometer. Chemical 
shifts (δ) are quoted in parts per million referenced to the residual solvent peak. 
The multiplicity of each signal is designated using the following abbreviations: s, 
singlet; d, doublet; t, triplet; q, quartet; quint, quintet; sext, sextet; hept, heptet; m, 
multiplet; br, broad singlet. Coupling constants (J) are reported in Hertz (Hz). 
Mass spectra were recorded on a Thermo Finningan LCQ-deca XP-plus mass 
spectrometer equipped with an ESI source and an ion trap detector. Melting points 
were determined using a Stuart Scientific SMP3 apparatus and remain 
uncorrected. 
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General preparation of chlorooximes (1, 8-12) 
The oxime (1 eq.) was dissolved in DMF and N-chlorosuccinimide (1 eq.) was 
added portionwise. The reaction was stirred at room temperature until all the 
oxime was consumed as judged by TLC (typically 2 hours). The reaction was 
poured in water, diethyl ether was added, and the two layers were separated. The 
ethereal phase was washed with water (x3) and brine (x1), dried over sodium 
sulfate and concentrated under reduced pressure. The aromatic chlorooximes were 
purified by column chromatography (PE/EtOAc 9:1) and stored at 4 °C; aliphatic 
chlorooximes were unstable and they were immediately used in the next step 
without further purification. 
All the chlorooximes used are known compounds and their nature was 
confirmed by comparision of their melting points or 1H and 13C-NMR spectra. 
 
General preparation of C-oximinoamidines (5, 24-35) 
The chlorooxime (1 eq.) was dissolved in dry dichloromethane. Isocyanide (1 
eq.), and amine (2 eq.) were added and the reaction was stirred at room temperature 
under a nitrogen atmosphere until all the chlorooxime was consumed (typically 3 
hours as judged by TLC). The reaction mixture was concentrated under reduced 
pressure and the crude material was purified by column chromatography.  
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(2Z)-N,N-dibenzyl-2-(hydroxyimino)-N'-pentyl-2-phenylacetimidamide (5).  
Oxime 400 mg (2.57 mmol), isocyanide 249 mg (2.57 
mmol), amine 1.014 g (5.14 mmol), DCM dry 4 mL, 
reaction time 3 hours. The crude material was purified by 
column chromatography (eluents: PE/EtOAc 9:1, 5:5, 
EtOAc, EtOAc/MeOH 9:1) and crystallized in methanol 
to give the product as white solid (755 mg, yield 71%). 
1H-NMR (300 MHz, DMSO-d6) δ 11.65 (s, 1H), 7.56 (br 
s, 2H), 7.38 (br s, 3H), 7.21 (br s, 10H), 4.36 (br s, 4H), 
3.04 (m; 2H), 1.45 (br s, 2H), 1.20 (br s, 4H), 0.79 (br t; 
3H); 13C-NMR (75 MHz, DMSO-d6) δ 153.2, 149.9, 137.7, 132.3, 129.2, 128.4, 
127.7, 127.6, 126.4, 125.3, 49.5, 48.5, 30.8, 28.8, 21.5, 13.4; IR (KBr) 2923, 2851, 
2632, 1593, 1451, 953 νmax/cm-1; M.P. 170-171 °C; Found: C, 78.35; H, 7.40; N, 
10.34; C27H31N3O requires C, 78.42; H, 7.56; N 10.16 %; MS (ESI) m/z 414 
(M+H)+. 
 
(1Z)-2-morpholino-2-(pentylimino)-1-phenylethanone oxime (24).  
Oxime 400 mg (2.57 mmol), isocyanide 249 mg (2.57 
mmol), amine 447 mg (5.14 mmol), DCM dry 4 mL, 
reaction time 2 hours. The crude material was purified by 
column chromatography (eluents: PE/EtOAc 8:2, 5:5, 
EtOAc, EtOAc/MeOH 9:1) and crystallized in methanol to 
give the product as white solid (503 mg, yield 65%). 
1H-NMR (300 MHz, DMSO-d6) δ 11.45 (br s, 1H), 7.61 (br 
s, 2H); 7.42 (br s, 3H), 3.54 (m, 4H), 3.29 (m, 2H), 3.16 (m, 
2H), 3.0-2.80 (m, 2H), 1.38 (m, 2H), 1.19 (br s, 1.18), 0.79 (t, J = 7.0 Hz); 13C-
NMR (75 MHz, DMSO-d6) δ 154.8, 150.7, 133.3, 130.5, 129.8, 126.3, 66.9, 50.5, 
45.6, 32.0. 30.0, 22.8, 14.8; IR (KBr) 2929, 2647, 1624, 1444, 1263, 1118 νmax/cm-
1; M.P. 156-157 °C; Found: C, 67.42; H, 8.35; N, 13.82; C17H25N3O2 requires C, 
67.30; H, 8.31; N 13.85 %; MS (ESI) m/z 304 (M+H)+. 
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(2Z)-N-butyl-2-(hydroxyimino)-N'-pentyl-2-phenylacetimidamide (25).  
Oxime 200 mg (1.29 mmol), isocyanide 125 mg (1.29 
mmol), amine 188 mg (2.58 mmol), DCM dry 2 mL, reaction 
time 4 hours. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 8:2, 5:5, EtOAc, 
EtOAc/MeOH 9:1) to give the product as yellowish oil (186 
mg, yield 50%). 
1H-NMR (300 MHz, DMSO-d6) δ 8.30 (s, 1H), 7.63 (m, 2H), 
7.48 (n, 3H), 3.22 (br s, 4H overlapped with water), 1.52 (br 
s, 4H), 1.25 (br s, 6H), 0.82 (br t, 6H); 13C-NMR (75 MHz, 
DMSO-d6) δ 156.9, 147.4, 131.8, 130.8, 129.6, 126.0, 40.4 
(2C, overlapped with DMSO), 31.2, 28.8, 28.7, 22.1, 19.8, 14.1, 13.9; IR (KBr) 
2959, 1652, 1557, 1456 νmax/cm-1; Found: C, 70.35; H, 9.24; N, 14.30; C17H27N3O 
requires C, 70.55; H, 9.40; N 14.52 %; MS (ESI) m/z 290 (M+H)+. 
 
(2Z)-N'-cyclohexyl-N,N-diethyl-2-(hydroxyimino)-2-phenylacetimidamide 
(26). 
Oxime 200 mg (1.29 mmol), isocyanide 141 mg (1.29 
mmol), amine 189 mg (2.58 mmol), DCM dry 2 mL, reaction 
time 12 hours. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 8:2, 7:3, 5:5, EtOAc, 
EtOAc/MeOH 9:1) and crystallized in methanol to give the 
product as yellowish solid (135 mg, yield 35%). 
1H-NMR (300 MHz, DMSO-d6) δ 7.56 (m, 2H), 7.40 (m, 3H), 3.4-3.0 (br s, 4H), 
2.78 (m, 1H), 1.8-1.0 (m, 10H), 0.98 (br t, 6H); 13C-NMR (75 MHz, DMSO-d6) δ 
151.1, 150.8, 133.8, 130.0, 120.2, 126.0, 58.6, 35.6, 35.4, 26.1, 24.7, 13.7; IR 
(KBr) 2930, 2852, 1582, 1436, 1257 νmax/cm-1; M.P. 157-157.5 °C; Found: C, 
71.70; H, 9.23; N, 14.05; C18H27N3O requires C, 71.72; H, 9.03; N 13.94 %; MS 
(ESI) m/z 302 (M+H)+. 
 
  
Chapter 4 
 60  
(2Z)-2-(hydroxyimino)-N'-pentyl-N,2-diphenylacetimidamide (27).  
Oxime 200 mg (1.29 mmol), isocyanide 125 mg (1.29 
mmol), amine 240 mg (2.58 mmol), DCM dry 2 mL, 
reaction time 2 hours. The crude material was purified by 
column chromatography (eluents: PE/EtOAc 7:3) to give 
the product as yellowish solid (102 mg, yield 26%). 
1H-NMR (300 MHz, DMSO-d6) δ 7.46 (br s, 2H), 7.28 (br 
s, 3H), 6.98 (br t, 2H), 6.76 (br s, 3H), 3.34 (br s, 2H), 1.64 
(br s, 2H), 1.30 (br s, 4H), 0,91 (br s, 3H); 13C-NMR (75 
MHz, DMSO-d6) δ 151.8, 151.6, 133.3, 129.5, 129.4, 
128.9, 126.2, 121.8 (2C), 120.4; 40.2 (overlapped with DMSO), 29.3, 28.7, 22.3, 
14.4; IR (KBr) 3309, 2931, 2664, 1589, 1688, 1406, 1209 νmax/cm-1; M.P. 150-
151 °C; Found: C, 73.97; H, 7.56; N, 13.32; C19H23N3O requires C, 73.76; H, 7.49; 
N 13.58 %; MS (ESI) m/z 310 (M+H)+. 
 
(1Z)-2-(tert-butylimino)-1-(4-chlorophenyl)-2-(piperidin-1-yl)ethanone 
oxime (28). 
Oxime 300 mg (1.57 mmol), isocyanide 131 mg (1.57 
mmol), amine 267 mg (3.14 mmol), DCM dry 3 mL, 
reaction time 2 hours. The crude material was purified by 
column chromatography (eluents: PE/EtOAc 5:5, 
EtOAc, EtOAc/MeOH 9:1) and crystallized in methanol 
to give the product as white solid (286 mg, yield 57%). 
1H-NMR (300 MHz, DMSO-d6) δ 11.45 (br s, 1H), 7.54 (d, J = 8.8 Hz, 2 H, 
AA′XX′), 7.41 (d, J = 8.8 Hz, 2 H, AA′XX′), 3.24 (br s, 2H), 3.10 (br s, 2H), 1.47-
1.30 (m. 6H), 0.98 (s, 9H); 13C-NMR (75 MHz, DMSO-d6) δ 153.2, 147.8, 134.4, 
133.9, 129.2, 128.0, 53.1, 45.1, 31.9, 26.1, 25.1; IR (KBr) 2856, 2582, 1568, 1488, 
1198, 932 νmax/cm-1; M.P. 216-216.5 °C; Found: C, 63.80; H, 7.68; N, 13.24; 
C17H24ClN3O requires C, 63.44; H, 7.52; N 13.06 %; MS (ESI) m/z 322 (M+H)+. 
 
(2Z)-1-morpholino-1-(pentylimino)-3-phenylpropan-2-one oxime (29). 
Oxime 400 mg (2.36 mmol), isocyanide 230 mg (2.36 
mmol), amine 411 mg (4.72 mmol), DCM dry 4 mL, 
reaction time 2 hours. The crude material was purified by 
column chromatography (eluents: PE/EtOAc 8:2, 7:3, 
5:5, EtOAc) to give the product as amorphous yellowish 
solid (269 mg, yield 36%). 
1H-NMR (300 MHz, DMSO-d6) mixture of geometrical 
isomers, the signals are referred to the main isomer) δ 7.24 (br s, 5H), 3.56 (m, 
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4H), 3.38 (m, 2H), 3,27 (m, 2H), 3.08 (m, 4H, overlapped with DMSO), 1.42 (m, 
2H), 1.25 (m, 4H), 0.87 (m, 3H) ; 13C-NMR (75 MHz, DMSO-d6 mixture of 
geometrical isomers, the signals are referred to the main isomer) δ 161.1, 154.7, 
150.0, 127.5, 125.5, 115.0, 66.6, 55.8, 50.1, 45.4, 31.5, 29.6, 22.4, 14.2 ; IR (KBr) 
2931, 2858, 1636, 1455, 1113, 700 νmax/cm-1; Found: C, 64.95; H, 8.36; N, 12.34; 
C18H27N3O3 requires C, 64.84; H, 8.16; N 12.60 %; MS (ESI) m/z 318 (M+H)+. 
 
(1Z)-1-(4-methoxyphenyl)-2-morpholino-2-(pentylimino)ethanone oxime 
(30).  
Oxime 250 mg (1.35 mmol), isocyanide 131 mg (1.35 
mmol), amine 235 mg (2.70 mmol), DCM dry 3 mL, 
reaction time 12 hours. The crude material was 
purified by column chromatography (eluents: 
PE/EtOAc 8:2, 5:5, EtOAc, EtOAc/MeOH 9:1) to 
give the product as amorphous yellowish solid (216 
mg, yield 48%). 
1H-NMR (300 MHz, DMSO-d6, mixture of 
geometrical isomers,  the signals are referred to the 
main isomer) δ 7.49 (m, 2H, AA′XX′), 6.98 (m, 2H, AA′XX′), 3.80 (s, 3H), 3,53 
(br s, 4H), 3,31 (m, 2H), 3.23-2.90 (m, 4H, overlapped with DMSO), 1.42 (m, 2H), 
1.22 (m, 4H), 0.80 (br t, 3H); 13C-NMR (75 MHz, DMSO-d6 mixture of 
geometrical isomers, the signals are referred to the main isomer) δ 161.1, 154.7, 
150.0, 127.5, 125.5, 115.0, 66.6, 55.8, 50.1, 45.4, 31.5, 29.6, 22.4, 14.2 ; IR (KBr) 
2930, 2855, 2681, 1608, 1511, 1252, 1115, 838 νmax/cm-1; Found: C, 64.95; H, 
8.36; N, 12.34; C18H27N3O3 requires C, 64.84; H, 8.16; N 12.60 %; MS (ESI) m/z 
334 (M+H)+. 
 
(1Z)-2-(benzylimino)-1-(4-methoxyphenyl)-2-morpholinoethanone oxime 
(31).  
Oxime 250 mg (1.35 mmol), isocyanide 158 mg (1.35 
mmol), amine 235 mg (2.70 mmol), DCM dry 3 mL, 
reaction time 12 hours. The crude material was 
purified by column chromatography (eluents: 
PE/EtOAc 8:2, 5:5, EtOAc, EtOAc/MeOH 9:1) and 
crystallized in methanol to give the product as white 
solid (250 mg, yield 53%). 
1H-NMR (300 MHz, DMSO-d6) δ 11.3 ( br s, 1H), 7.53 (d, 2H, J = 8.6 Hz, 
AA′XX′), 7. 23 (d + m, 5H), 6.99 (d, 2H, J = 8.6 Hz, AA′XX′), 4.16 (d, 1H, J = 
15.6 Hz, AB), 4.11 (d, 1H, J = 15.6 Hz, AB), 3.79 (s, 3H), 3.56 (m, 4H), 3.38 (m, 
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2H), 3.30 (m. 2H); 13C-NMR (75 MHz, DMSO-d6) δ 161.2, 155.4, 150.0, 142.6, 
128.3, 127.9, 127.6, 126.4, 125.3, 115,1, 66.8, 55.9, 53.9, 45.4; IR (KBr) 2970, 
2847, 2554, 1591, 1511, 1240, 831 νmax/cm-1; M.P. 199-199.5 °C; Found: C, 68.15; 
H, 6.83; N, 11.74; C20H23N3O3 requires C, 67.97; H, 6.56; N 11.89 %; MS (ESI) 
m/z 354 (M+H)+. 
 
 
(2Z)-N-benzyl-N'-(tert-butyl)-2-(hydroxyimino)-2-(4-methoxyphenyl) 
acetimidamide (32). 
Oxime 250 mg (1.35 mmol), isocyanide 112 mg 
(1.35 mmol), amine 289 mg (2.70 mmol), DCM dry 
3 mL, reaction time 12 hours. The crude material 
was purified by column chromatography (eluents: 
PE/EtOAc 8:2, 5:5, EtOAc, EtOAc/MeOH 9:1) to 
give the product as yellowish solid (177 mg, yield 
39%). 
1H-NMR (300 MHz, DMSO-d6, mixture of 
geometrical isomers,  the signals are referred to the main isomer) δ 7.40 (m, 2H, 
AA′XX′), 7.2-6.9 (m, 5 H), 6.80 (m, 2H, AA′XX′), 3.9 (br s, 2H), 3.6 (s, 3H), 1.28 
(s, 3H); 13C-NMR (75 MHz, DMSO-d6 mixture of geometrical isomers, the signals 
are referred to the main isomer) δ 160.7, 152.3, 150.1, 143.2, 128.1, 127.6 (2C), 
126.5, 126.0, 114.6, 55.7, 54.0, 51.5, 29.8; IR (KBr) 2971, 2633, 1629, 1518, 1252 
νmax/cm-1; M.P. 112-113 °C; Found: C, 70.02; H, 7.65; N, 12.34; C20H25N3O2 
requires C, 70.77; H, 7.42; N 12.38 %; MS (ESI) m/z 340 (M+H)+. 
 
(1Z)-2-(cyclohexylimino)-1-phenyl-2-(pyrrolidin-1-yl)ethanone oxime (33).  
Oxime 250 mg (1.61 mmol), isocyanide 176 mg (1.61 
mmol), amine 229 mg (3.22 mmol), DCM dry 3 mL, 
reaction time 3 hours. The crude material was purified by 
column chromatography (eluents: PE/EtOAc, 5:5, EtOAc, 
EtOAc/MeOH 9:1) and crystallized in methanol to give the 
product as off-white solid (220 mg, yield 46%). 
1H-NMR (300 MHz, DMSO-d6) δ 9.97 (s, 1H), 7.62 (br s, 2H), 7.52 (br s, 3H), 
4.0-3.8 (m, 2H), 3.4-3.2 (m, 2H), 3.0 (overlapped to water, 1H), 2.1-0.8 (m, 10 H); 
13C-NMR (75 MHz, DMSO-d6) δ 155.4, 146.2, 131.6, 130.1, 129.9, 125.7, 57.4, 
50.8, 50.0, 33.2, 32.5, 25.2, 24.9, 24.3; IR (KBr) 3414, 3054, 1652, 1446, 1410, 
1053 νmax/cm-1; M.P. 302-304 °C (dec.); Found: C, 72.45; H, 8.64; N, 13.82; 
C18H25N3O requires C, 72,21; H, 8.42; N 14.03 %; MS (ESI) m/z 300 (M+H)+. 
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(2Z)-N-benzyl-2-(hydroxyimino)-N'-pentyl-2-phenylacetimidamide (34).  
Oxime 250 mg (1.61 mmol), isocyanide 156 mg (1.61 
mmol), amine 345 mg (3.22 mmol), DCM dry 3 mL, 
reaction time 12 hours. The crude material was purified 
by column chromatography (eluents: PE/EtOAc 5:5, 
EtOAc, EtOAc/MeOH 9:1) to give the product as 
amorphous yellowish solid (418 mg, yield 80%). 
1H-NMR (300 MHz, DMSO-d6, mixture of geometrical 
isomers and tautomeric forms, the signals are referred to 
the main isomer) δ 7.80-7.23 (m, 10 H), 6.59 (br s, NH), 
4.03 (br s, 2H), 3.27 (br s, 2H), 1.56 (br s, 2H), 1.24 (br s, 
4H), 0.83 (br s, 3H); 13C-NMR (75 MHz, DMSO-d6 mixture of geometrical 
isomers and tautomeric forms, the signals are referred to the main isomer) δ 156.8, 
147.8, 135,7, 132.0, 130.5, 129.4, 128.9, 128.6, 128.0, 127.8, 49.1, 43.3, 28.9, 
28.8, 22.2, 14.2; IR (KBr) 3010, 2573, 1652, 1455, 1382, 694 νmax/cm-1; Found: 
C, 74.56; H, 8.13; N, 12.65; C20H25N3O requires C, 74.27; H, 7.79; N 12.99 %; 
MS (ESI) m/z 324 (M+H)+. 
 
(1E)-2-(tert-butylimino)-2-(piperidin-1-yl)-1-(thiophen-2-yl)ethanone oxime 
(35). 
Oxime 250 mg (1.55 mmol), isocyanide 129 mg (1.55 mmol), 
amine 264 mg (3.10 mmol), DCM dry 3 mL, reaction time 12 
hours. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 9:1, 5:5, EtOAc, 
EtOAc/MeOH 9:1) and crystallized in methanol to give the 
product as white solid (224 mg, yield 50%). 
1H-NMR (300 MHz, DMSO-d6) δ 7.48 (dd, J = 4.9/1.2 Hz, 1H), 7.04 (m, 2H), 3.3 
(m, 2H), 3.1 (m overlapped with water, 2H), 1.6-1.4 (m, 6H), 1.06 (s, 9H); 13C-
NMR (75 MHz, DMSO-d6) δ 150.3, 147.0, 139.1, 128.4, 127.8 (2C), 53.0, 45.3, 
31.8, 26.1, 25.2; IR (KBr) 2932, 2861, 2662, 1563, 1427, 1197 νmax/cm-1; M.P. 
196-196.5 °C; Found: C, 61.42; H, 7.90; N, 14.46; C15H23N3OS requires C, 61.40; 
H, 7.90; N 14.32 %; MS (ESI) m/z 294 (M+H)+. 
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Single crystal X-ray diffraction  
 
Prismatic crystals of 24, obtained from methanol, were used for data collection 
on an Enraf Nonius CAD-4 diffractometer with graphite monochromated Mo-
Kα radiation. The lattice parameters were determined and refined by least squares 
fit of 25 high angle reflections. The structure was solved by direct methods22 and 
refined by full matrix least-squares on F2.23 All the non-hydrogen atoms were 
refined anisotropically. The H-atoms positions, were introduced in calculated 
positions in their described geometries and allowed to ride on the attached carbon 
atom with fixed isotropic thermal parameters (1.2 Ueq or 1.5 Ueq of the parent 
carbon atom). All non-H-atoms were refined anisotropically. For the morpholine 
ring, two set of positions were defined for C14 and C16 atoms, and their site-
occupation factors were refined as 0.75(1) for major orientation.  
 
A summary of the crystal data and structure refinement is presented in Table 1.  
CCDC number 963850 for 24 (excluding structure factors) contains the 
supplementary crystallographic data for this paper. These data can be obtained free 
of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
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formula C17H25N3O2 
FW (g mol-1) 303.4 
T (K) 293(2) 
λ (Å)  0.71073 
Crystal system monoclinic 
Space group P 21/a 
a (Å) 11.620(8) 
b (Å) 8.989(8) 
c (Å) 15.810(8) 
β (°) 93.74(1) 
V(Å3) 1640(2) 
Z 4 
ρ(calc) (Mg m-3) 1.229 
 F(000) 656 
Sample Size (mm3) 0.6×0.13×0.08 
θ range (°) 2.59 – 25.04 
Limiting indices 
-13≤ h≤ 13, -1≤ k ≤10, -1≤ l ≤18 
Reflections collected / unique 3670 / 2893 
Completeness to θ 99.6% 
Data, restrains, parameters 2893, 0, 230 
Refinement method Full-matrix least-squares on F2 
Goodness-of-fit on F2 0.988 
R(F), wR(F2) for I > 2σ(I)R(F)  0.078, 0.1916 
Largest diff. peak and hole (e 
Å-3) 
0.311, -0.326 
 
Table 1. Summary of crystal data and structure refinement for 24 
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Chapter 5 
Reaction between 
Z‑arylchlorooximes 
and 
α‑isocyanoacetamides: 
a procedure for the 
synthesis of aryl-α-
ketoamide amides
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5.1 Results and discussion 
 
As demonstrated in Chapter 3 and 4, nitrile N-oxide species (generated via base 
dehydrochlorination of Z-chlorooximes 1 – Huisgen’s in situ method)1 are able to 
react in a stereospecific way with isocyanides 3 under mild reaction conditions 
(TEA, room temperature, dichloromethane) to give a nitrilium ion 4, which can be 
further intercepted by a third nucleophiles (Scheme 1).2,3  
Cl
N OH
N O R NC
R1 R1
N OH
R1
N R
N OH
R1
N
Nu
R
base
Nu
1
5
4
2
3
 
Scheme 1. Proposed scheme for the formation of novel MCRs via 
nitrile-N-oxide species. 
It was therefore reasonable to think that an isocyanide containing an internal 
nucleophile could intramolecularly intercept the nitrilium ion species generating a 
novel molecular framework (Figure 1).  
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Figure 1. Intramolecularly trapping of the nascent nitrilum ion. 
Inspired by pioneering works by Zhu, who demonstrated that α-
isocyanoacetamides 9, when involved in a three component reaction, along with 
aldehydes 7 and primary or secondary amines 8, are able to afford 5-aminooxazoles 
10 through interception of the nitrilium ion by the oxygen atom of the amide,4 we 
reasoned that α-isocyanoacetamides could in principle react with the nitrile-N-
oxides and then intermolecularly intercept the nascent nitrilium species (Scheme 
2).  
 
Scheme 2. Comparison between Zhu’s work and the reaction described in 
this chapter. 
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As starting point for our study, we chose the reaction between 
phenylchlooroxime 12 and the 4-(isocyanoacetyl)morpholine 13. The reaction was 
carried out without TEA and with 1 equivalent of TEA in dichloromethane at room 
temperature. With our delight the reaction with 1 equivalent of TEA was completed 
after 2 h giving the desired compound 14 in 74% yield after column 
chromatography (Scheme 3).  
 
Scheme 3. Reaction between Z-phenylchlorooxime and 4-
(isocyanoacetyl)morpholine. 
Not surprisingly, when the reaction was carried out without TEA, we did not 
notice the formation of the desired product 14 and the Z-phenylchlorooxime 12 was 
recovered after column chromatography.  
Using these already optimized reaction conditions (1 eq. of TEA, rt, DCM), the 
scope and limitations of this novel reaction were explored. Z-Phenylchloroxime 
(12) or Z-phenylchloroximes bearing electron-withdrawing (15, 19, 20, 21, 22) or 
electron-donating (methyl- or methoxy-, 16 and 17, respectively) substituents on 
the para position were chosen, as well as one Z-heteroarylchloroxime with a 
thiophene ring (18). α-isocyanoacetamides (13, 23-30) exhibit two points of 
diversity: the amide function derived from cyclic secondary amines (as for 13, 23-
25, 29, 30) or noncyclic secondary amine (as 28) and the α-substitution (methyl- or 
benzyl, 23 and 24, 25, respectively) (Figure 2). 
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Figure 2. Structure of Z-chlorooximes and α-isocyanoacetamides used. 
Arylchlorooximes were prepared by chlorination of the corresponding oximes 
with N-chlorosuccinimide,5 while α-isocyanoacetamides were easily accessible by 
amidation of the corresponding α-isocyanomethylester using the Dömling 
procedure,6 while for the α-substituted α-isocyanoacetamides the alkylation was 
carried out in the presence of cesium hydroxide.7 
The reaction appeared to be quite general, not depending on electronic factors, 
as Z-arylchloroximes bearing both electronwithdrawing and electron-donating 
substituents reacted smoothly with the different isocyanoacetamides giving the 
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desired 1,3-oxazol-2-oxime derivatives (31-47) in good yields (ranging from 32% 
to 88%) (Figure 3). 
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 Figure 3. Synthesized 1,3-oxazol-2-oxime derivatives. 
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Figure 3. Synthesized 1,3-oxazol-2-oxime derivatives (Continued). 
When isocyanoacetamide 29 was used, TEA was not necessary, as the basic 
nitrogen of piperazine was able to trigger the formation of the nitrile N-oxide 
species. The reaction failed when a secondary amide was present in the 
isocyanoacetamides (26 and 27); anyway this behavior is not surprisingly as it was 
already shown by Zhu.4,8 
1,3-Oxazol-2-oxime revealed to be unstable molecules with isomerization of the 
oxime, especially when the oxazole ring was substituted at the 4-position, and 
formation of decomposition products. Although we have fully characterized them, 
they cannot be stored for long time (even at 0 °C) but they have to be immediately 
used. 
At the beginning, we attempted a one-pot procedure for the conversion of 1,3-
oxazol-2-oximes into aryl-α-ketoamides. 
Hydrolysis of these intermediates in the presence of HCl, at room temperature, 
afforded the oxime−dipeptide analogue 48, favoring, at the same time, the partial 
isomerization of the oxime. When the reaction was heated, we did observe the 
hydrolysis of the oxime and also the formation of several byproducts, which 
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decrease the yield and make difficult the chromatographic purification. For these 
reasons, we opted to use milder catalysts as a Lewis acid, and we identified the 
copper(II) chloride9 as the reagent of choice. After the aminooxazole ring was 
opened with HCl, the deoximation reaction in the presence of copper(II) chloride 
was carried out. Both reactions proceeded well and only a purification step was 
required (Scheme 4).  
 
Scheme 4. Acid hydrolysis and deoximation of 1,3-oxazol-2-oximino derivatives. 
 
By using this protocol, we prepared different aryl-α-ketoamide amides (50-66) 
in good yields (Figure 4). 
 
Figure 4. Synthesized aryl-α-ketoamides. 
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Figure 4. Synthesized aryl-α-ketoamides (Continued). 
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5.2 Conclusions 
 
In conclusion a general and straightforward methodology to structurally diverse 
aryl α-ketoamide amides has been demonstrated. These latter are privileged 
scaffolds in medicinal chemistry due to their ability to act as inhibitors reacting 
with the key cysteine or lysine residues in protease,10,11 lipase12 and histone 
deacetylase13 or as useful intermediates for a variety of transformations in organic 
chemistry. 
It is important to highlight that the entire sequence of reactions is realized under 
mild reaction conditions avoiding the use of expensive coupling agents and using 
simple and easily available starting materials (Z-arylchlorooximes and α-
isocyanoacetamides).  
This method is complementary to those previously reported for the synthesis of 
alkyl α-ketoamide amides. Indeed, Mossetti et al.14 reported the reaction between 
acyl chlorides and α-isocyanoacetamides to form α-ketoamides via ketene 
intermediate. This reaction is characterized by the lack of reactivity of aroyl 
chlorides due to the concomitant reduced nucleophilicity of the isocyano group and 
the reduced electrophilicity of the aroyl chloride. Any attempts to react, in a 
productive way, an aroyl chloride with an α-isocyanoacetamides failed, and this 
gap is now filled by the reaction between aryl-chlorooximes and α-
isocyanoacetamides. 
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5.3 Experimental section 
 
General Methods. Commercially available reagents and solvents were used 
without further purification. Dichloromethane was dried by distillation from P2O5 
and stored over activated molecular sieves (4 Å). When necessary, the reactions 
were performed in oven-dried glassware under a positive pressure of dry nitrogen. 
Melting points were determined in open glass capillaries and are uncorrected. All 
the compounds were characterized by IR. 1H and 13C APT NMR were recorded on 
a 300 MHz. Mass spectrometry was equipped with an ESI source and an ion-trap 
detector. HRMS were recorded on ORBITRAP mass spectrometer equipped with 
an ESI source. Chemical shifts (δ) are reported in parts per million (ppm) relative 
to the residual solvent peak. Column chromatography was performed on silica gel 
(70−230 mesh ASTM) using the reported eluents. Thin-layer chromatography 
(TLC) was carried out on 5 × 20 cm plates with a layer thickness of 0.25 mm 
(silica gel 60 F254). When necessary, they were developed with KMnO4. Elemental 
analysis (C, H, N) of all of the new compounds were within ±0.4% of the 
calculated values. Chloroximes 12 and 15-22 are not new, and they were prepared 
following literature procedure.5 Isocyanoacetamides 13 and 23-25 were prepared 
following Dömling’s procedure,6 while isocyanoacetammides 26-29 were prepared 
following Zhu’s procedure.7 
Synthesis of 4-Benzyl-1-(isocyanoacetyl)piperidine (30).  
Methyl isocyanoacetate (1 eq.) was reacted with 4-
benzylpiperidine (1 eq.) overnight under neat 
conditions. The solution was evaporated and the crude 
was purified by column chromatography Ex/EtOAc 
7:3 to give 37 as amorphous solid (yield 75%): 1H 
NMR (400 MHz, CDCl3) δ 7.26.7.09 (m, 5H), 4.45 (br d, 1H), 4.24 (br d, 2H), 3.45 
(br d, 1H), 2.93 (br t, 1H), 2.51.2.49 (m, 3H), 1.73.1.64 (m, 3H), 1.17.1.10 (m, 2H); 
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13C NMR (75 MHz, CDCl3) δ 160.7, 160.4, 139.7, 129.1, 128.3, 126.1, 45.6, 44.6, 
42.8, 42.6, 37.7, 32.0, 31.3; HRMS (ESI) m/z (M + H)+ calcd for C15H18N2O 
242.1419, found 242.1422. 
 
General Preparation of 1,3-Oxazol-2-oximes (14, 31-49). 
The chlorooxime (1 eq.) was dissolved in dry dichloromethane, and α-
isocyanoacetamide (1 eq.) was added dropwise or portionwise at room temperature. 
Finally, TEA (1 eq.) was added dropwise (the reaction is slightly exothermic and 
on a large scale the addition should be done at 0 °C), and the reaction was stirred at 
room temperature under a nitrogen atmosphere until all the chlorooxime was 
consumed (typically 2−3 h as judged by TLC). The reaction mixture was 
concentrated under reduced pressure, and the crude material was purified by 
column chromatography. 
 
(Z)-(5-Morpholinooxazol-2-yl)phenylmethanone Oxime (14). 
Starting material: chlorooxime 150 mg (0.96 mmol), 
isocyanoacetamide 148 mg (0.96 mmol). The crude 
material was purified by column chromatography 
(PE/EtOAc 7:3) to give 195 mg of product as yellow 
solid (yield 74%). 1H NMR (300 MHz, CDCl3) δH 
7.66−7.62 (m, 2H), 7.44−7.40 (m, 3H), 6.26 (br s, 1H), 3.78 (br t, 4H), 3.16 (br t, 
4H); 13C NMR (75 MHz, CDCl3) δC 156.2, 146.9, 141.9, 133.0, 129.5, 128.4 (2C), 
101.5, 65.8, 47.3; HRMS (ESI) m/z: (M+Na)+ Calcd for C14H15N3NaO3 296.1011, 
found 296.1012. 
 
(Z)-(4-chlorophenyl)(5-morpholinooxazol-2-yl)methanone oxime (31).  
Starting material: chlorooxime 150 mg (0.79 
mmol), isocyanoacetamide 122 mg (0.79 mmol). 
The crude material was purified by column 
chromatography (PE/EtOAc 6:4) to give 187 mg of 
product as yellow solid (yield 78%). 1H-NMR (300 
MHz, CDCl3) δH 7.60-7.56 (m, 2 H, AA′XX′), 7.44-7.36 (m, 2 H, AA′XX′), 6.26 
(br s, 1H), 3.80-3.77 (m, 4H), 3.18-3.15 (m, 4H); 13C-NMR (75 MHz, CDCl3) δC 
156.2, 146.5, 141.0, 135.6, 131.5, 129.7, 128.7, 101.6, 65.7, 47.2; HMRS (ESI) 
m/z: (M+H)+ Calcd for C14H14ClN3O3 307.0724; Found 307.0727.  
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(Z)-(4-methyl-5-(pyrrolidin-1-yl)oxazol-2yl)(phenyl)methanone oxime (32).  
Starting material: chlorooxime 150 mg (0.96 mmol), 
isocyanoacetamide 147 mg (0.96 mmol). The crude 
material was purified by column chromatography 
(PE/EtOAc 7:3) to give 180 mg of product as yellow solid 
(yield 69%). 1H-NMR (300 MHz, CDCl3) δH 7.69-7.66 
(m, 2H), 7.40-7.38 (m, 3H), 3.42-3.38 (m, 4H), 2.27 (s, 
3H), 1.95-1.91 (m, 4H);13C-NMR (75 MHz, CDCl3) δC 150.2, 143.9, 141.4, 133.3, 
129.2, 128.4, 128.3, 108.4, 48.8, 25.4, 11.7; HMRS (ESI) m/z: (M+H)+ Calcd for 
C15H17N3O2 271.1321; Found 271.1321.  
 
(Z)-(4-chlorophenyl)(4-methyl-5-(pyrrolidin-1-yl)oxazol-2-yl)methanone oxime 
(33). 
Starting material: chlorooxime 150 mg (0.79 mmol), 
isocyanoacetamide 120 mg (0.79 mmol). The crude 
material was purified by column chromatography 
(PE/EtOAc 6:4) to give 190 mg of product as orange 
solid (yield 79%). 1H-NMR (300 MHz, CDCl3) δH 
7.65-7.62 (m, 2H, AA′XX′), 7.40-7.37 (m, 2H, 
AA′XX′), 3.45-3.43 (m, 4H), 2.29 (s, 3H), 1.98-1.92 (m, 4H); 13C-NMR (75 MHz, 
CDCl3) δC 150.3, 143.7, 140.5, 135.3, 131.9, 129.8, 128.6, 108.5, 48.9, 25.5, 11.7; 
HMRS (ESI) m/z: (M+H)+ Calcd for C15H16ClN3O2  305.0931; Found 305.0933.  
 
(Z)-(4-methoxyphenyl)(5-morpholinooxazol-2-yl)methanone oxime (34).  
Starting material: chlorooxime 150 mg (0.81 
mmol), isocyanoacetamide 125 mg (0.81 mmol). 
The crude material was purified by column 
chromatography (PE/EtOAc 5:5) to give 196 mg 
of product as yellow solid (yield 80%). 1H-NMR 
(300 MHz, CDCl3) δH 7.60-7.56 (m, 2H, 
AA′XX′), 6.97-6.91 (m, 2H, AA′XX′), 6.25 (br s, 1H), 3.81-3.78 (m, 7H), 3.17-
3.15 (m, 4H); 13C-NMR (75 MHz, CDCl3) δC 160.6, 156.1, 147.1, 141.5, 129.7, 
125.5, 113.8, 101.5, 65.8, 55.4, 47.3; HMRS (ESI) m/z: (M+Na)+ Calcd for 
C15H17N3NaO4  326.1117; Found 326.1120. 
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(E)-(5-morpholinooxazol-2-yl)(thiophen-2-yl)methanone oxime (35).  
Starting material: chlorooxime 150 mg (0.93 mmol), 
isocyanoacetamide 143 mg (0.93 mmol). The crude 
material was purified by column chromatography 
(PE/EtOAc 6:4) to give 108 mg of product as brown 
solid (yield 42%). 1H-NMR (300 MHz, CDCl3) δH 
7.60-7.58 (m, 1H), 7.36-7.34 (m, 1H), 7.10-7.06 (m, 1H), 6.26 (br s, 1H), 3.87-3.83 
(m, 4H), 3.28-3.26 (m, 4H); 13C-NMR (75 MHz, CDCl3) δC 156.2, 146.1, 137.1, 
135.6, 127.6, 127.3, 127.2, 101.4, 65.8, 47.3; (M+H)+ Calcd for C12H13N3O3S  
279.0678; Found 279.0677. 
 
(Z)-(4-benzyl-5-morpholinooxazol-2-yl)(phenyl)methanone oxime (36).  
Starting material: chlorooxime 150 mg (0.96 mmol), 
isocyanoacetamide 236 mg (0.96 mmol). The crude 
material was purified by column chromatography 
(PE/EtOAc 7:3) to give 169 mg of product as yellow 
oil (yield 55%). Mixture of E/Z isomers, signals are 
referred to the main isomer: 1H-NMR (300 MHz, 
CDCl3) δH 7.69-7.66 (m, 2H), 7.45-7.39 (m, 3H), 7.35-
7.21 (m, 5H), 3.94 (s, 2H), 3.75-3.71 (m, 4H), 3.10-
3.06 (m, 4H); 13C-NMR (75 MHz, CDCl3) δC 151.2, 
148.3, 141.9, 138.3, 132.8, 129.5, 128.7, 128.4, 128.3, 128.0, 126.7, 121.4, 66.5, 
49.9, 31.80; (M+H)+ Calcd for C21H21N3O3  363.1583; Found 363.1583. 
 
(Z)-(4-benzyl-5-morpholinooxazol-2-yl)(4-chlorophenyl)methanone oxime (37).  
Starting material: chlorooxime 150 mg (0.79 
mmol), isocyanoacetamide 193 mg (0.79 mmol). 
The crude material was purified by column 
chromatography (PE/EtOAc 7:3) to give 200 mg of 
product as white solid (yield 64%). Mixture of E/Z 
isomers, signals are referred to the main isomer: 1H-
NMR (300 MHz, CDCl3) δH 7.65-7.58 (m, 2H), 
7.43-7.36 (m, 2H), 7.32-7.18 (m, 5H), 3.96 (s, 2H), 
3.75-3.67 (m, 4H), 3.09-3.06 (m, 4H); 13C-NMR 
(75 MHz, CDCl3) δC 151.3, 147.7, 141.2, 138.3, 135.5, 131.4, 129.6, 128.8, 
128.59, 128.32, 126.65, 121.3, 66.6, 49.8, 31.81; (M+H)+ Calcd for C21H20ClN3O3  
397.1193; Found 397.1197. 
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(Z)-(5-(benzyl(methyl)amino)oxazol-2-yl)(4-methoxyphenyl)methanone oxime 
(38).  
Starting material: chlorooxime 150 mg (0.81 mmol), 
isocyanoacetamide 152 mg (0.81 mmol). The crude 
material was purified by column chromatography 
(PE/EtOAc 7:3) to give 210 mg product as yellow 
solid (yield 77%). 1H-NMR (300 MHz, CDCl3) δH 
7.61-7.56 (m, 2H, AA′XX′), 7.37-7.27 (m, 3H), 7.25-
7.19 (m, 2H), 6.94-6.90 (m, 2H, AA′XX′), 6.15 (br s, 
1H), 4.37 (s, 2H), 3.85 (s, 3H); 13C-NMR (75 MHz, 
CDCl3) δC 160.5, 156.1, 145.8, 141.3, 136.1, 129.7, 128.8, 127.9, 127.7, 125.6, 
113.7, 55.5, 55.3, 36.6; (M+H)+ Calcd for C19H19N3O3  337.1426; Found 337.1426. 
 
(Z)-(5-(4-methylpiperazin-1-yl)oxazol-2-yl)(p-tolyl)methanone oxime (39).  
Starting materials: chlorooxime 150 mg (0.88 
mmol), isocyanoacetamide 147 mg (0.88 
mmol). The crude material was purified by 
column chromatography (DCM/MeOH 95:5) 
to give 232 mg product as yellow solid (88% 
yield ). 1H-NMR (400 MHz, CDCl3) δH 7.56 
(d, J = 7.8 Hz, 2H), 7.23 (m, 2H) partially overlapped to the solvent, 6.23 (s, 1H), 
3.22 (br t, 4H), 2.50 (br t, 4H), 2.39 (s, 3H), 2.33 (s, 3H); 13C-NMR (100 MHz, 
CDCl3) δC 156.2, 146.7, 142.0, 139.3, 130.4, 128.9, 128.1, 101.4, 53.6, 46.9, 46.0, 
21.3; (M+H)+ Calcd for C16H20N4O2  300.1586; Found 300.1590.  
 
(Z)-(4-chlorophenyl)-(5-(4-methylpiperazin-1-yl)oxazol-2-yl)methanone oxime 
(40).  
Starting materials: chlorooxime 150 mg (0.79 
mmol), isocyanoacetamide 132 mg (0.79 
mmol). The crude material was purified by 
column chromatography (DCM/MeOH 97:3) to 
give the product as yellow solid (195 mg, 77% 
yield ). 1H-NMR (400 MHz, CDCl3) δH 7.57-7.55 (m, 2H, AA′XX′), 7.36-7.34 (m, 
2H, AA′XX′), 6.23 (s, 1H), 3.23 (br t, 4H), 2.52 (br t, 4H), 2.33 (s, 3H); 13C-NMR 
(100 MHz, CDCl3) δC 156.3, 146.2, 141.2, 135.3, 131.9, 129.5, 128.5, 101.7, 53.6, 
46.9, 46.0; (M+H)+ Calcd for C15H17ClN4O2  320.1040; Found 320.1042.  
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(Z)-(5-morpholinooxazol-2-yl)(p-tolyl)methanone oxime (41).  
Starting materials: chlorooxime 150 mg (0.88 
mmol), isocyanoacetamide 136 mg (0.88 mmol). 
The crude material was purified by column 
chromatography (n-hexane/AcOEt 7:3) to give the 
product as yellow solid (197 mg, 78% yield ). 1H 
NMR (400 MHz, CDCl3) δH 7.54 (m, 2H, AA′XX′), 7.23 (m, 2H, AA′XX′), 6.26 
(s, 1H), 3.80 (m, 4H), 3.17 (m, 4H), 2.39 (s, 3H); 13C NMR (100 MHz, CDCl3) δC 
156.0, 147.0, 141.7, 139.4, 130.0, 129.0, 128.2, 101.3, 65.7, 47.2, 21.3; (M+H)+ 
Calcd for C15H17N3O3  287.1270; Found 287.1268.  
 
(4-benzyl-5-(pyrrolidin-1-yl)oxazol-2-yl)(p-tolyl)methanone oxime (42).  
Starting materials: chlorooxime 150 mg (0.88 
mmol), isocyanoacetamide 202 mg (0.88 mmol). The 
crude material was purified by column 
chromatography (n-hexane/AcOEt 7:3) to give the 
product as yellow solid (168 mg, 53% yield). 
Mixture of E/Z isomers, signals are referred to the 
main isomer: 1H NMR (400 MHz, CDCl3) δH 7.61 
(m, 2H, AA’XX’), 7.31-7.22 (m, 7H) partially 
overlapped to the solvent, 3.99 (s, 2H), 3.42 (br t, 4H), 2.40 (s, 3H), 1.93 (br t, 4H); 
13C NMR (100 MHz, CDCl3) δC 150.3, 144.3, 141.3, 140.0, 139.1, 130.3, 128.9, 
128.6, 128.2, 128.1, 126.3, 110.7, 48.8, 31.8, 25.3, 21.3; (M+H)+ Calcd for 
C22H23N3O2  361.1790; Found 361.1793.  
 
(Z)-(4-benzyl-5-(pyrrolidin-1-yl)oxazol-2-yl)(phenyl)methanone oxime (43).  
Starting materials: chlorooxime 150 mg (0.96 mmol), 
isocyanoacetamide 219 mg (0.96 mmol). The crude 
material was purified by column chromatography (n-
hexane/AcOEt 7:3) to give the product as yellow solid 
(233 mg, 70% yield). Mixture of E/Z isomers, signals are 
referred to the main isomer: 1H NMR (400 MHz, CDCl3) 
δH 7.71 (br d, 2H), 7.63-7.57 (m, 1H), 7.43-7.41 (m, 3H), 
7.33-7.20 (m, 4H) partially overlapped to the solvent, 
4.00 (s, 2H), 3.41 (br t, 4H), 1.92 (br t, 4H); 13C NMR 
(100 MHz, CDCl3) δC 150.3, 144.1, 141.4, 140.0, 133.2, 129.1, 128.6, 128.3, 
128.2, 128.1, 126.3, 110.7, 48.7, 31.8, 25.3; (M+H)+ Calcd for C21H21N3O2  
347.1634; Found 347.1637.  
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(Z)-(5-(4-benzylpiperidin-1-yl)oxazol-2-yl)(4-nitrophenyl)methanone oxime 
(44).  
Starting materials: chlorooxime 150 mg 
(0.75 mmol), isocyanoacetamide 182 mg 
(0.75 mmol). The crude material was 
purified by column chromatography (n-
hexane/AcOEt 9:1) to give the product as 
bright-yellow solid (97 mg, 32% yield). 
1H NMR (400 MHz, CDCl3) δH 8.28 (d, J = 8.7 Hz, 2H), 7.89 (d, J = 8.6 Hz,  2H), 
7.29-7.12 (m, 6H), 6.23 (s, 1H), 3.54 (br d, 2H), 2.83 (br t, 2H), 2.58 (br d, 2H), 
1.77-1.73 (m, 3H), 1.39-1.33 (m, 2H); 13C NMR (100 MHz, CDCl3) δC 156.5, 
148.2, 145.2, 139.9, 139.5, 139.2, 129.1, 129.0, 128.3, 126.1, 123.5, 100.7, 47.5, 
42.8, 37.3, 30.7 ; (M+H)+ Calcd for C22H22N4O4  406.1641; Found 406.1646. 
 
(Z)-(5-(4-benzylpiperidin-1-yl)oxazol-2-yl)(naphthalen-2-yl)methanone oxime 
(45).  
Starting materials: chlorooxime 150 mg (0.73 
mmol), isocyanoacetamide 178 mg (0.73 
mmol). The crude material was purified by 
column chromatography (n-hexane/AcOEt 
9:1) to give the product as yellow solid (177 
mg, 59% yield). 1H NMR (400 MHz, CDCl3) 
δH 8.18 (s, 1H), 7.89-7.85 ( m, 3H), 7.79 (br 
d, 1H), 7.52-7.50 (m, 2H), 7.30-7.25 (m, 3H), 7.21 (br d, 1H), 7.13 (br d, 2H), 6.23 
(s, 1H), 3.54 (br d, 2H), 2.79 (br t, 2H), 2.56 (br d, 2H), 1.72-1.70 (m, 3H), 1.38-
1.29 (m, 2H); 13C NMR (100 MHz, CDCl3) δC 156.5, 146.2, 141.7, 139.7, 133.6, 
133.0, 130.5, 129.1, 128.5, 128.3, 128.2, 127.9, 127.6, 126.8, 126.4, 126.1, 125.6, 
100.6, 47.5, 42.8, 37.3, 30.7; (M+H)+ Calcd for C26H25N3O2  411.1947; found 
411.1950. 
 
(Z)-[1,1'-biphenyl]-4-yl(5-(4-benzylpiperidin-1-yl)oxazol-2-yl)methanone 
oxime (46).  
Starting materials: chlorooxime 150 
mg (0.65 mmol), isocyanoacetamide 
158 mg (0.73 mmol). The crude 
material was purified by column 
chromatography (n-hexane/AcOEt 9:1) 
to give the product as yellowish solid 
(142 mg, 50% yield). 1H NMR (400 
MHz, CDCl3) δH 7.76 (br d, 2H), 7.67-7.63 ( m, 4H), 7.47-7.44 (m, 3H), 7.38 (br d, 
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1H), 7.31-7.27 (m, 2H), 7.22 (br d, 1H), 7.14 (br d, 2H), 6.22 (s, 1H), 3.56 (br d, 
2H), 2.81 (br t, 2H), 2.58 (br d, 2H), 1.75-1.72 (m, 3H), 1.41-1.32 (m, 2H); 13C 
NMR (100 MHz, CDCl3) δC 156.5, 146.2, 142.0, 141.4, 140.3, 139.7, 132.0, 129.1, 
128.8, 128.7, 128.3, 127.6, 127.1, 127.0, 126.1, 100.6, 47.6, 42.9, 37.4, 30.7; 
(M+H)+ Calcd for C26H25N3O2  411.1947; found 411.1948. 
 
(Z)-(5-(benzyl(methyl)amino)oxazol-2-yl)(4-fluorophenyl)methanone oxime 
(47).  
Starting material: chlorooxime 150 mg (0.87 
mmol), isocyanoacetamide 163 mg (0.81 mmol). 
The crude material was purified by column 
chromatography (PE/EtOAc 7:3) to give 198 mg 
product as yellow solid (yield 70%). Mixture of 
E/Z isomers, signals are referred to the main isomer: 1H-NMR (300 MHz, CDCl3) 
δH 7.65-7.53 (m, 3H), 7.37-7.19 (m, 3H), 7.10-7.02 (m, 3H), 6.18 (br s, 1H), 4.38 
(s, 2H), 2.90 (s, 3H); 13C-NMR (75 MHz, CDCl3) δC 164.9, 161.7, 156.2, 140.8, 
136.0, 131.8, 130.3, 128.7, 128.6, 127.8, 115.4, 99.5, 55.3, 36.6; (M+H)+ Calcd for 
C18H16FN3O2 325.1227; found 325.1229. 
 
General preparation of aryl-α-ketoamide amides (49-66) 
The 1,3-oxazol-2-oxime was dissolved in THF (0.8 M), concentrated HCl (1 eq.; 
2 eq. for oxazoles 39 and 40) was added and the reaction was stirred at room 
temperature for 30 minutes. The reaction mixture was diluted with water and 
extracted with EtOAc (x 3). The organic phase was washed with NaHCO3 std. sln. 
(x1) and brine (x1), dried over sodium sulfate, filtered, and concentrated under 
reduced pressure. The crude was dissolved in acetonitrile (0.25 M), water (55 eq) 
and copper (II) chloride (2 eq) were added. The solution was stirred for 1 hour at 
75 °C. The reaction mixture was diluted with water and extracted with EtOAc (x2). 
The organic phase was washed with brine (x1), dried over sodium sulfate, filtered, 
and concentrated under reduced pressure and the crude material was purified by 
column chromatography.  
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2-(4-chlorophenyl)-N-(2-morpholino-2-oxoethyl)-2-oxoacetamide (49).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.49 
mmol). The crude material was purified by column 
chromatography (PE/EtOAc 2:8) to give 100 mg of 
product as white solid (yield 66%). 1H-NMR (300 MHz, 
CDCl3) δH 8.21-8.18 (m, 2H, AA′XX′), 8.03 (br s, NH), 
7.41-7.38 (m, 2H, AA′XX′), 4.12 (d, J = 4.6 Hz, 2H), 3.65-
3.59 (m, 6H), 3.44.3.41 (m, 2H); 13C-NMR (75 MHz, 
CDCl3) δC 185.8, 165.8, 161.9, 141.1, 132.4, 131.6, 128.9, 
66.6, 66.3, 44.9, 42.4, 40.9; m/z 311 (M+H)+; IR νmax/cm-1 (KBr) 3239, 3096, 1670, 
1652, 1533, 1465, 1246, 855 ; mp 122-123 °C. Anal. Calcd for C14H15ClN2O4: C, 
54.12; H, 4.87; N, 9.02. Found: C, 53.95; H, 4.80; N, 9.31.  
 
N-(2-morpholino-2-oxoethyl)-2-oxo-2-phenylacetamide (50).  
Starting materials: 1,3-oxazol-2-oxime 150 mg (0.55 mmol). The crude 
material was purified by column chromatography (n-hexane/EtOAc 
5:5) to give the product as yellowish solid (103 mg, 68% yield). 1H 
NMR (400 MHz, CDCl3) δH 8.28 (br d, 2H), 7.93 (br s, NH), 7.62 (br 
t, 1H), 7.47 (br t, 2H), 4.18 (d, J = 4.0 Hz, 2H), 3.72-3.66 (m, 6H), 
3.47-3.45 (m, 2H); 13C NMR (100 MHz, CDCl3) δC 187.1, 165.8, 
162.2, 134.4, 133.1, 130.9, 128.5, 66.6, 66.3, 44.9, 42.3, 40.8; m/z 277 
(M+H)+; IR νmax/cm-1 (KBr) 3380, 1687, 1667, 1642, 1505, 1474, 
1275, 745; mp 164-165 °C. Anal. Calcd for C14H16N2O4: C, 60.86; H, 
5.84; N, 10.14. Found: C, 60.95; H, 5.97; N, 10.01.  
 
 
N-(1-morpholino-1-oxopropan-2-yl)-2-oxo-2-phenylacetamide (51).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.55 mmol). The crude 
material was purified by column chromatography (PE/EtOAc 3:7) to 
give 92 mg of product as yellow oil (yield 60%). Mixture of rotamers, 
signals are referred to the main rotamer:1H-NMR (300 MHz, CDCl3) 
δH 8.20-8.17 (m, 2H), 8.03 (br d, NH), 7.56-7.38 (m, 3H), 4.80-4.72 
(m, 1H), 3.64-3.35 (m, 4H), 1.98-1.78 (m, 4H), 1.39 (d, J = 6.9 Hz, 
3H); 13C-NMR (75 MHz, CDCl3) δC 187.5, 169.9, 161.6, 134.2, 
133.23, 130.9, 128.4, 46.9, 46.4, 46.2, 26.0, 24.1, 17.9; m/z 275 
(M+H)+; IR νmax/cm-1 (KBr) 3253, 3062, 1638, 1667, 1510, 1449, 
1264, 715. Anal. Calcd for C15H18N2O3: C, 65.68; H, 6.61; N, 10.21. Found: C, 
65.66; H, 6.65; N, 10.25. 
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2-(4-chlorophenyl)-N-(1-morpholino-1-oxopropan-2-yl)-2-oxoacetamide (52).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.49 mmol). The 
crude material was purified by column chromatography (PE/EtOAc 
4:6) to give 80 mg of product as colorless oil (yield 53%). 1H-NMR 
(300 MHz, CDCl3) δH 8.25-8.23 (m, 2H, AA′XX′), 7.97 (br d, NH), 
7.43-7.40 (m, 2H, AA′XX′), 4.77-4.72 (m, 1H), 3.66-3.39 (m, 4H), 
2.03-1.83 (m, 4H), 1.42 (d, J = 7.0 Hz, 3H);13C-NMR (75 MHz, 
CDCl3) δC 186.1, 169.9, 161.0, 141.1, 132.6, 131.8, 129.0, 47.1, 46.5, 
46.3, 26.2, 24.2, 18.1; m/z 309 (M+H)+; IR νmax/cm-1 (KBr) 3239, 
3062, 1670, 1668, 1586, 1455, 856. Anal. Calcd for C15H17ClN2O3: 
C, 58.35; H, 5.55; N, 9.07. Found: C, 58.23; H, 5.21; N, 9.2. 
 
2-(4-methoxyphenyl)-N-(2-morpholino-2-oxoethyl)-2-oxoacetamide (53).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.49 mmol). The 
crude material was purified by column chromatography (PE/EtOAc 
2:8) to give 70 mg of product as white solid (yield 46%). 1H-NMR 
(300 MHz, CDCl3) δH 8.33-8.8.30 (m, 2H, AA′XX′), 7.97 (br s, 
NH), 6.94-6.91 (m, 2H, AA′XX′), 4.16 (br d, 2H), 3.87 (s, 3H), 
3.71-3.65 (m, 6H), 3.46-43 (m, 2H);13C-NMR (75 MHz, CDCl3) δC 
185.3, 165.9, 164.8, 162.8, 133.8, 126.3, 114.0, 66.8, 66.4, 55.7, 
45.0, 42.4, 41.0; m/z 307 (M+H)+; IR νmax/cm-1 (KBr) 3349, 3078, 
1682, 1647, 1594, 1474, 1257, 861; mp 169-169.5 °C. Anal. Calcd 
for C15H18N2O5: C, 58.82; H, 5.92; N, 9.15. Found: 58.93; H, 6.24; 
N, 9.36. 
 
N-(2-morpholino-2-oxoethyl)-2-oxo-2-(thiophen-2-yl)acetamide (54).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.54 mmol). The crude 
material was purified by column chromatography (PE/EtOAc 2:8) to 
give 85 mg of product as white solid (yield 56%). 1H-NMR (300 MHz, 
CDCl3) δH 8.36 (d, J = 4.0 Hz, 1H), 8.19 (br s, NH), 7.80 (d, J = 4.8 
Hz, 1H), 7.18-7.15 (m, 1H), 4.15 (d, J = 4.5 Hz, 2H), 3.71-3.66 (m, 
6H), 3.53-3.42 (m, 2H); 13C-NMR (75 MHz, CDCl3) δC 177.6, 165.7, 
161.0, 138.5, 138.0, 136.9, 128.4, 66.6, 66.40, 42.5, 41.1, 40.7; m/z 
283 (M+H)+; IR νmax/cm-1 (KBr) 3371, 3071, 1691, 1658, 1495, 1359, 
1275, 737; mp 193-194 °C. Anal. Calcd for C12H14N2O4S: C, 51.05; H, 
5.00; N, 9.92. Found: C, 51.34; H, 5.36; N, 10.10. 
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N-(1-morpholino-1-oxo-3-phenylpropan-2-yl)-2-oxo-2-phenylacetamide (55).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.41 mmol). 
The crude material was purified by column chromatography 
(PE/EtOAc 4:6) to give 76 mg of product as white solid 
(yield 50%). Mixture of rotamers, signals are referred to the 
main rotamer: 1H-NMR (300 MHz, CDCl3) δH 8.21 (d, J = 
8.2 Hz, 2H), 7.87 (br d, NH), 7.64-7.59 (br t, 1H), 7.52-7.38 
(br t, 2H), 7.34-7.23 (m, 5H), 5.18 (br q, 1H), 3.62-3.44 (m, 
6H), 3.16-2.94 (m, 4H); 13C-NMR (75 MHz, CDCl3) δC 
187.4, 169.0, 161.6, 135.8, 134.5, 131.0, 129.7, 129.6, 128.8, 
128.6, 127.4, 66.4, 66.0, 49.7, 46.1, 42.4, 39.8; m/z 367 (M+H)+; IR νmax/cm-1 
(KBr) 3277, 3027, 1665, 1642, 1524, 1486, 1211; mp 151.5-152 °C. Anal. Calcd 
for C21H22N2O4: C, 68.84; H, 6.05; N, 7.65. Found: C, 68.95; H, 6.40; N, 7.34. 
 
2-(3-chlorophenyl)-N-(1-morpholino-1-oxo-3-phenylpropan-2-yl)-2-
oxoacetamide (56). 
Starting material: 1,3-oxazol-2-oxime 150 mg (0.38 
mmol). The crude material was purified by column 
chromatography (PE/EtOAc 5:5) to give 78 mg of 
product as white solid (yield 52%). 1H-NMR (300 MHz, 
CDCl3) δH 8.19 (d, J = 8.1 Hz, 2H), 7.93 (br d, NH), 7.42 
(br d, 2H), 7.34-7.22 (m, 5H), 5.16 (br q, 1H), 3.64-3.58 
(m, 2H), 3.55-3.25 (m, 4H), 3.14-2.87 (m, 4H); 13C-
NMR (75 MHz, CDCl3) δC 185.8, 169.0, 160.9, 141.3, 
135.7, 132.6, 131.6, 129.7, 129.0, 128.9, 127.5, 66.5, 
66.1, 49.8, 46.1, 42.4, 39.9; m/z 401 (M+H)+; IR 
νmax/cm-1 (KBr) 3246, 3064, 1665, 1617, 1586, 1476, 1218, 858; mp 128-129 °C. 
Anal. Calcd for C21H21ClN2O4: C, 62.92; H, 5.28; N, 6.99. Found: C, 63.04; H, 
5.46; N, 6.74. 
 
O
OHN
O
N
O
Aryl-α-ketoamide amides 
91 
N-benzyl-2-(2-(4-methoxyphenyl)-2-oxoacetamido)-N-methylacetamide (57).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.44 mmol). The 
crude material was purified by column chromatography (PE/EtOAc 
5:5) to give 133 mg of product as colorless oil (yield 88%). Mixture 
of rotamers, signals are referred to the main rotamer: 1H-NMR (300 
MHz, CDCl3) δH 8.35-8.31 (m, 2H), 8.05 (br s, NH), 7.38-7.14 (m, 
5H), 6.94-6.89 (m, 2H), 4.61 (s, 2H), 4.24-4.20 (br t, 2H),  3.85 (s, 
3H), 2.92 (s, 3H); 13C-NMR (75 MHz, CDCl3) δC 185.4, 167.4, 
164.7, 162.8, 136.4, 133.7, 129.2, 128.8, 127.8, 126.3, 113.9, 55.6, 
51.3, 41.3, 33.7; m/z 341 (M+H)+; IR νmax/cm-1 (KBr) 3387, 3300, 
1646, 1653, 1511, 1453, 1263, 1028. Anal. Calcd for C19H20N2O4: C, 
67.05; H, 5.92; N, 8.23. Found: C, 67.14; H, 6.12; N, 8.46. 
 
N-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)-2-oxo-2-(p-tolyl)acetamide (58).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.50 mmol). The 
crude material was purified by column chromatography 
(DCM/MeOH 97:3) to give the product as yellow solid (75 mg, 
50% yield). 1H-NMR (400 MHz, CDCl3) δH 8.19 (br d, 2H, 
AA′XX′), 7.92 (br s, NH), 7.27-7.25 (m, 2H, AA′XX′) partially 
overlapped to the solvent, 4.17 (d, J = 4.2 Hz, 2H), 3.68 (br t, 2H), 
3.47 (br t, 2H), 2.44 (br s, 7H), 2.32 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δC 186.8, 165.5, 162.5, 145.5, 131.0, 130.7, 129.2, 54.6, 
54.3, 45.8, 44.3, 41.9, 40.9, 21.8; m/z 304 (M+H)+; IR νmax/cm-1 
(KBr) 3351, 3000, 1669, 1642, 1504, 1475, 1276, 789; mp 97-98 
°C. Anal. Calcd for C16H21N3O3: C, 63.35; H, 6.98; N, 13.85. 
Found: C, 63.67; H, 7.12; N, 14.12. 
 
2-(4-chlorophenyl)-N-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)-2-oxoacetamide 
(59).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.47 mmol). The 
crude material was purified by column chromatography 
(DCM/MeOH 97:3) to give the product as yellowish solid (64 mg, 
42% yield). 1H NMR (400 MHz, CDCl3) δH 8.23 (d, J = 8.4 Hz, 2H, 
AA′XX′), 7.98 (br s, NH), 7.41 (d, J = 8.4 Hz, 2H, AA′XX′), 4.12 
(d, J = 4.0 Hz 2H), 3.63 (br t, 2H), 3.43 (br t, 2H), 2.40-2.37 (m, 
4H), 2.28 (s, 3H); 13C NMR (100 MHz, CDCl3) δC 185.7, 165.3, 
161.7, 141.0, 132.4, 131.5, 128.8, 54.7, 54.4, 46.0, 44.4, 42.0, 40.9; 
m/z 324 (M+H)+; IR νmax/cm-1 (KBr) 3344, 1673, 1645, 1586, 1443, 
1273, 857; mp 127-128 °C. Anal. Calcd for C15H18ClN3O3: C, 
55.64; H, 5.60; N, 12.98. Found: C, 55.54; H, 5.42; N, 12.78.  
Me
O
NH
O
N
O
N
Me
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N-(2-morpholino-2-oxoethyl)-2-oxo-2-(p-tolyl)acetamide (60).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.52 mmol). The 
crude material was purified by column chromatography 
(DCM/MeOH 97:3) to give the product as yellow solid (98 mg, 65% 
yield). 1H NMR (400 MHz, CDCl3) δH 8.20 (d, J = 8.2 Hz, 2H), 7.92 
(br s, NH), 7.28-7.25 (m, 2H) partially overlapped to the solvent, 
4.17 (d, J = 4.0 Hz, 2H), 3.71-3.67 (m, 6H), 3.47-3.46 (m, 2H), 2.42 
(s, 3H); 13C NMR (100 MHz, CDCl3) δC 186.6, 165.8, 162.4, 145.6, 
131.1, 130.7, 129.2, 66.6, 66.3, 44.9, 42.3, 40.8, 21.8; m/z 291 
(M+H)+; IR νmax/cm-1 (KBr) 3430, 3423, 1695, 1660, 1494, 1276, 
785; mp 83-84 °C. Anal. Calcd for C15H18N2O4: C, 62.06; H, 6.25; N, 
9.65. Found: C, 62.34; H, 6.43; N, 9.78. 
 
 
2-oxo-N-(1-oxo-3-phenyl-1-(pyrrolidin-1-yl)propan-2-yl)-2-(p-tolyl)acetamide 
(61).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.41 mmol). The 
crude material was purified by column chromatography (n-
hexane/AcOEt 7:3) to give the product as a light yellow solid (78 
mg, 52% yield). 1H NMR (400 MHz, CDCl3) δH 8.12 (d, J = 8.0 
Hz, 2H), 7.79 (br d, NH), 7.28-7.23 (m, 7H), 4.95 (br q, 1H), 
3.47-3.30 (m, 3H), 3.09 (d, J = 7.4 Hz, 2H), 2.69-2.63 (m, 1H), 
2.40 (s, 3H), 1.80-1.55 (m, 4H); 13C NMR (100 MHz, CDCl3) 
mixture of rotamers: δC 186.8, 168.6, 161.7, 145.5, 136.1, 132.0, 
131.1, 130.7, 129.5, 128.5, 127.1, 52.4, 46.3, 45.8, 39.5, 25.8, 
23.9, 21.8; m/z 365 (M+H)+; IR νmax/cm-1 (KBr) 3239, 3062, 1680, 1662, 1624, 
1454, 1228, 763; mp 88-89 °C. Anal. Calcd for C22H24N2O3: C, 72.51; H, 6.64; N, 
7.69. Found: C, 72.52; H, 6.65; N, 7.65. 
 
2-oxo-N-(1-oxo-3-phenyl-1-(pyrrolidin-1-yl)propan-2-yl)-2-phenylacetamide 
(62).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.43 mmol). The 
crude material was purified by column chromatography (n-
hexane/AcOEt 7:3) to give the product as a yellowish solid (110 mg, 
73% yield). 1H NMR (400 MHz, CDCl3) δ 8.21 (d, J = 7.8 Hz, 2H), 
7.76 (br d, NH), 7.60 (t, J = 7.4 Hz, 1H), 7.45 (t, J = 7.7 Hz, 2H), 
7.31-7.25 (m, 6H), 4.96 (br q, 1H), 3.49-3.36 (m, 3H), 3.10 (d, J = 
7.4 Hz, 2H), 2.70-2.64 (m, 1H), 1.81-1.56 (m, 4H); 13C NMR (100 
MHz, CDCl3) mixture of rotamers: δC 187.4, 168.6, 161.6, 136.0, 
134.2, 133.2, 130.8, 129.4, 128.8, 128.5, 128.4, 128.4, 127.0, 52.4, 
46.3, 45.8, 39.4, 25.7, 23.9; m/z 351 (M+H)+; IR νmax/cm-1 (KBr) 3240, 3062, 1682, 
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1664, 1621, 1555, 1454, 1222; mp 118-119 °C. Anal. Calcd for C21H22N2O3: , 
71.98; H, 6.33; N, 7.99. Found: C, 72.21; H, 6.12; N, 8.21. 
 
N-(2-(4-benzylpiperidin-1-yl)-2-oxoethyl)-2-(4-nitrophenyl)-2-oxoacetamide 
(63).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.37 mmol). The 
crude material was purified by column chromatography (n-
hexane/AcOEt 5:5) to give the product as a yellowish solid (100 mg, 
66% yield). 1H NMR (400 MHz, CDCl3) δH 8.48 (d, J = 8.6 Hz, 2H), 
8.31 (d, J = 8.8 Hz, 2H), 8.08 (br s, NH), 7.31-7.12 (m, 5H), 4.59 (br 
d, 1H), 4.17-4.14 (m, 2H), 3.72 (br d, 1H), 3.02 (br t, 1H), 2.58-2.55 
(m, 2H), 1.83-1.76 (m, 3H), 1.21-1.15 (m, 3H); 13C NMR (100 
MHz, CDCl3) δC 185.5, 164.8, 160.8, 150.8, 139.6, 137.9, 132.1, 
129.0, 128.4, 126.2, 123.4, 44.8, 42.8, 42.6, 41.0, 38.0, 32.2, 31.5; 
m/z 410 (M+H)+; IR νmax/cm-1 (KBr) 3280, 1665, 1651, 1602, 1519; 
mp 78-79 °C. Anal. Calcd for C22H23N3O5: C, 64.54; H, 5.66; N, 
10.26. Found: C, 64.78; H, 5.84; N, 10.02.  
 
 
N-(2-(4-benzylpiperidin-1-yl)-2-oxoethyl)-2-(naphthalen-2-yl)-2-oxoacetamide 
(64).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.36 
mmol). The crude material was purified by column 
chromatography (n-hexane/AcOEt 5:5) to give the product 
as a sticky solid (81 mg, 54% yield). 1H NMR (400 MHz, 
CDCl3) δH 9.06 (s, 1H), 8.18 (br d, AA’XX’, 1H), 8.06 (br 
s, NH), 7.98 (d, J = 8.1 Hz, 1H), 7.90-7.85 (m, 2H), 7.64-
7.60 (m, 1H), 7.56-7.53 (m, 1H), 7.31-7.19 (m, 3H), 7.13 
(br d, 2H), 4.60 (br d, 1H), 4.22-4.19 (m, 2H), 3.75 (br d, 
1H), 3.01 (br t, 1H), 2.61-2.55 (m, 2H), 1.82-1.72 (m, 3H), 
1.25-1.14 (m, 3H); 13C NMR (100 MHz, CDCl3) δC 186.9, 
165.1, 162.3, 139.6, 136.1, 134.5, 132.3, 130.5, 130.2, 129.2, 129.0, 128.3, 128.3, 
127.7, 126.7, 126.1, 125.1, 44.8, 42.8, 42.6, 41.0, 38.0, 32.2, 31.5; m/z 415 
(M+H)+; IR νmax/cm-1 (KBr) 3280, 1665, 1651, 1602, 1519. Anal. Calcd for 
C26H26N2O3: C, 75.34; H, 6.32; N, 6.76. Found: C, 75.36; H, 6.46; N, 6.73. 
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2-([1,1'-biphenyl]-4-yl)-N-(2-(4-benzylpiperidin-1-yl)-2-oxoethyl)-2-
oxoacetamide (65).  
Starting material: 1,3-oxazol-2-oxime 150 mg (0.34 mmol). 
The crude material was purified by column chromatography 
(n-hexane/AcOEt 5:5) to give the product as a white solid 
(112 mg, 75% yield). 1H NMR (400 MHz, CDCl3) δH 8.38 
(br d, AA’XX’, 2H), 8.01 (br s, NH), 7.70 (br d, AA’XX’, 
2H), 7.64  (br d, AA’XX’, 2H), 7.49-7.38 (m, 3H), 7.31-7.19 
(m, 3H), 7.13 (br d, AA’XX’, 2H), 4.60 (br d, 1H), 4.24-4.12 
(m, 2H), 3.74 (br d, 1H), 3.01 (br t, 1H), 2.64-2.55 (m, 3H), 
1.82-1.75 (m, 3H), 1.25-1.14 (m, 2H); 13C NMR (100 MHz, 
CDCl3) δC 186.7, 165.16, 162.3, 146.9, 139.7, 139.6, 132.0, 
131.6, 129.0, 128.9, 128.4, 128.3, 127.3, 127.1, 126.1, 44.8, 
42.8, 42.6, 41.0, 38.0, 32.2, 31.5; m/z 441 (M+H)+; IR 
νmax/cm-1 (KBr) 3364, 2919, 1682, 1628, 1475; mp 140-141 °C. Anal. Calcd for 
C28H28N2O3: C, 76.34; H, 6.41; N, 6.36. Found: C, 76.29; H, 6.42; N, 6.78. 
 
N-Benzyl-2-(2-(4-fluorophenyl)-2-oxoacetamido)-N-methylacetamide (66). 
Starting material: 1,3-oxazol-2-oxime 150 mg (0.46 
mmol). The crude material was purified by column 
chromatography (PE/ EtOAc 5:5) to give 106 mg of 
product as yellow oil (yield 70%). Mixture of rotamers, 
signals are referred to the main rotamer: 1H NMR (300 
MHz, CDCl3) δH 8.37−8.29 (m, 2H), 8.11 (br s, NH), 
7.34−7.21 (m, 4H), 7.19−7.05 (m, 3H), 4.59 (s, 2H), 
4.20 (d, J = 4 Hz, 2H), 2.91 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δC 185.4, 167.2, 164.8, 162.1, 136.4, 134.1, 
129.7, 128.7, 128.1, 127.7, 115.9, 51.3, 41.2, 33.6; MS 
m/z 329 (M + H)+; IR νmax/cm−1 (KBr) 3377, 2926, 1647, 1595, 1230, 1089. Anal. 
Calcd for C18H17FN2O3: C, 65.84; H, 5.22; N, 8.53. Found: C, 65.52; H, 4.98; N, 
8.76. 
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Chapter 6 
Solution-phase parallel 
synthesis of aryloxyimino 
amides via a novel 
multicomponent reaction 
among aromatic 
Z‑chlorooximes, 
isocyanides, and  
electron-deficient phenols
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6.1 Results and discussion 
 
As a continuation of our previous studies, we questioned whether an electron 
deficient phenol could be a good nucleophile third component able to intercept the 
nitrilium ion, generated reacting an isocyanide with a nitrile N-oxide to obtain 
aryloxyiminoamides. After formation of the imidate, the hydroxyl group of the 
oxime, which is properly positioned, thanks to the stereoselective addition of 
isocyanide to the nitrile N-oxide,1 can trigger a Smiles rearrangement,2,3 in a 
manner reminiscent of the Passerini−Smiles reaction developed by Prof. El 
Kaïm.4,5 In this case, a six-membered transition state should occur,6 contrary to the 
typical Smiles rearrangement which forms a five-membered transition state 
(Scheme 1).  
 
Scheme 1. Three-component synthesis of imidate intermediate and 
following Smiles rearrangement. 
When the reaction was carried out in the presence of 2 equivalents of 
triethylamine (TEA), in dichloromethane at room temperature (2 h), we obtained a 
mixture from which the desired product (5) {1,3,1} and the imidate (4) {1,3,1} 
could be separated with yields of 14% and 20%, respectively. These two 
compounds were easily identified via 13C NMR (see Experimental section). The 
result did not change when the reaction was heated at reflux in toluene (6 h). We 
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reasoned that the difficulty in triggering the Smiles rearrangement could be due to 
the inability of TEA (pKa= 10.65) to fully deprotonate the oxime (pKa = 10.78). 
The use of 2 equivalents of potassium tert-butoxide (pKa = 18) did not, however, 
improve the result. Under such conditions the reaction was not clean and we were 
able to isolate the desired compound (5) {1,3,1} only in very low yield (less than 
10%). We therefore searched for a base stronger than TEA but weaker than t-
BuOK, and we opted for 2 equivalents of DBU (pKa = 12) which allowed us to 
isolate desired product (5) {1,3,1} in 20% yield and without observing the 
formation of the imidate. 
In this case, as with TEA, heating the reaction at 80 °C in toluene (6 h) did not 
change the yield. Reasoning that, while the formation of the nitrile N-oxide species 
required an equimolar amount of base, the Smiles rearrangement occurring after the 
addition of p-nitrophenol to the nitrilium ion could proceed in the presence of a 
catalytic amount of base. Thus, by reducing the amount of DBU to 1.2 equivalents 
in dicloromethane (room temperature, overnight) we were able to isolate the 
product in 37% yield. Again, the imidate was not isolated. Such yield represented a 
notable advance, since p-nitrophenol (3){1} was reported to be more problematic 
than o-nitrophenol in favoring the Smiles rearrangement and El Kaïm shows it was 
less reactive in the Ugi-Smiles,7,8 and completely non reactive in the Passerini-
Smiles rearrangement.4,5 
We were pleased to find the aryloxyimino amide to be stable, in particular with 
respect to a potential Beckmann rearrangement because of the presence of a 
nitrophenol leaving group. No sign of Beckmann product could be detected after 
refluxing in toluene for several hours. As there was in literature only one precedent 
for the synthesis of aryloxyimino amides,9 with the optimized conditions for this 
novel multicomponent reaction in our hands, and after verifying that both the work 
up and the chromatographic purification were experimentally easy, we explored the 
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generality of this transformation by employing it in the combinatorial parallel 
synthesis of a library of compounds.  
Three aryl-Z-chlorooximes 1{1−3} bearing either electron-deficient or electro-
donor substitutents, three isocyanides 2{1−3}, and five electron-deficient arenes 
3{1−5} were used (Figure 1). By combination of these reagents in a three-
component reaction a library of 45 compounds should be obtained. 
 
Figure 1. Building blocks used. 
To optimize the management of such a large number of reactions and minimize 
the chances of trivial operator errors (such as miscalculations which could 
compromise the outcome of some of the reactions), we used a computer program, 
prepared by Dr. Massaroti, called MCRcombiS, able to manage large amounts of 
data and quickly output the correct quantities/concentrations of reagents (mmol, 
mg/mL, etc.) to be used in each reaction.10  
As shown in Figure 2 the reactions proceeded efficiently (22-63% yield) and 
only in four cases we were not able to isolate the desired aryloxyimino amide 
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(compounds in red). The reaction does not seem to be very sensitive to steric or 
electronic factors. 
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Figure 2. Aryloxymino amide synthesized (in red the products of the 
reactions that have not been successful). 
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Figure 2. Aryloxymino amide synthesized (in red the products of the 
reactions that have not been successful) (continued). 
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Figure 2. Aryloxymino amide synthesized (in red the products of the 
reactions that have not been successful) (continued). 
 
The purity of all the final compounds were evaluated by HPLC-UV-MS. Thus, 
the application of this novel multicomponent reaction to combinatorial synthesis 
afforded 41 of the expected 45 compounds with an overall success rate for this 
library of 93% and an average purity of 93%, after a simple silica gel filtration. 
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Four compounds [5{1,3,5}, 5{2,3,1}, 5{2,3,5} and 5{3,3,5}] were found to be 
mixtures of Z and E isomers of the oxime, detected by both 1H NMR and HPLC, 
while six compounds [5{1,1,1}, 5{1,2,1}, 5{1,1,2}, 5{2,2,1}, 5{2,1,2}, and 5{2,2,2}] 
showed the presence of less than 5% of the E isomer visible only by HPLC. In this 
case, the E-isomer was easily removed by crystallization (Table 1).  
 
Compound Purity A Purity B  
5{1,1,1} 98.1* 98.1* 
5{1,2,1} 99.2* 98.7* 
5{1,3,1} 93.0 93.4 
5{1,1,2} 97.0* 99.9* 
5{1,2,2} 94.8 95.0 
5{1,3,2} 96.1 96.1 
5{1,1,3} 90.3 90.9 
5{1,2,3} 90.4 91.1 
5{1,3,3} 91.2 92.4 
5{1,1,4} 97.9 98.3 
5{1,2,4} 93.9 95.7 
5{1,3,4} 95.9 95.3 
5{1,2,5} 93.5 92.5 
5{1,3,5} 88.9* 92.4* 
5{2,2,1} 98.0* 96.0* 
5{2,3,1} 95.3* 95.3* 
5{2,1,2} 94.1* 92.0* 
Compound Purity A Purity B  
5{2,2,2} 96.5* 96.5* 
5{2,3,2} 93.6 95.1 
 
  
5{2,1,3} 79.8 80.0 
5{2,2,3} 83.5 84.6 
5{2,3,3} 86.1 85.8 
5{2,1,4} 90.9 90.5 
5{2,2,4} 89.6 89.6 
5{2,3,4} 91.8 91.4 
5{2,2,5} 85.5 86.4 
5{2,3,5} 85.7 90.8 
5{3,1,1} 90.2 89.7 
5{3,2,1} 94.6 94.3 
5{3,3,1} 95.5 95.6 
5{3,1,2} 93.9 95.4 
5{3,2,2} 96.6 96.6 
5{3,3,2} 97.7 97.6 
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Compound Purity A Purity B  
5{3,1,3} 87.2 83.4 
5{3,2,3} 93.4 91.7 
5{3,3,3} 96.1 95.5 
5{3,1,4} 97.1 97.3 
5{3,2,4} 95.3 96.2 
Compound Purity A Purity B  
 
  
5{3,3,4} 96.6 96.5 
5{3,2,5} 96.9 98.5 
5{3,3,5} 97.4* 98.5* 
 
Table 1. Purity of aryloxyimino amides synthesized. *Purity refers to the mixture of 
Z and E isomers  
 
Although, aryloxyimino amides are interesting compounds per se, we were also 
intrigued by their potential use as intermediates for further synthetic 
transformations. As an example, we explored the synthesis of benzo[d]isoxazole-3-
carboxamides, a well-known scaffold in medicinal chemistry, which usually 
requires a long and tedious synthesis (Scheme 2).11  
 
 
Scheme 2. Classical synthesis of benzo[d]isoxazole-3-carboxamides. 
(a) EtOH, H2SO4, toluene reflux; (b) isoamyl nitrite, NaOEt, EtOH; (c) NaH, 
diglyme; (d) 70% H2SO4; (e) SOCl2. 
 
As it has been demonstrated that SN2 reactions can occur at the sp2 nitrogen of 
oximes,12–14 we reasoned that the aryloxyimino amide 7, derived from the Z-
Chapter 6 
108 
chlorooxime of salicylaldeyde 6 may, after deprotection, triggers an intramolecular 
SN2 type reaction affording benzo[d]isoxazole-3-carboxamides 8 (Scheme 3). We 
were pleased to find that, when TBAF was used to cleave the silyl protecting 
group, the desired transformation occurred in quantitative yield. 
 
Scheme 3. Synthesis of benzo[d]isoxazole-3-carboxamides by MCR. 
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6.2 Conclusions 
 
In conclusion, we reported in this Chapter the discovery of a novel 
multicomponent reaction among Z-chlorooximes, isocyanides and electron-
deficient arenes. The oxime-mediated Smiles rearrangement drives the reaction 
from the less stable imidates toward the formation of stable amides.  
 
The reaction is robust enough to be used in a combinatorial process, and one 
example of use as a synthetic intermediate for the preparation of a 3-substituted 
benzo[d]isoxazole was demonstrated, raising the possibility of a shorter synthetic 
pathway for the production of this heterocycle. 
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6.3 Experimental section 
 
Solvents and Reagents. Commercially available solvents and reagents were used 
without further purification. Dichloromethane was dried by distillation over P2O5 
and stored over activated molecular sieves (4 Å). When needed, the reactions were 
performed in oven-dried glassware under a positive pressure of dry nitrogen. 
Chromatography. Column chromatography was performed on silica gel 60 
(Kieselgel 230−400 mesh ASTM) using the indicated eluents. Thin layer 
chromatography (TLC) was carried out on 5 × 20 cm plates with a layer thickness 
of 0.25 mm (Silica gel 60 F254). When needed they were visualized using KMnO4 
reagent.  
Spectra. Infrared spectra were recorded on a FT-IR with absorption maxima 
(νmax) recorded in wavenumbers (cm−1). NMR spectra were recorded using a 300 
or 400 MHz spectrometer. Chemical shifts (δ) are quoted in parts per million and 
referenced to the residual solvent peak. The multiplicity of each signal is 
designated using the following abbreviations: s, singlet; d, doublet; t, triplet; q, 
quartet; quint, quintet; sext, sextet; hept, heptet; m, multiplet; br, broad singlet. 
Coupling constants (J) are reported in Hertz (Hz). HRMS were recorded on 
ORBITRAP mass spectrometer equipped with an ESI source. Melting points were 
determined and remain uncorrected. Chloroximes 1{1}, 1{2}, and 1{3} are not new, 
and they were prepared following literature procedure.15 
 
General Preparation of Aryloxyimino Amides.  
The chlorooxime (1 eq.) was dissolved in dry dichloromethane and isocyanide (1 
eq.), phenol (1.1 eq.), and DBU (1.2 eq.) were added. The reaction was stirred at 
room temperature under a nitrogen atmosphere until all the chlorooxime was 
consumed (typically overnight as judged by TLC). The reaction mixture was 
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concentrated under reduced pressure, and the crude material was purified by 
column chromatography. 
 
(2Z)-4-nitrophenyl 2-(hydroxyimino)-N-pentyl-2-phenylacetimidate, 4{1,3,1}  
The crude material was purified by column 
chromatography (PE/EtOAc 95:5, 9:1) to give the 
product as white solid. 1H-NMR (300 MHz, CDCl3, 
CD3OD) δ 8. 16 (d, J = 7.3 Hz, 2H), 7.58 (d, 2H), 
7.37 (m, 5H), 7.08 (br s, NH), 3,12 (br s, 2H), 1.45-
1.33 (m, 2H), 1.15 (m, 4H), 0.57 (m, 3H); 13C-NMR 
(75 MHz, CDCl3) δ 158.3, 153.4, 148.9, 144.4, 131.2, 
130.2, 129.0, 128.6, 125.9, 125.1, 122.4, 50.1, 30.2, 
29.5, 22.3, 13.9. 
 
(Z)-N-benzyl-2-((4-nitrophenoxy)imino)-2-phenylacetamide, 5{1,1,1} 
The crude material was purified by column 
chromatography (PE/EtOAc 9:1, 8:2) to give the product 
as yellow solid (yield 33%). 1H-NMR (300 MHz, CDCl3) 
δ 8.23-8.13 (m, 2H), 7.81-7.69 (m, 2H), 7.55-7.18 (m, 
10H), 6.52 (br t, NH), 4.67 (d, J = 5.8 Hz, 2H); 13C-NMR 
(75 MHz, CDCl3) δ 163.4, 162.2, 157.6, 142.9, 137.4, 
131.8, 129.6, 129.1 (2C), 128.9, 128.0, 127.4, 125.8, 
114.5, 43.6; νmax/cm-1 (KBr) 3412, 3258, 1646, 1591, 
1342, 919; mp 151-152 °C; HRMS (EI+): m/z: calcd for 
C21H17N3O4: 375.1219, Found: 375.1220. 
 
(Z)-N-(tert-butyl)-2-((4-nitrophenoxy)imino)-2-phenylacetamide, 5{1,2,1} 
The crude material was purified by column chromatography 
(PE/EtOAc 9:1, 8:2) to give the product as white solid (yield 
41%). 1H-NMR (300 MHz, CDCl3) δ 8.13-8.09 (m, 2H), 7.70-
7.67 (m, 2H), 7.44-7.34 (m, 3H), 7.23-7.20 (m, 2H), 6.21 (br 
s, NH), 1.45 (s, 9H); 13C-NMR (75 MHz, CDCl3) δ 136.5, 
161.5, 157.7, 142.5, 131.5, 129.7, 128.9, 127.3, 125.7, 114.3, 
52.9, 28.7; νmax/cm-1 (KBr) 3280, 2969, 1646, 1589, 1519, 
1341, 918; mp 154.3-155 °C; HRMS (EI+): m/z: calcd for 
C18H19N3O4: 341.1376, Found: 341.1376. 
Chapter 6 
112 
(Z)-2-((4-nitrophenoxy)imino)-N-pentyl-2-phenylacetamide, 5{1,3,1} 
The crude material was purified by column chromatography 
(PE/EtOAc 9:1, 8:2) to give the product as yellow solid 
(yield 37%). 1H-NMR (300 MHz, CDCl3) δ 8.26-8.19 (m, 
2H), 7.81-7.76 (m, 2H), 7.53-7.26 (m, 5H), 5.97 (br s, NH), 
3.56-3.49 (m, 2H), 1.69-1.64 (m, 2H), 1.42-1.38 (m, 4H), 
0.95-0.90 (m, 3H); 13C-NMR (75 MHz, CDCl3) δ 163.5, 
162.1, 157.9, 142.9, 131.7, 129.8, 129.1, 127.4, 125.8, 
114.5, 39.7, 29.2, 29.1, 22.4, 14.1; νmax/cm-1 (KBr) 3233, 
2932, 1650, 1589, 1517, 1338, 921; mp 124-129.9 °C; 
HRMS (EI+): m/z: calcd for C19H21N3O4: 355.1532, Found: 355.1539. 
 
(Z)-N-benzyl-2-((2-nitrophenoxy)imino)-2-phenylacetamide, 5{1,1,2} 
 
The crude material was purified by column 
chromatography (PE/EtOAc 9:1, 8:2) to give the product 
as brown solid (yield 25%). 1H-NMR (300 MHz, CDCl3) 
δ 8.01-7.98 (m, 1H), 7.80-7.77 (m, 3H), 7.64-7.15 (m, 
10H), 6.70 (br t, NH), 4.75 (d, J = 5.5 Hz, 2H); 13C-NMR 
(75 MHz, CDCl3) δ 161.6, 157.9, 152.5, 138.0, 137.3, 
135.0, 131.6, 129.3, 129.0, 128.9, 128.4, 127.9, 127.8, 
125.9, 123.1, 118.1, 44.1; νmax/cm-1 (KBr) 3418, 3235, 
1636, 1616, 1523, 918; mp 137.2-138 °C; HRMS (EI+): m/z: calcd for 
C21H17N3O4: 375.1219, Found: 375.1221. 
 
 
(Z)-N-(tert-butyl)-2-((2-nitrophenoxy)imino)-2-phenylacetamide, 5{1,2,2} 
The crudematerial was purified by column chromatography 
(PE/EtOAc 9:1, 8:2) to give the product as yellow solid 
(yield 42%). 1H-NMR (300 MHz, CDCl3) δ7.92 (dd, J= 8.3, 
1.5 Hz, 1H), 7.78-7.72(m, 3H), 7.58 (td, J= 7.8, 1.5 Hz, 1H), 
7.46-7.37 (m, 3H), 7.14 (td, J=7.8, 1.2 Hz, 1H), 6.12 (br s, 
NH), 1.52 (s, 9H); 13C-NMR (75 MHz, CDCl3) δ160.9, 
157.7, 152.5, 137.9, 134.7, 131.4, 130.2, 128.9, 127.5, 
125.5, 122.8, 118.2, 53.2, 28.7; νmax/cm-1 (KBr)3270, 
2964, 1647, 1519, 1563, 1354, 923; mp 139.5-139.9 °C; 
HRMS (EI+): m/z: calcd for C18H19N3O4: 341.1376, Found: 341.1379. 
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(Z)-2-((2-nitrophenoxy)imino)-N-pentyl-2-phenylacetamide, 5{1,3,2} 
The crudematerial was purified by column 
chromatography (PE/EtOAc 9:1, 8:2) to give the 
productas yellow amorphous solid (yield 51%). 1H-NMR 
(300 MHz, CDCl3) δ 7.96 (dd, J = 8.2, 1.8 Hz, 1H), 7.81-
7.74 (m, 3H),7.59 (td, J = 7.9, 1.5 Hz, 1H), 7.49-7.35 (m, 
3H), 7.16 (td, J =7.2, 1.2 Hz, 1H) 6.50 (br s, NH) 3.56-
3.49 (m, 2H), 1.69-1.65(m, 2H), 1.37-1.35 (m, 4H), 0.92-
0.88 (m, 3H); 13C-NMR (75 MHz, CDCl3) δ161.6, 157.9, 
152.4, 137.6, 134.8, 131.3, 130.0, 128.8, 127.6, 125.6, 122.7, 117.8,39.8, 29.1, 
28.8, 22.3, 14.0; νmax/ cm-1 (KBr)3266, 2953, 1668, 1523, 1344, 915; HRMS 
(EI+):m/z: calcd forC19H21N3O4: 355.1532, Found: 355.1532. 
 
(Z)-N-benzyl-2-((2,4-dinitrophenoxy)imino)-2-phenylacetamide, 5{1,1,3} 
The crudematerial was purified by column chromatography 
(PE/EtOAc9:1, 8:2) to give the productas whitesolid (yield 
30%).1H-NMR (300 MHz, CDCl3+ 1 gtt CD3OD)δ 8.85 (d, 
J= 2.7 Hz, 1H), 8.44 (dd, J= 9.2, 2.7 Hz, 1H), 8.01 (d, J= 9.2 
Hz, 1H),7.79-7.72 (m, 2H), 7.50-7.24 (m. 9H), 4.64(s, 2H); 
13C-NMR (75 MHz,CDCl3+ 1 gtt CD3OD)δ 161.8, 160.4, 
156.6, 141.3, 137.0, 136.3, 132.2, 129.8, 129.3, 129.0, 128.6, 
128.0, 127.6, 127.5, 121.9, 117.4, 43.5; νmax/cm-1 
(KBr)3332, 3116, 1660,1527, 1345, 927, 902;mp155-
156°C;HRMS (EI+): m/z: calcd forC21H16N4O6: 420.1070, 
Found: 420.1075. 
 
 
(Z)-N-(tert-butyl)-2-((2,4-dinitrophenoxy)imino)-2-phenylacetamide, 5{1,2,3} 
The crudematerial was purified by column chromatography 
(PE/EtOAc 9:1, 8:2) to give the productas yellow solid (yield 
38%).1H -NMR (300 MHz, CDCl3) δ 8.83 (d, J = 2.7 Hz, 
1H),8.43 (dd, J = 9.2 ,2.7 Hz, 1H), 7.98 (d, J = 9.2 Hz, 1H), 
7.76 (dd, J = 8.5, 1.5 Hz, 2H), 7.52-7.41 (m, 3H), 5.98 (br 
s,NH) 1.55 (s, 9H); 13C-NMR (75 MHz, CDCl3) δ 160.3, 
159.6, 156.6, 141.3, 136.3, 132.1, 129.3, 129.2, 161.6, 157.9, 
152.5, 138.0, 137.3, 135.0, 131.6, 129.3, 129.0, 128.9, 128.4, 
127.9, 127.8, 125.9, 123.1, 118.1, 44.1; νmax/cm-1 (KBr) 
3418, 3235, 1636, 1616, 1523, 918; mp 137.2-138 °C; HRMS 
(EI+): m/z: calcd for C21H17N3O4: 375.1219, Found: 
375.1221. 
O
N
N O
NO2
NO2
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(Z)-N-(tert-butyl)-2-((2-nitrophenoxy)imino)-2-phenylacetamide, 5{1,2,2} 
The crude material was purified by column chromatography 
(PE/EtOAc 9:1, 8:2) to give the product as yellow solid 
(yield 42%). 1H-NMR (300 MHz, CDCl3) δ 7.92 (dd, J = 8.3, 
1.5 Hz, 1H), 7.78-7.72 (m, 3H), 7.58 (td, J = 7.8, 1.5 Hz, 
1H), 7.46-7.37 (m, 3H), 7.14 (td, J = 7.8, 1.2 Hz, 1H), 6.12 
(br s, NH), 1.52 (s, 9H); 13C-NMR (75 MHz, CDCl3) δ 
160.9, 157.7, 152.5, 137.9, 134.7, 131.4, 130.2, 128.9, 127.5, 
125.5, 122.8, 118.2, 53.2, 28.7; νmax/cm-1 (KBr) 3270, 2964, 
1647, 1519, 1563, 1354, 923; mp 139.5-139.9 °C; HRMS (EI+): m/z: calcd for 
C18H19N3O4: 341.1376, Found: 341.1379. 
 
(Z)-2-((2-nitrophenoxy)imino)-N-pentyl-2-phenylacetamide, 5{1,3,2} 
The crude material was purified by column chromatography 
(PE/EtOAc 9:1, 8:2) to give the product as yellow 
amorphous solid (yield 51%). 1H-NMR (300 MHz, CDCl3) 
δ 7.96 (dd, J = 8.2, 1.8 Hz, 1H), 7.81-7.74 (m, 3H), 7.59 (td, 
J = 7.9, 1.5 Hz, 1H), 7.49-7.35 (m, 3H), 7.16 (td, J = 7.2, 1.2 
Hz, 1H) 6.50 (br s, NH) 3.56-3.49 (m, 2H), 1.69-1.65 (m, 
2H), 1.37-1.35 (m, 4H), 0.92-0.88 (m, 3H); 13C-NMR (75 
MHz, CDCl3) δ 161.6, 157.9, 152.4, 137.6, 134.8, 131.3, 
130.0, 128.8, 127.6, 125.6, 122.7, 117.8, 39.8, 29.1, 28.8, 22.3, 14.0; νmax/cm-1 
(KBr) 3266, 2953, 1668, 1523, 1344, 915; HRMS (EI+): m/z: calcd for 
C19H21N3O4: 355.1532, Found: 355.1532. 
 
(Z)-N-benzyl-2-((2,4-dinitrophenoxy)imino)-2-phenylacetamide, 5{1,1,3} 
The crude material was purified by column 
chromatography (PE/EtOAc 9:1, 8:2) to give the product 
as white solid (yield 30%). 1H-NMR (300 MHz, CDCl3 + 
1 gtt CD3OD) δ 8.85 (d, J = 2.7 Hz, 1H), 8.44 (dd, J = 
9.2, 2.7 Hz, 1H), 8.01 (d, J = 9.2 Hz, 1H),7.79-7.72 (m, 
2H), 7.50-7.24 (m. 9H), 4.64 (s, 2H); 13C-NMR (75 
MHz, CDCl3 + 1 gtt CD3OD) δ 161.8, 160.4, 156.6, 
141.3, 137.0, 136.3, 132.2, 129.8, 129.3, 129.0, 128.6, 
128.0, 127.6, 127.5, 121.9, 117.4, 43.5; νmax/cm-1 (KBr) 
3332, 3116, 1660, 1527, 1345, 927, 902; mp155-156 °C; 
HRMS (EI+): m/z: calcd for C21H16N4O6: 420.1070, Found: 420.1075. 
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(Z)-N-(tert-butyl)-2-((2,4-dinitrophenoxy)imino)-2-phenylacetamide, 5{1,2,3} 
The crude material was purified by column chromatography 
(PE/EtOAc 9:1, 8:2) to give the product as yellow solid (yield 
38%). 1H-NMR (300 MHz, CDCl3) δ 8.83 (d, J = 2.7 Hz, 
1H),8.43 (dd, J = 9.2, 2.7 Hz, 1H), 7.98 (d, J = 9.2 Hz, 1H), 
7.76 (dd, J = 8.5, 1.5 Hz, 2H), 7.52-7.41 (m, 3H), 5.98 (br s, 
NH) 1.55 (s, 9H); 13C-NMR (75 MHz, CDCl3) δ 160.3, 159.6, 
156.6, 141.3, 136.3, 132.1, 129.3, 129.2, 129.1, 127.7, 121.8, 
117.7, 53.4, 28.6; νmax/cm-1 (KBr) 3398, 2975, 1685, 1519, 
1344, 929, 901; mp 156.5-157 °C; HRMS (EI+): m/z: calcd 
for C18H18N4O6: 386.1226, Found: 386.1228. 
 
(Z)-2-((2,4-dinitrophenoxy)imino)-N-pentyl-2-phenylacetamide, 5{1,3,3} 
The crude material was purified by column chromatography 
(PE/EtOAc 9:1, 8:2) to give the product as yellow solid 
(yield 32%). 1H-NMR (300 MHz, CDCl3) δ 8.72-8.70 (m, 
1H), 8.36-8.31 (m, 1H), 7.90-7.85 (m, 1H), 7.64-7.63 (m, 
2H), 7.45-7.27 (m, 3H), 6.67 (br d, NH), 3.46-3.38 (m, 2H), 
1.58 (br s, 2H), 1.31-1.29 (m, 4H), 0.88-0.74 (m, 3H); 13C-
NMR (75 MHz, CDCl3) δ 161.2, 160.1, 156.5, 141.3, 136.1, 
132.2, 129.4, 129.1, 128.9, 127.8, 122.0, 117.4, 40.0, 29.1, 
28.8, 22.3, 14.0; νmax/cm-1 (KBr) 3267, 2952, 1648, 1526, 
1344, 929, 904; mp 139.7-141.3 °C; HRMS (EI+): m/z: calcd for C19H20N4O6: 
400.1383, Found: 400.1389. 
 
(Z)-N-benzyl-2-((2-chloro-4-nitrophenoxy)imino)-2-phenylacetamide, 5{1,1,4} 
The crude material was purified by column 
chromatography (PE/EtOAc 9:1, 8:2) to give the product 
as white solid (yield 43%). 1H-NMR (300 MHz, CDCl3) 
δ 8.17 (d, J = 2.8 Hz, 1H), 8.06 (dd, J = 9.2, 2.1 Hz, 1H), 
7.77-7.61 (m, 3H), 7.45-7.26 (m, 9H), 4.59 (br s, 2H); 
13C-NMR (75 MHz, CDCl3) δ 161.8, 159.1, 158.8, 142.5, 
137.0, 131.9, 129.4, 129.0, 128.8, 128.2, 127.8, 127.5, 
125.9, 123.7, 120.8, 115.0, 43.6; νmax/cm-1 (KBr) 3249, 
3084, 1653, 1584, 1351, 919, 743; mp 152.8-153 °C; 
HRMS (EI+): m/z: calcd for C21H16ClN3O4: 409.0829, Found: 409.0832. 
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(Z)-N-(tert-butyl)-2-((2-chloro-4-nitrophenoxy)imino)-2-phenylacetamide, 
5{1,2,4} 
The crude material was purified by column chromatography 
(PE/EtOAc 9:1, 8:2) to give the product as white solid (yield 
45%). 1H-NMR (300 MHz, CDCl3) δ 8.26 (br d, 1H), 8.13 
(dd, J = 9.2, 1.2 Hz, 1H), 7.78-7.70 (m, 3H), 7.52-7.41 (m, 
3H), 5.98 (br s, NH), 1.52 (s, 9H); 13C-NMR (75 MHz, 
CDCl3) δ 161.4, 159.3, 158.7, 142.2, 131.6, 129.6, 128.8, 
127.2, 125.8, 123.7, 120.5, 114.8, 52.7, 28.4; νmax/cm-1 
(KBr) 3263, 3085, 1654, 1583, 1365, 922, 742; mp 143-144 
°C; HRMS (EI+): m/z: calcd for C18H18ClN3O4: 375.0986, 
Found: 375.0983. 
 
 
(Z)-2-((2-chloro-4-nitrophenoxy)imino)-N-pentyl-2-phenylacetamide, 5{1,3,4} 
The crude material was purified by column chromatography 
(PE/EtOAc 9:1, 8:2) to give the product as white solid (yield 
53%). 1H-NMR (300 MHz, CDCl3) δ 8.15 (d, J = 2.8 Hz, 
1H), 8.05 (dd, J = 9.1, 2.4 Hz, 1H), 7.71-7.68 (m, 2H), 7.61 
(dd, J = 9.1, 1H), 7.48-7.35 (m, 3H), 6.54 (br t, NH), 3.42 
(br q, 2H), 1.62 (br quintet, 2H), 1.38-1.31 (m, 4H), 0.90-
0.86 (m, 3H); 13C-NMR (75 MHz, CDCl3) δ 161.7, 159.1, 
158.9, 142.4, 131.8, 129.5, 129.0, 127.6, 125.9, 123.8, 
120.7, 114.9, 39.9, 29.2 (2 ), 22.4, 14.0; νmax/cm-1 (KBr) 
3261, 2963, 1653, 1589, 1352, 927, 742; mp 121-122 °C; HRMS (EI+): m/z: calcd 
for C19H20ClN3O4: 389.1142, Found: 389.1144. 
 
(Z)-N-(tert-butyl)-2-(((5-nitropyridin-2-yl)oxy)imino)-2-phenylacetamide, 
5{1,2,5} 
The crude material was purified by column chromatography 
(PE/EtOAc 9:1, 8:2) to give the product as white solid (yield 
20%). 1H-NMR (300 MHz, CDCl3) δ 9.13 (d, J = 2.5 Hz, 1H), 
8.49 (dd, J = 9.2, 2.7 Hz, 1H), 7.79 (dd, J = 8.3, 1.3 Hz, 2H), 
7.56-7.36 (m, 4H), 5.88 (br s, NH), 1.53 (s, 9H); 13C-NMR 
(75 MHz, CDCl3) δ 167.7, 161.4, 159.6, 145.0, 140.7, 135.1, 
131.9, 130.1, 129.1, 127.5, 109.2, 52.9, 28.7; νmax/cm-1 
(KBr) 3290, 2970, 1674, 1516, 1347, 929; mp 169-171.2 °C; 
HRMS (EI+): m/z: calcd for C17H18N4O4: 342.1328, Found: 
342.1327. 
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(Z)-2-(((5-nitropyridin-2-yl)oxy)imino)-N-pentyl-2-phenylacetamide, 5{1,3,5} 
The crude material was purified by column chromatography 
(PE/EtOAc 9:1, 8:2) to give the product as brown 
amorphous solid (yield 33%). Mixture of E/Z isomers, 
signals are referred to the main isomer: 1H-NMR (300 MHz, 
CDCl3) δ 8.96 (d, J = 2.8 Hz, 1H), 8.45 (dd, J = 9.1, 2.8 Hz, 
1H), 7.73-7.70 (m, 3H), 7.55-7.47 (m, 4H), 6.69 (br t, NH), 
3.51 (br q, 2H), 1.69-1.59 (m, 2H), 1.43-1.33 (m, 4H), 0.92-
0.82 (m, 3H); 13C-NMR (75 MHz, CDCl3) δ 167.7, 161.7, 
159.4, 148.2, 144.9, 135.2, 133.8, 130.1, 129.3, 127.6, 
109.0, 39.8, 29.5, 29.1, 22.4, 14.1; νmax/cm-1 (KBr) 3549, 3417, 1636, 1579, 1345, 
937; HRMS (EI+): m/z: calcd for C18H20N4O4: 356.1485, Found: 356.1485. 
 
(Z)-N-(tert-butyl)-2-(4-methoxyphenyl)-2-((4-nitrophenoxy)imino)acetamide, 
5{2,2,1} 
The crude material was purified by column 
chromatography (PE/EtOAc 95:5, 9:1) to give the 
product as yellow solid (yield 33%). 1H-NMR (300 
MHz, CDCl3) δ 8.06 (d, J = 9.2 Hz, 2H), 7.57 (d, J = 8.7 
Hz, 2H), 7.16 (d, J = 9.2 Hz, 2H), 6.81 (d, J = 8.7 Hz, 
2H), 6.32 (br s, NH), 3.76 (s, 3H), 1.42 (s, 9H); 13C-
NMR (75 MHz, CDCl3) δ 163.6, 162.0, 161.7, 157.3, 
142.2, 128.8, 125.5, 121.9, 114.2, 114.0, 55.3, 52.7, 
28.6; νmax/cm-1 (KBr) 3277, 2968, 1646, 1511, 1335, 
1239, 914; mp 133.2-134 °C; HRMS (EI+): m/z: calcd for C19H21N3O5: 371.1481, 
Found: 371.1483. 
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(Z)-2-(4-methoxyphenyl)-2-((4-nitrophenoxy)imino)-N-pentylacetamide, 
5{2,3,1} 
The crude material was purified by column 
chromatography (PE/EtOAc 9:1, 8:2) to give the 
product as yellow solid (yield 39%). Mixture of E/Z 
isomers, signals are referred to the main isomer: 1H-
NMR (300 MHz, CDCl3) δ 8.13-8.09 (m, 2H), 7.63-
7.59 (m, 2H), 7.22-7.19 (m, 2H), 6.87-6.82 (m, 2H), 
6.53 (br t, NH), 3.80 (s, 3H), 3.47-3.42 (m, 2H), 1.60-
1.57 (m, 2H), 1.34-1.32 (m, 4H), 0.90-0.87 (m, 3H); 
13C-NMR (75 MHz, CDCl3) δ 163.6, 162.6, 162.4, 
157.5, 142.6, 129.0, 125.7, 121.9, 114.4, 114.3, 55.5, 
39.7, 29.1, 29.0, 22.3, 14.0; νmax/cm-1 (KBr) 3266, 2930, 1650, 1515, 1337, 1180, 
931; mp 116.8-117 °C; HRMS (EI+): m/z: calcd for C20H23N3O5: 385.1638, Found: 
385.1640. 
 
 
(Z)-N-benzyl-2-(4-methoxyphenyl)-2-((2-nitrophenoxy)imino)acetamide, 
5{2,1,2} 
The crude material was purified by column 
chromatography (PE/EtOAc 9:1, 8:2) to give the 
product as yellow solid (yield 26%). 1H-NMR (300 
MHz, CDCl3) δ 7.98 (dd, J = 7.9, 1.5 Hz, 1H), 
7.79-7.71 (m, 3H), 7.60 (td, J = 7.8, 1.5 Hz, 1H), 
7.43-7.27 (m, 5H), 7.16 (td, J = 7.9, 1.2 Hz, 1H), 
6.97-6.91 (m, 2H), 6.60 (br t, NH), 4.75 (d, J = 5.8 
Hz, 2H), 3.85 (s, 3H); 13C-NMR (75 MHz, CDCl3) 
δ 162.4, 162.0, 157.6, 152.6, 137.3, 134.9, 129.5, 129.2, 128.9, 128.3, 127.9, 125.8, 
122.7, 122.2, 117.9, 114.5, 55.6, 44.0; νmax/cm-1 (KBr) 3411, 3285, 1646, 1522, 
1352, 1176, 924; mp 130.8-131.6 °C; HRMS (EI+): m/z: calcd for C22H19N3O5: 
405.1325, Found: 405.1326. 
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(Z)-N-(tert-butyl)-2-(4-methoxyphenyl)-2-((2-nitrophenoxy)imino)acetamide, 
5{2,2,2} 
The crude material was purified by column 
chromatography (PE/EtOAc 9:1, 8:2) to give the 
product as yellow solid (yield 49%). 1H-NMR (300 
MHz, CDCl3) δ 7.89 (dd, J = 8.3, 1.5 Hz, 1H), 7.73-7.68 
(m, 3H), 7.58-7.53 (m, 1H), 7.14-7.09 (m, 1H), 6.90 
(dd, J = 8.8, 1.8 Hz, 2H), 6.07 (br s, NH), 3.82 (s, 3H), 
1.51 (s, 9H); 13C-NMR (75 MHz, CDCl3) δ 162.2, 
161.2, 157.6, 152.7, 138.0, 134.6, 129.2, 125.4 (2C), 
122.5, 118.2, 114.4, 55.5, 53.1, 28.7; νmax/cm-1 (KBr) 3262, 2968, 1646, 1522, 
1473, 1230, 918; mp 115.8-116.3 °C; HRMS (EI+): m/z: calcd for C19H21N3O5: 
371.1481, Found: 371.1478. 
 
 
(Z)-2-(4-methoxyphenyl)-2-((2-nitrophenoxy)imino)-N-pentylacetamide, 
5{2,3,2} 
The crude material was purified by column 
chromatography (PE/EtOAc 9:1, 8:2) to give the 
product as brown solid (yield 45%). 1H-NMR (300 
MHz, CDCl3) δ 7.96-7.89 (m, 1H), 7.77-7.65 (m, 3H), 
7.57-7.51 (m, 1H), 7.12-7.06 (m, 1H), 6.89-6.86 (m, 
2H), 6.51 (br s, NH), 3.81 (s, 3H), 3.48-3.44 (m, 2H), 
1.65-1.61 (m, 2H), 1.34-1.32 (m, 4H), 0.90-0.85 (m, 
3H); 13C-NMR (75 MHz, CDCl3) δ 162.2, 161.9, 
157.7, 152.6, 137.7, 134.7, 129.3, 125.6, 122.5, 122.3, 117.8, 114.3, 55.4, 39.9, 
29.1, 28.9, 22.3, 14.0; νmax/cm-1 (KBr) 3244, 2936, 1645, 1558, 1344, 1179, 916; 
mp 105-106 °C; HRMS (EI+): m/z: calcd for C20H23N3O5: 385.1638 Found: 
385.1641. 
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(Z)-N-benzyl-2-((2,4-dinitrophenoxy)imino)-2-(4-methoxyphenyl)acetamide, 
5{2,1,3} 
The crude material was purified by column 
chromatography (PE/EtOAc 8:2, 7:3) to give the 
product as white solid (yield 40%). 1H-NMR (300 
MHz, CDCl3 1 gtt DMSO-d6) δ 8.74 (d, J = 2.5 
Hz, 1H), 8.33 (dd, J = 9.5, 2.7 Hz, 1H), 7.88 (dd, J 
= 9.5, 3.9 Hz, 1H), 7.59 (d, J = 8.6 Hz, 2H), 7.27-
7.18 (m, 5H), 6.83 (d, J = 8.6 Hz, 2H), 4.56 (s, 
2H), 3.77 (s, 3H); 13C-NMR (75 MHz, CDCl3 + 1 
gtt DMSO-d6) δ 163.0, 160.3, 156.9 (2C), 141.5, 
137.1, 136.4, 129.7, 129.5, 128.9, 128.3, 128.0, 
122.2, 121.1, 117.6, 114.8, 55.6, 43.9; νmax/cm-1 (KBr) 3269, 1643, 1535, 1340, 
1255, 927; mp 163.3-164 °C; HRMS (EI+): m/z: calcd for C22H18N4O7: 450.1175, 
Found: 450.1177. 
 
 
(Z)-N-(tert-butyl)-2-((2,4-dinitrophenoxy)imino)-2-(4-
methoxyphenyl)acetamide, 5{2,2,3} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as yellow solid (yield 33%). 1H-NMR (400 
MHz, CDCl3) δ 8.86 (s, 1H), 8.45 (d, J = 9.0 Hz, 1H), 
7.99 (d, J = 9.3 Hz, 1H), 7.75 (d, J = 7.6 Hz, 2H), 6.97 
(d, J = 7.6 Hz, 2H), 5.80 (br s, NH), 3.87 (s, 3H), 1.54 (s, 
9H); 13C-NMR (100 MHz, CDCl3) δ 162.6, 160.5, 159.2, 
156.7, 141.1, 136.2, 129.4, 129.1, 121.7, 121.3, 117.6, 
114.5, 55.4, 53.3, 28.5; νmax/cm-1 (KBr) 3295, 2971, 
1666, 1526, 1340, 833; mp 148-149 °C; HRMS (EI+): 
m/z: calcd for C19H20N4O7: 416.1332, Found: 416.1332. 
Aryloxymino amides 
121 
 
 
(Z)-2-((2,4-dinitrophenoxy)imino)-2-(4-methoxyphenyl)-N-pentylacetamide, 
5{2,3,3} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as pale yellow solid (yield 40%). 1H-NMR 
(400 MHz, CDCl3) δ 8.82 (br s, 1H), 8.40 (br d, 
AA’XX’, 1H), 7.95 (d, J = 9.3 Hz, 1H), 7.68 (d, J = 
8.6 Hz, 2H), 6.91 (d, J = 8.6 Hz, 2H), 6.24 (br t, NH), 
3.84 (s, 3H), 3.53-3.48 (m, 2H), 1.67-1.63 (m, 2H), 
1.37-1.35 (m, 4H), 0.92-0.89 (m, 3H); 13C-NMR (100 
MHz, CDCl3) δ 162.8, 161.4, 159.8, 156.6, 141.1, 
136.1, 129.5, 129.2, 121.9, 121.0, 117.4, 114.4, 55.4, 
39.9, 29.1, 28.8, 22.2, 13.9; νmax/cm-1 (KBr) 3283, 2929, 1654, 1521, 1343, 1260, 
833; mp 139-140 °C; HRMS (EI+): m/z: calcd for C20H22N4O7: 430.1488, Found: 
430.1489. 
 
 
(Z)-N-benzyl-2-((2-chloro-4-nitrophenoxy)imino)-2-(4-
methoxyphenyl)acetamide, 5{2,1,4} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 8:2) to give the 
product as light yellow solid (yield 63%). 1H-NMR 
(400 MHz, CDCl3) δ 8.28 (s, 1H), 8.16 (br d, 1H), 
7.76-7.71 (m, 3H), 7.42-7.30 (m, 5H), 6.96 (d, 
J=7.7, 2H), 6.23 (br s, NH), 4.72 (d, J=5.5, 2H), 
3.87 (s, 3H); 13C-NMR (100 MHz, DMSO-d6) δ 
162.6, 161.8, 159.8, 159.2, 142.4, 138.7, 129.5 
128.7, 128.2, 127.5, 126.1, 124.9, 121.9, 119.8, 
115.8, 115.1, 55.9, 42.7; νmax/cm-1 (KBr) 3263, 
1650, 1512, 1254, 926; mp 149-150 °C; HRMS (EI+): m/z: calcd for 
C22H18ClN3O5: 439.0935 Found: 439.0939. 
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(Z)-N-(tert-butyl)-2-(2-chloro-4-nitrophenoxy)imino)-2-(4-
methoxyphenyl)acetamide, 5{2,2,4} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as amorphous dark-red solid (yield 38%). 1H-
NMR (400 MHz, CDCl3) δ 8.29 (br s, 1H), 8.16 (br d, 
1H), 7.75-7.72 (m, 3H), 6.95 (d, J = 8.7 Hz, 2H), 5.79 
(br s, NH), 3.86 (s, 3H), 1.53 (s, 9H); 13C-NMR (100 
MHz, CDCl3) δ 162.3, 161.0, 159.3, 158.1, 142.0, 
129.1, 125.8, 123.6, 121.7, 120.5, 114.7, 114.4, 55.4, 
52.9, 28.7; νmax/cm-1 (KBr) 3566, 1652, 1516, 1338, 
1255, 920; HRMS (EI+): m/z: calcd for C19H20ClN3O5: 
405.1091, Found: 405.1093. 
 
 
(Z)-2-((2-chloro-4-nitrophenoxy)imino)-2-(4-methoxyphenyl)-
Npentylacetamide, 5{2,3,4} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 8:2) to give the 
product as yellowish solid (yield 50%). 1H-NMR (400 
MHz, CDCl3) δ 8.28 (s, 1H), 8.15 (br d, 1H), 7.75-
7.71 (m, 3H), 6.95 (d, J = 8.7 Hz, 2H), 5.99 (br s, 
NH), 3.86 (s, 3H), 3.55-3.50 (m, 2H), 1.69-1.66 (m, 
2H), 1.40-1.36 (m, 4H), 0.93-0.90 (m, 3H); 13C-NMR 
(100 MHz, CDCl3) δ 162.5, 161.8, 159.1, 158.5, 
142.3, 129.2, 125.8, 123.7, 121.5,120.6, 114.8, 114.3, 
55.4, 39.8, 29.1, 29.0, 22.3, 13.9; νmax/cm-1 (KBr) 3261, 2958, 1646, 1582, 1335, 
1255, 921; mp 124-125 °C; HRMS (EI+): m/z: calcd for C20H22ClN3O5: 419.1248, 
Found: 419.1248. 
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(Z)-N-(tert-butyl)-2-(4-methoxyphenyl)-2-(((5-nitropyridin-2-
yl)oxy)imino)acetamide, 5{2,2,5} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as white solid (yield 22%). 1H-NMR (400 
MHz, CDCl3) δ 9.16 (br s, 1H), 8.50 (br d, AA’XX’, 
1H), 7.76 (d, J = 7.7 Hz, 2H), 7.40 (d, J = 9.2 Hz, 1H), 
6.96 (d, J = 7.9 Hz, 2H), 5.65 (br s, NH), 3.86 (s, 3H), 
1.53 (s, 9H); 13C-NMR (100 MHz, DMSO-d6) δ 168.1, 
162.4, 161.3, 159.3, 145.4, 140.8, 136.2, 129.4, 122.3, 
115.1, 108.8, 55.9, 51.9, 28.9; νmax/cm-1 (KBr) 3419, 
1613, 1515, 1347, 1258, 927; mp 174-175 °C; HRMS 
(EI+): m/z: calcd for C18H20N4O5: 372.1434, Found: 372.1439. 
 
 
(Z)-2-(4-methoxyphenyl)-2-(((5-nitropyridin-2-yl)oxy)imino)-N-
pentylacetamide, 5{2,3,5} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as sticky dark-red solid (yield 39%). Mixture 
of E/Z isomers, signals are referred to the main 
isomer: 1H-NMR (400 MHz, CDCl3) δ 9.16 (br s, 1H), 
8.80 (br s, NH), 8.02 (br d, AA’XX’, 1H), 7.68 (d, J = 
8.7 Hz, 1H), 7.51 (d, J = 8.6 Hz, 2H), 6.88 (d, J = 8.7 
Hz, 2H), 3.81 (s, 3H), 3.37-3.34 (m, 2H), 1.65-1.60 
(m, 2H), 1.29-1.25 (m, 4H), 0.90-0.84 (m, 3H); 13C-
NMR (100 MHz, CDCl3) δ 167.6, 162.6, 161.0, 149.1, 
136.9, 133.7, 131.9, 128.0, 123.8, 120.8, 114.1, 55.3, 52.0, 29.7, 28.9, 22.2, 13.9; 
νmax/cm-1 (KBr) 3473, 3414, 1682, 1616, 1255, 933; HRMS (EI+): m/z: calcd for 
C19H22N4O5: 386.1590, Found: 386.1587. 
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(Z)-N-benzyl-2-(4-chlorophenyl)-2((4-nitrophenoxy)imino)acetamide, 5{3,1,1} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 8:2) to give the 
product as pale yellow solid (yield 55%). 1H-NMR (400 
MHz, CDCl3) δ 8.23 (d, J = 9.2 Hz, 2H), 7.73 (d, J = 8.5 
Hz, 2H), 7.44-7.35 (m, 7H), 7.27-7.25 (m, 2H), 6.22 (br 
t, NH), 4.72 (br d, 2H); 13C-NMR (100 MHz, CDCl3) δ 
163.0, 161.6, 156.4, 143.0, 138.0, 137.1, 129.3, 128.9, 
128.5, 128.0, 127.9, 127.9, 125.7, 114.3, 43.6; νmax/cm-1 
(KBr) 3411, 1654, 1515, 1345, 1220, 929, 850; mp 159-
160 °C; HRMS (EI+): m/z: calcd for C21H16ClN3O4: 
409.0829, Found: 409.0831. 
 
 
(Z)-N-(tert-butyl)-2-(4-chlorophenyl)-2((4-nitrophenoxy)imino)acetamide, 
5{3,2,1} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as yellow solid (yield 53%). 1H-NMR (400 MHz, 
CDCl3) δ 8.25 (d, J = 9.2 Hz, 2H), 7.73 (d, J = 8.5 Hz, 
2H), 7.44 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 9.2 Hz, 2H), 
5.61 (br s, NH), 1.53 (s, 9H); 13C-NMR (100 MHz, 
CDCl3) δ 163.2, 161.0, 156.6, 142.7, 137.7, 129.2, 128.4, 
128.1, 125.6, 114.2, 53.0, 28.7; νmax/cm-1 (KBr) 3272, 
2965, 1651, 1517, 1342, 1237, 917, 841; mp 160-161 °C; 
HRMS (EI+): m/z: calcd for C18H18ClN3O4: 375.0986, 
Found: 375.0989. 
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(Z)- 2-(4-chlorophenyl)-2((4-nitrophenoxy)imino)-N-pentylacetamide, 5{3,3,1} 
 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as yellow solid (yield 43%). 1H-NMR (400 
MHz, CDCl3) δ 8.23 (br d, AA’XX’, 2H), 7.72 (d, J = 
8.6 Hz, 2H), 7.42 (d, J = 8.6 Hz, 2H), 7.33 (br d, J = 9.2 
Hz, 2H), 5.94 (br t, NH), 3.55-3.50 (m, 2H), 1.68-1.63 
(m, 2H), 1.42-1.38 (m, 4H), 0.94-0.91 (m, 3H); 13C-
NMR (100 MHz, CDCl3) δ 163.1, 161.6, 156.6, 142.7, 
137.7, 129.2, 128.5, 128.1, 125.6, 114.3, 39.6, 29.0, 
28.9, 22.2, 13.9; νmax/cm-1 (KBr) 3301, 2953, 1660, 
1508, 1339, 927, 854; mp 106-107 °C; HRMS (EI+): m/z: calcd for C19H20ClN3O4: 
389.1142, Found: 389.1141. 
 
 
(Z)-N-benzyl-2-(4-chlorophenyl)-2((2-nitrophenoxy)imino)acetamide, 5{3,1,2} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as pale yellow solid (yield 42%). 1H-NMR 
(400 MHz, CDCl3) δ 8.00 (d, J = 8.2 Hz, 2H), 7.77-
7.72 (m, 3H), 7.63 (br t, 1H), 7.42-7.29 (m, 7H), 
7.22-7.18 (m, 1H), 6.80 (br s, NH), 4.74 (br d, 2H); 
13C-NMR (100 MHz, CDCl3) δ 161.0, 156.5, 152.1, 
137.6, 137.0, 134.8, 129.1, 129.0, 128.8, 128.4, 
128.1, 127.7, 125.7, 123.1, 117.9, 43.9; νmax/cm-1 (KBr) 3412, 3248, 1638, 1525, 
1337, 1225, 926, 832; mp 145-146 °C; HRMS (EI+): m/z: calcd for C21H16ClN3O4: 
409.0829, Found: 409.0832. 
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(Z)-N-(tert-butyl)-2-(4-chlorophenyl)-2((2-nitrophenoxy)imino)acetamide, 
5{3,2,2} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as yellow solid (yield 48%). 1H-NMR (400 MHz, 
CDCl3) δ 7.96 (br d, AA’XX’, 1H), 7.74-7.71 (m, 3H), 
7.63-7.59 (m, 1H), 7.41-7.39 (m, 2H), 7.21-7.17 (m, 1H), 
6.07 (br s, NH), 1.53 (s, 9H); 13C-NMR (100 MHz, 
CDCl3) δ 160.4, 156.5, 152.2, 137.8, 137.4, 134.5, 129.0, 
128.7, 128.6, 125.4, 122.8, 118.0, 53.1, 28.5; νmax/cm-1 
(KBr) 3249, 2972, 1634, 1515, 1347, 1228, 915, 739; mp 
125-126 °C; HRMS (EI+): m/z: calcd for C18H18ClN3O4: 375.0986, Found: 
375.0983. 
 
 
(Z)- 2-(4-chlorophenyl)-2((2-nitrophenoxy)imino)-N-pentylacetamide, 5{3,3,2} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as brown solid (yield 41%). 1H-NMR (400 
MHz, CDCl3) δ 7.99 (d, J = 8.2 Hz, 1H), 7.75-7.71 (m, 
3H), 7.62 (br t, 1H), 7.40 (d, J = 8.2 Hz, 2H), 7.20 (br 
t, 1H), 6.52 (br s, NH), 3.56-3.51 (m, 2H), 1.70-1.67 
(m, 2H), 1.37-1.32 (m, 4H), 0.92-0.89 (m, 3H); 13C-
NMR (100 MHz, CDCl3) δ 161.0, 156.7, 152.1, 137.7, 
137.4, 134.7, 129.0, 128.9, 128.6, 125.6, 123.0, 117.8, 39.9, 29.0, 28.8, 22.2, 13.9; 
νmax/cm-1 (KBr) 3255, 2929, 1652, 1521, 1347, 1226, 921, 833; mp 60-61 °C; 
HRMS (EI+): m/z: calcd for C19H20ClN3O4: 389.1142, Found: 389.1141. 
 
N O H
N
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(Z)-N-benzyl-2-(4-chlorophenyl)-2((2,4-dinitrophenoxy)imino)acetamide, 
5{3,1,3} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as yellow solid (yield 34%). 1H-NMR (400 
MHz, CDCl3) δ 8.92 (br s, 1H), 8.48 (br d, 
AA’XX’, 1H), 8.00 (d, J = 9.4 Hz, 1H), 7.75 (d, J = 
8.5 Hz, 2H), 7.46-7.37 (m, 7H), 6.42 (br s, NH), 
4.75 (br d, 2H); 13C-NMR (100 MHz, DMSO-d6) δ 
161.0, 159.8, 155.7, 141.8, 138.2, 137.4, 136.7, 
130.2, 129.9, 129.6, 128.9, 128.4, 128.0, 127.6, 
122.2, 118.0, 42.9; νmax/cm-1 (KBr) 3236, 1604, 
1533, 1342, 835; mp 142-143 °C; HRMS (EI+): m/z: calcd for C21H15ClN4O6: 
454.0680, Found: 454.0683. 
 
 
(Z)-N-(tert-butyl)-2-(4-chlorophenyl)-2((2,4-dinitrophenoxy)imino)acetamide, 
5{3,2,3} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as yellow solid (yield 46%). 1H-NMR (400 MHz, 
CDCl3) δ 8.86 (s, 1H), 8.46 (d, J = 9.3 Hz, 1H), 7.96 (d, J 
= 9.3 Hz, 1H), 7.73 (d, J = 8.1 Hz, 2H), 7.43 (d, J = 8.0 
Hz, 2H), 5.93 (br s, NH), 1.53 (s, 9H); 13C-NMR (100 
MHz, CDCl3) δ 159.7, 158.5, 156.3, 141.5, 138.4, 136.4, 
129.3, 129.1, 128.9, 127.7, 121.7, 117.7, 53.5, 28.5; 
νmax/cm-1 (KBr) 3275, 2972, 1660, 1540, 1344, 1283, 
833, 740; mp 118-119 °C; HRMS (EI+): m/z: calcd for 
C18H17ClN4O6: 420.0837, Found: 420.0840. 
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(Z)- 2-(4-chlorophenyl)-2((2,4-dinitrophenoxy)imino)-N-pentylacetamide, 
5{3,3,3} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as yellow solid (yield 32%). 1H-NMR (400 
MHz, CDCl3) δ 8.90 (br s, 1H), 8.47 (br d, AA’XX’, 
1H), 7.98 (d, J = 9.3 Hz, 1H), 7.74 (d, J = 8.6 Hz, 2H), 
7.44 (d, J = 8.5 Hz, 2H), 6.18 (br s, NH), 3.57-3.52 (m, 
2H), 1.70-1.67 (m, 2H), 1.39-1.37 (m, 4H), 0.93-0.90 
(m, 3H); 13C-NMR (100 MHz, CDCl3) δ 160.6, 158.9, 
156.2, 141.5, 138.5, 136.2, 129.3, 129.3, 129.0, 127.4, 
121.9, 117.4, 40.0, 29.0, 28.7, 22.2, 13.9; νmax/cm-1 (KBr) 3284, 1652, 1558, 
1472, 1344, 834, 739; mp 156-157 °C; HRMS (EI+): m/z: calcd for C19H19ClN4O6: 
434.0993, Found: 434.0995. 
 
 
(Z)-N-benzyl-2-((2-chloro-4-nitrophenoxy)imino)-2-(4-chlorophenyl) 
acetamide, 5{3,1,4} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 8:2) to give the 
product as light yellow solid (yield 63%). 1H-NMR 
(400 MHz, CDCl3) δ 8.22 (br s, 1H), 8.11 (br d, 
AA’XX’, 1H), 7.69-7.65 (m, 3H), 7.38-7.25 (m, 8H), 
4.61 (s, 2H); 13C-NMR (100 MHz, DMSO-d6) δ 
161.2, 158.9, 158.9, 142.7, 138.4, 137.1, 129.8, 
129.4, 128.8, 128.7, 128.2, 127.6, 126.1, 124.9, 
119.9, 115.9, 42.8; νmax/cm-1 (KBr) 3353, 3104, 
1676, 1523, 1344, 933, 741; mp 165-166 °C; HRMS 
(EI+): m/z: calcd for C21H15Cl2N3O4: 443.0440, Found: 443.0441. 
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(Z)-N-(tert-butyl)-2-((2-chloro-4-nitrophenoxy)imino)-2-(4-
chlorophenyl)acetamide, 5{3,2,4}  
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as yellow solid (yield 47%). 1H-NMR (400 MHz, 
CDCl3) δ 8.30 (s, 1H), 8.18 (d, J = 9.0, 1H), 7.75-7.72 (m, 
3H), 7.43 (d, J = 8.2 Hz, 2H), 5.84 (br s, NH), 1.53 (s, 
9H); 13C-NMR (100 MHz, CDCl3) δ 160.3, 158.9, 157.3, 
142.3, 137.8, 129.1, 128.6, 128.0, 125.8, 123.6, 120.5, 
114.7, 53.0, 28.7; νmax/cm-1 (KBr) 3300, 2972, 1652, 
1555, 1344, 1233, 930; mp 144-145 °C; HRMS (EI+): 
m/z: calcd for C18H17Cl2N3O4: 409.0596, Found: 409.0595. 
 
 
(Z)-2-((2-chloro-4-nitrophenoxy)imino)-2-(4-chlorophenyl)-N-
pentylacetamide, 5{3,3,4} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as yellow solid (yield 56%). 1H-NMR (400 
MHz, CDCl3) δ 8.29 (br s, 1H), 8.16 (br d, AA’XX’, 
1H), 7.74-7.69 (m, 3H), 7.42 (d, J = 8.6 Hz, 2H), 6.12 
(br s, NH), 3.54-3.49 (m, 2H), 1.69-1.66 (m, 2H), 1.38-
1.36 (m, 4H), 0.93-0.90 (m, 3H); 13C-NMR (100 MHz, 
CDCl3) δ 161.1, 158.8, 157.7, 142.4, 138.0, 129.1, 
128.6, 127.8, 125.8, 123.6, 120.6, 114.6, 39.8, 31.5, 
29.0, 22.2, 13.9; νmax/cm-1 (KBr) 3246, 2929, 1646, 
1582, 1343, 928, 834; mp 136-137 °C; HRMS (EI+): m/z: calcd for 
C19H19Cl2N3O4: 423.0753, Found: 423.0757. 
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(Z)-N-(tert-butyl)-2-(4-chlorophenyl)-2(((4-nitropyridin-2-
yl)oxy)imino)acetamide, 5{3,2,5} 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 7:3) to give the 
product as white solid (yield 42%). 1H-NMR (400 MHz, 
CDCl3) δ 9.18 (br s, 1H), 8.52 (br d, AA’XX’, 1H), 7.76 
(d, J = 8.6 Hz, 2H), 7.45-7.39 (m, 3H), 5.70 (br s, NH), 
1.53 (s, 9H); 13C-NMR (100 MHz, CDCl3) δ 167.8, 160.8, 
158.6, 145.4, 141.1, 136.9, 136.3, 129.7, 129.4, 129.1, 
109.0, 52.1, 28.8; νmax/cm-1 (KBr) 3414, 3293, 1675, 
1577, 1349, 935, 833; mp 193-194 °C; HRMS (EI+): m/z: 
calcd for C17H17ClN4O4: 376.0938, Found: 376.0939. 
 
 
(Z)-2-(4-chlorophenyl)-2-(((5-nitropyridin-2-yl)oxy)imino)-N-pentylacetamide, 
5{3,3,5} 
 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as sticky dark-red solid (yield 35%). Mixture 
of E/Z isomers, signals are referred to the main 
isomer: 1H-NMR (400 MHz, CDCl3) δ 9.15 (s, 1H), 
9.03 (br s, NH), 8.05 (br d, AA’XX’, 1H), 7.70 (d, J 
= 8.5 Hz, 1H), 7.52 (d, J = 8.5 Hz, 2H), 7.34 (d, J = 
8.6 Hz, 2H), 3.34-3.30 (m, 2H), 1.65-1.62 (m, 2H), 
1.27-1.25 (m, 4H), 0.92-0.85 (m, 3H); 13C-NMR 
(100 MHz, CDCl3) δ 167.2, 160.9, 148.8, 148.0, 144.9, 136.6, 135.1, 133.9, 130.0, 
129.0, 127.7, 52.1, 29.7, 28.9, 22.2, 13.9; νmax/cm-1 (KBr) 2932, 1691, 1564, 
1345, 1273, 935, 834; HRMS (EI+): m/z: calcd for C18H19ClN4O4: 390.1095, 
Found: 390.1098. 
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(Z)-2-(2-((tert-butyldimethylsilyl)oxy)phenyl)-2-((2,4-dinitrophenoxy)imino)-
N-pentylacetamide, 7 
The crude material was purified by column 
chromatography (PE/EtOAc 9:1) to give the 
product as yellow solid (yield 48%). 1H-NMR 
(300 MHz, CDCl3) δ 8.86 (d, J = 2.7 Hz, 1H), 
8.42 (dd, J = 6.7, 2.4 Hz, 1H), 7.99 (d, J = 9.5 
Hz, 1H), 7.46 (dd, J = 7.6, 1.5 Hz , 1H), 6.99-
6.85 (m, 3H), 3.42-3.38 (m, 2H), 1.67-1.62 (m, 
2H), 1.33-1.31 (m, 4H), 0.90 (s, 12H), 0,19 (s, 
6H); 13C-NMR (75 MHz, CDCl3) δ 159.7, 
159.4, 156.5, 154.3, 141.6, 136.1, 132.1, 
131.0, 129.5, 122.5, 122.1, 121.3, 119.6, 117.9, 40.3, 29.2, 28.7, 25.8, 22.3, 18.4, 
14.0, -4.0; m/z 532 (M+H)+; νmax/cm-1 (KBr) 3292, 1607, 1537, 1486, 1260, 914; 
mp 110.8-111.2°C; HRMS (EI+): m/z: calcd for C25H34N4O7Si: 530.2197, Found: 
530.2201. 
 
 
N-pentylbenzo[d]isoxazole-3-carboxamide, 8 
The crude material was purified by column chromatography 
(PE/EtOAc 9:1) to give the product as yellow amorphous 
solid (yield quantitative). 1H-NMR (300 MHz, CDCl3) δ 8. 
26 (d, J = 9.3 Hz, 1H), 7.56 (br d, 2H), 7.36 (m, 1H), 7.08 
(br s, NH), 3.49 (m, 2H), 1.65-1.61 (m, 2H), 1.36-1.33 (m, 
4H), 0.89-0.87 (m, 3H); 13C-NMR (75 MHz, CDCl3) δ 
164.15, 159.3, 152.0, 130.4, 124.9, 124.0, 120.0, 109.7, 
39.5, 29.2, 29.1, 22.4, 14.0; m/z 233 (M+H)+; νmax/ cm-1 
(KBr) 3271, 1672, 1548, 1254, 913; HRMS (EI+): m/z: 
calcd for C13H16N2O2: 232.1212, Found: 232.1212. 
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HPLC data 
 
The HPLC-UV analyses were performed using two different chromatographic 
methods on 200 ppm methanolic solution of each compound, setting the 
temperature of the column at 35 °C and the UV detection at 254 nm. 
 
METHOD A: X-Terra Phenyl 3.5um 3.0*150 mm; isocratic elution water: 
methanol 30 : 70, run time 20 min; injection volume 3 µl; flow rate 500 µl/min 
 
METHOD B: Syncronis C18 5 u 4.6*150 mm; isocratic elution water : 
methanol 15 : 85, run time 20 min; injection volume 5 µl; flow rate 800 µl/min 
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A multicomponent reaction 
among Z-chlorooximes, 
isocyanides and 
hydroxylamines as 
hypernucleophilic traps. A 
one-pot route to 
aminodioximes and their 
transformation into 
5‑amino-1,2,4-oxadiazoles by 
Mitsunobu−Beckmann 
rearrangement
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7.1 Results and discussion 
 
We envisaged a novel multicomponent reaction using a hyper-nucleophile, like 
hydroxylamine as the third component, even though literature reports on the 
isocyanide-mediated multicomponent processes involving hydroxylamine were 
somewhat discouraging. Indeed, the reactive nature of hydroxylamine, due to its 
three nucleophile sites, renders poor yields and several side products in the Ugi 
reaction.1–3. Moreover, hydroxylamines have been shown to react very quickly with 
the nitrile N-oxides, and low temperatures were necessary to give satisfactory 
yields.4,5 
In order to demonstrate the untamed nature of the reaction between 
hydroxylamine and nitrile N-oxides at room temperature, we carried out a two-
component reaction between Z-phenychlorooxime and hydroxylamine in 
dichloromethane in the presence of TEA. The result was a plethora of spots on 
TLC and we were able to isolate only trace amounts of the desired compound. 
After these preliminary results, we set up a three-component reaction among Z-
phenylchlorooxime 1, pentylisocyanide 2, and hydroxylamine 3 in 
dichloromethane using 1 equiv of TEA at room temperature. Hydroxylamine was 
used as free base, prepared starting from its hydrochloric salt as reported in 
literature.6 
In this case, we observed a clean reaction and the smooth formation of two 
products. 1H NMR analysis revealed the formation of the desired aminodioxime 4 
in 45% yield and the amide 5 in 15% yield (Scheme 1).  
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Scheme 1. The novel three component reaction with hydroxylamine. 
We rationalized the formation of the amide 5 due to the reaction between the 
nitrilium ion and the hydroxyl group of hydroxylamine to give an unstable imidate 
7 prone to undergo hydrolysis to the amide (Scheme 2).  
 
Scheme 2. Proposed mechanism for the formation of the amide 5. 
In order to verify this hypothesis, the reaction was run using either o-
benzylhydroxylamine 8 or o-methylhydroxylamine 10. The corresponding 
aminodioxime 9 and 11 were obtained in 82 and 84% yield, respectively, without 
observable formation of the amide byproduct (Scheme 3).  
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Scheme 3. Multicomponent reaction using o-benzylhydroxylamine 9 
or o-methylhydroxylamine 11. 
Motivated by these preliminary results, and with the goal of 
suppressing/reducing the formation of the undesired amide, and hence decrease the 
formation of the alcholate of hydroxylamine, we decided to screen different bases 
in dichloromethane. The results are shown in Table 1.  
Entry Base eq. Yield % 4 Yield % 5 
1 N-methylmorpholine 1 65% 11% 
2 TEA 3 47% 10% 
4 imidazole 1 67% 8% 
5 NaHCO3 1 72% 10% 
6 N-methylmorfoline 2 18% 16% 
7 2,6-Lutidine 1 52% 9% 
 
Table 1. Optimization of the reaction conditions. 
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We observed that the use of the less basic sodium bicarbonate (entry 5) was able 
to reduce the formation the amide probably due to the reduced ionization to the 
corresponding alcoholate and it increased the yield of aminodioxime to 72%. 
With such optimized conditions in hand, we explored the scope of this novel 
multicomponent reaction using different Z-chlorooximes (1 and 12-19) and 
isocyanides (2 and 20-22) (Figure 1).  
 
Figure 1. Building blocks used. 
 
The library of compounds synthesized is shown in Figure 2. 
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Figure 2. Aminodioximes synthesized (amide by-product was always 
isolate in less then 10% yield). 
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As show in Figure 2, the reaction is quite general: primary, secondary, tertiary 
isocyanides are able to initiates the multicomponent process while the reaction fails 
with the less reactive aromatic isocyanides. Aromatic, heteroaromatic and aliphatic 
Z-chlorooximes were successfully used as generators of the nitrile N-oxide species. 
 
The 1H and 13C NMR spectra of the aminodioximes 4, recorded in DMSO-d6, 
revealed the presence of an equilibrium between the imino and the amino forms, 
which is shifted prevalently toward the amino tautomer.7,8  
In the most plausible mechanistically scenario from the [3+1] cycloaddition of 
isocyanide and nitrile N-oxide should be obtained a four-membered ring, which 
readily opens, in order to relieve the ring strain, affording the nitrilium intermediate 
which could now be attacked by a third nucleophile, the hydroxylamine, finally 
forming the novel product (Scheme 4). 
 
Scheme 4. Proposed mechanism for the selective addition of isocyanides to 
nitrile N-oxide in the presence of a third nucleophile. 
 
On the basis of the proposed reaction mechanism and considering that the 
transition from one oxime geometrical isomer to another requires either high 
temperature or acid or base catalysis or ultraviolet light,9 it is reasonable to assume 
that the first oxime retains the syn configuration while the amidoxime moiety can, 
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in principle, exist as a mixture of tautomers. As one major isomer is always 
formed, it is reasonable to think that it is the more stable amphi form (Z,Z).  
In order to unambiguously establish the stereochemistry of the aminodioximes 
synthesized, a single-crystal X-ray diffraction analysis on derivative 23 was carried 
out and its crystallographic structure is presented in Figure 3 confirm the amphi 
form. 
 
Figure 3. ORTEP19 view of 23, showing the arbitrary atom-labeling scheme. Atomic 
displacement parameters for non-H atoms are at 40% probability level. 
The overall molecular conformation is determined by the “Z” conformation of 
the C7=N1 double bond, as shown by the value of the torsional angle C8-C7-N1-
O2 of 7(1)°, and by the “E” conformation of the C8=N2 moiety, characterized by 
the torsional angle C7-C8-N2-O1 of 180(1)°. The orientation of the benzene ring 
with respect to the oxime groups is defined by dihedral angles of 24.0(2)° and 
80.3(2)°between the ring and the C7-N1-O2-H21 and C8-N2-O1-H12 planes, 
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respectively. In the solid state are present only intermolecular interactions and a 
hydrogen-bond pattern is observed, in agreement with the crystal data of oximes 
previously published10,11 (see Experimental section). 
Aminodioxines are also pivotal reagent for the synthesis of 2-aminofurazans12,13 
under dehydrative conditions (4 M NaOH). Depending on the substrate 
functionalization such strong basic conditions are not always viable, rendering this 
transformation poor in scope. We recently demonstrated that for sensitive 
substrates mild dehydrative conditions using the Mitsunobu reaction on vicinal bis-
oximes can afford furazans.14 We therefore decided to employ the same 
dehydrative conditions with the newly formed aminodioximes.  
In particular, we tried dehydrative Mitsunobu conditions on the compound 24. 
Serendipitously, we did not obtain the expected 2-aminofurazan but the 
corresponding 5-amino-1,2,4-oxadiazole 38 in 74% yield (Scheme 5). The reaction 
was completely chemoselective as no other isomers were detected. In order to 
confirm the proposed structure, the same compound was prepared according a 
literature procedure reacting amidoximes with carbodiimides and the spectroscopic 
data were in agreement with those reported.15,16  
 
Scheme 5. Formation of the 5-amino-1,2,4-oxadiazole starting from the 
aminodioxime 24. 
To explain this result, we propose the following mechanistic scenario. The 
TPP−DEAD Morrison−Brunn−Huisgen betain extracts the proton of the 
aminooxime. Subsequently, the resulting alcoholate reacts with the TPP−DEAD 
adduct to give the intermediate 39, which spontaneously undergoes a Beckmann 
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rearrangement with the concomitant expulsion of TPPO. Finally the hydroxyl 
group of hydroxylamine, properly positioned, quenches the carbocationic species to 
afford the 1,2,4-oxadiazole nucleus (Scheme 6). A different mechanism involving a 
cycloaddition between cyanamides and nitrile N-oxides deriving from a Beckmann 
fragmentation was also considered but readily ruled out because when the reaction 
was run in the presence of a strong dipolarophile such as phenylacetylene the 
formation of the corresponding isooxazole deriving from the reaction between 
phenylacetylene and the nitrile N-oxide was not detected.17–19 
N OH
HN
N OH
DEAD
TPP
N OH
HN
N O P Ph
Ph Ph
TPPO
HN
N
NHO
HN
ON
NH
24 39
4038
 
Scheme 6. Proposed mechanism for the formation of 5-amino-1,2,4-
oxadiazoles starting from aminodioxides using Mistunobu conditions. 
We therefore applied this novel transformation to afford a small library of 5- 
amino-1,2,4-oxadiazoles (41-51) (Figure 4).  
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Figure 4. 5-amino-1,2,4-oxadiazoles synthesized. 
The reaction appears to be general in scope irrespective of which isomer 
prevails on the synthesized amidoximes. The unprecedented transformation of 
aminodioximes into 5-amino-1,2,4-oxadiazoles through a Beckmann rearrangement 
was also confirmed by a few reports where 3,5-diaryl-1,2,4- oxadiazoles were 
prepared from symmetrical 1,2-aryldioximes of α-aryl diketones.20,21 
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7.2 Conclusions 
 
In conclusion, with this work we have established a straightforward synthetic 
route which with only two synthetic steps affords at first aminodioximes and then 
5-aminosubstituted 1,2,4-oxadiazoles which, until now, required long syntheses. 
Both these class of compounds play important roles in several branches of 
chemistry22. 
Apart from their undisputed role in analytical chemistry, the obtained 
aminodioximes (also known as vic-dioximes) are an important class of ligands able 
to form complexes with several transition metals. Such complexes have been 
shown to be useful in different fields of chemistry,23 and some were also found to 
exhibit semiconducting properties.24,25 Their preparation by means of a one-pot 
multicomponent reaction constitutes a significant improvement on the previous 
methods, which typically require at least four to six reaction/purification steps 
when starting from acetophenones.  
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7.3 Experimental section 
 
General Methods. Commercially available reagents and solvents were used 
without further purification. Dichloromethane was dried by distillation from P2O5 
and stored over activated molecular sieves (4 Å). When necessary the reactions 
were performed in oven-dried glassware under a positive pressure of dry nitrogen. 
Melting points were determined in open glass capillaries and are uncorrected. All 
the compounds were characterized by IR. 1H and 13C APT NMR were recorded on 
a 300 MHz. High-resolution ESI-MS spectra were performed on a Thermo LTQ 
Orbitrap XL mass spectrometer. The spectra were recorded by infusion into the ESI 
source using MeOH as the solvent. Chemical shifts (δ) are reported in part per 
million (ppm) relative to the residual solvent peak. Column chromatography 
was performed on silica gel 70–230 Mesh ASTM or silica gel 230–400 Mesh 
ASTM when it was used Biotage Isolera. Thin layer chromatography (TLC) 
was carried out on 5 x 20 cm plates with a layer thickness of 0.25 mm (Silica gel 
60 F254). When necessary they were developed with KMnO4. 
 
General preparation of hydroxylamine solution. 
Hydroxylamine hydrochloride (15 mmol) in methanol (10 mL), was added to a 
stirred solution of potassium hydroxide (15 mmol) in methanol (4 mL) at 0 °C. The 
mixture was stirred for 30 min at room temperature and the precipitate potassium 
chloride was removed and the filtrate was used as such.16 
 
General preparation of C-oximinoimidamides (4, 9, 11, 23-37) 
The chlorooxime (1 eq.) was dissolved in dry dichloromethane. Isocyanide (1 
eq.), hydroxylamine (solution 1M in methanol, 1.2 eq.) and sodium bicarbonate (1 
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eq.) were added and the reaction was stirred at room temperature under a nitrogen 
atmosphere until all the chlorooxime was consumed (typically 16 hours as judged 
by TLC). The reaction mixture was concentrated under reduced pressure and the 
crude material was purified by column chromatography.  
 
General preparation of oxadiazoles (38, 41-51) 
To a cooled (0 °C) suspension of C-oximinoimidamide (1 eq.) in dry toluene 
was added triphenylphosphine (2 eq.). Diethyl azodicarboxylate (DEAD, 2 eq.) was 
then added dropwise and the resulting solution was heated at reflux under a 
nitrogen atmosphere. When reagents were consumed (typically 16 hours as judged 
by TLC) the reaction mixture was concentrated under reduced pressure and the 
crude material was purified by column chromatography.  
 
(1Z,2Z)-N'-hydroxy-2-(hydroxyimino)-N-pentyl-2-phenylacetimidamide (4). 
(Z)-N-hydroxybenzimidoyl chloride 100 mg (0.643 
mmol), 1-pentil isocyanide 0.081 mL (0.643 mmol), 
hydroxylamine 0.720 mL (solution 1M in methanol, 0.772 
mmol), sodium bicarbonate 54 mg (0.643 mmol), DCM 
dry 1 mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 8:2, 6:4) to give the 
product as white solid (114 mg, yield 71.6%). 
Signals are referred to the main isomer: 1H-NMR (300 MHz, DMSO-d6) δ 11.67 (s, 
OH), 9.38 (s, OH), 7.60 (m, 2H), 7.37 (m, 3H), 5.89 (t, NH, J = 6.4 Hz), 2.77 (br q, 
2H) 1.31 (m, 2H), 1.09 (m, 4H), 0.73 (t, 3H, J = 6.7 Hz); 13C-NMR (75 MHz, 
DMSO-d6) δ 148.8, 148.4, 135.0, 129.7, 128.9, 126.5, 42.4, 30.6, 28.8, 22.7, 14.3; 
IR (KBr) 3265, 1653, 1442, 1409, 948, 897, 691 νmax/cm-1; MS (ESI) m/z (M+H)+ 
Calcd for C13H19N3O2: 249.1477; Found: 272.1370 [M+Na]+.  
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(Z)-2-(hydroxyimino)-N-pentyl-2-phenylacetamide (5). 
White solid; yield 11.5%; 1H-NMR (300 MHz, DMSO-
d6) δ 11.45 (s, OH), 8.44 (t, NH, J = 5.5 Hz), 7.62 (m, 
2H), 7.39 (m, 3H), 3.21 (br q, 2H) 1.46 (m, 2H), 1.30 (m, 
4H), 0.87 (t, 3H, J = 6.7 Hz); 
13C-NMR (75 MHz, DMSO-d6) δ 163.9, 153.5, 133.0, 
129.9, 129.2, 126.2, 40.1 (peak overlaps with DMSO-d6), 
38.7, 29.1, 22.3, 14.5; IR (KBr) 3330, 2955, 1633, 1560, 1430, 1258, 946 νmax/cm-
1; MS (ESI) m/z (M+H)+ Calcd for C13H18N2O2: 234.1368; Found: 235.1341 
[M+H]+.   
 
(1Z,2Z)-N'-(benzyloxy)-2-(hydroxyimino)-N-pentyl-2-phenylacetimidamide 
(9). 
(Z)-N-hydroxybenzimidoyl chloride 100 mg (0.643 
mmol), 1-pentyl isocyanide 0.081 mL (0.643 mmol), O-
benzylhydroxylamine 0.720 mL (solution 1M in 
methanol, 0.772 mmol), sodium bicarbonate 54 mg 
(0.643 mmol), DCM dry 1 mL. The crude material was 
purified by column chromatography (eluents: 
PE/EtOAc 9:1, 8:2) to give the product as white solid 
(179 mg, yield 82%). 
Signals referred to the main isomer: 1H-NMR (300 
MHz, DMSO-d6) δ 11.78 (s, OH), 7.50-7.30 (m, 10H), 
6.33 (br t, NH), 4.93 (s, 2H), 2.78 (m, 2H), 1.30 (m, 2H), 1.07 (m, 4H), 0.71 (br t, 
3H); 13C-NMR (75 MHz, DMSO-d6) δ 148.5, 147.5, 139.2, 133.9, 129.2, 128.4, 
128.0, 127.6, 127.2, 125.8, 74.0, 42.6, 30.0, 28.2, 21.6, 13.7; IR (KBr) 3110, 1630, 
1439, 1053, 955, 944, 726 νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for C20H25N3O2: 
339.1947; Found: 340.2011 [M+H]+.  
 
(1Z,2Z)-2-(hydroxyimino)-N'-methoxy-N-pentyl-2-phenylacetimidamide (10).  
(Z)-N-hydroxybenzimidoyl chloride 100 mg (0.645 mmol), 
1-pentyl isocyanide 0.086 mL (0.645 mmol), methoxyl 
amine 0.772 mL (solution 1M in methanol, 0.772 mmol), 
sodium bicarbonate 54 mg (0.645 mmol), DCM dry 1 mL. 
The crude material was purified by column 
chromatography (eluents: PE/EtOAc 9:1, 8:2) to give the 
product as white solid (141.8 mg, yield 84%).  
Signals referred to the main isomer: 1H-NMR (300 MHz, DMSO-d6) δ 11.78 (s, 
OH), 7.61 (m, 2H), 7.40 (m, 3H), 6.18 (br t, NH), 3.65 (s, 3H), 2.78 (m, 2H), 1.30 
(m, 2H), 1.09 (m, 4H), 0.75 (br t, 3H); 13C-NMR (75 MHz, DMSO-d6) δ 147.9, 
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147.6, 134.1, 129.3, 128.5, 125.8, 60.4, 42.6, 29.9, 28.2, 21.7, 13.7; IR (KBr) 3137, 
1630, 1439, 1414, 1052, 955, 693 νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for 
C14H21N3O2: 263.1634; Found: 286.1518 [M+Na]+. 
 
(1Z,2Z)-N-(tert-butyl)-N'-hydroxy-2-(hydroxyimino)-2-phenylacetimidamide 
(23).  
(Z)-N-hydroxybenzimidoyl chloride 250 mg (1.61 mmol), 
tert-butyl isocyanide 0.182 mL (1.61 mmol), hydroxylamine 
1.8 mL (solution 1M in methanol, 1.93 mmol), sodium 
bicarbonate 135 mg (1.61 mmol), DCM dry 3 mL. The crude 
material was purified by column chromatography (eluents: 
PE/EtOAc 7:3, 6:4) to give the product as white solid (162.5 
mg, yield 43%).  
Signals are referred to the main isomer: 1H-NMR (300 MHz, DMSO-d6) δ 11.72 (s, 
OH), 9.79 (s, OH), 7.65 (br d, 2H), 7.38 (m, 3H), 5.36 (s, NH), 1.08 (s, 9H); 13C-
NMR (75 MHz, DMSO-d6) δ 149.7, 145.7, 135.2, 129.0, 128.4, 126.1, 50.8, 30.7; 
IR (KBr) 3062, 1638, 1404, 1370, 949, 900, 694 νmax/cm-1; MS (ESI) m/z (M+H)+ 
Calcd for C12H17N3O2: 235.1321; Found: 258.1219 [M+Na]+. 
 
(1Z,2Z)-N-cyclohexyl-N'-hydroxy-2-(hydroxyimino)-2-phenylacetimidamide 
(24).  
(Z)-N-hydroxybenzimidoyl chloride 250 mg (1.61 mmol), 
cyclohexyl isocyanide 0.200 mL (1.61 mmol), 
hydroxylamine 1.8 mL (solution 1M in methanol, 1.93 
mmol), sodium bicarbonate 135 mg (1.61 mmol), DCM dry 
3 mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 7:3, 6:4) to give the 
product as white solid (250.5 mg, yield 60%). 
Signals are referred to the main isomer: 1H-NMR (300 MHz, DMSO-d6) δ 11.66 (s, 
OH), 9.40 (s, OH), 7.65 (m 2H), 7.37 (m, 3H), 5.73 (br d, NH), 2.71 (m, 1H), 1.64 
(m, 4H), 1.44 (m, 1H), 1.19 (m, 2H), 1.00 (m, 3H); 13C-NMR (75 MHz, DMSO-d6) 
δ 148.3, 146.9, 134.6, 129.2, 128.5, 125.9, 51.8, 40.1 (peak overlaps with DMSO-
d6), 34.5, 24.9; IR (KBr) 3263, 1660, 1449, 1412, 950, 903, 694 νmax/cm-1; MS 
(ESI) m/z (M+H)+ Calcd for C14H19N3O2: 261.1477; Found: 262.1542 [M+H]+. 
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(1Z,2Z)-N'-hydroxy-2-(hydroxyimino)-2-(4-methoxyphenyl)-N-
pentylacetimidamide (25).  
(Z)-N-hydroxy-4-methoxybenzimidoyl chloride 250 
mg (1.34 mmol), 1-pentyl isocyanide 0.168 mL (1.34 
mmol), hydroxylamine 1.5 mL (solution 1M in 
methanol, 1.61 mmol), sodium bicarbonate 113 mg 
(1.34 mmol), DCM dry 3 mL. The crude material was 
purified by column chromatography (eluents: 
PE/EtOAc 5:5, 4:6) to give the product as white solid 
(286 mg, yield 76%). 
Signals referred to the main isomer: 1H-NMR (300 MHz, DMSO-d6) δ 11.40 (s, 
OH), 9.34 (s, OH), 7.55 (d, J = 8.8 Hz, 2 H, AA′XX′), 6.97 (d, J = 8.8 Hz, 2 H, 
AA′XX′), 5.85 (br t, NH), 3.77 (s, 3H), 2.78 (m, 2H), 1.31 (m, 2H), 1.10 (m, 4H), 
0.74 (br t, 3H); 13C-NMR (75 MHz, DMSO-d6) δ 160.1, 148.2, 148.0, 127.4, 127.0, 
114.0, 55.3, 42.4, 30.2, 28.3, 21.8, 13.8; IR (KBr) 3274, 1652, 1255, 1182, 947, 
899, 833 νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for C14H21N3O3: 279.1583; 
Found: 280.1646 [M+H]+. 
 
(1Z,2Z)-2-(4-chlorophenyl)-N'-hydroxy-2-(hydroxyimino)-N-
pentylacetimidamide, (26). 
(Z)-4-chloro-N-hydroxybenzimidoyl chloride 250 mg 
(1.31 mmol), cyclohexyl isocyanide 0.166 mL (1.31 
mmol), hydroxylamine 1.46 mL (solution 1M in 
methanol, 1.57 mmol), sodium bicarbonate 110 mg (1.31 
mmol), DCM dry 3 mL. The crude material was purified 
by column chromatography (eluents: PE/EtOAc 7:3, 6:4) 
to give the product as white solid (274 mg, yield 74%). 
Signals referred to the main isomer: 1H-NMR (300 MHz, 
DMSO-d6) δ 11.86 (br s, OH), 9.48 (br s, OH), 7.62 (d, J = 8.6 Hz, 2H, AA′XX′), 
7.49 (d, J = 8.6 Hz, 2H, AA′XX′), 6.01 (br s, NH), 2.77 (m, 2H), 1.27 (m, 6H), 
0.75 (m, 3H); 13C-NMR (75 MHz, DMSO-d6) δ 148.1, 147.9, 134.4, 133.9, 129.2, 
128.1, 42.9, 30.7, 28.8, 22.2, 14.3; IR (KBr) 3292, 1640, 1493, 1449, 1093, 946, 
832 νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for C13H18ClN3O2: 283.1088; Found: 
284.1142 [M+H]+. 
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(1Z,2Z)-N-(tert-butyl)-N'-hydroxy-2-(hydroxyimino)-2-(pyridin-3-
yl)acetimidamide (27).  
(Z)-N-hydroxynicotinimidoyl chloride 200 mg (1.28 mmol), 
tert-butyl isocyanide 0.145 mL (1.28 mmol), hydroxylamine 
1.4 mL (solution 1M in methanol, 1.53 mmol), sodium 
bicarbonate 107.5 mg (1.28 mmol), DCM dry 3 mL. The 
crude material was purified by column chromatography 
(eluents: PE/EtOAc 6:4, 5:5) to give the product as white 
solid (75.4 mg, yield 25%). 
Signals referred to the main isomer: 1H-NMR (300 MHz, DMSO-d6) δ 11.46 (s, 
OH), 9.95 (s, OH), 8.63 (s, 1H), 8.55 (br d, 1H), 7.84 (br d, 1H), 7.43 (m, 1H), 5.26 
(s, NH), 1.32 (s, 9H); 13C-NMR (75 MHz, DMSO-d6) δ 149.5, 149.1, 147.0, 145.2, 
132.9, 129.4, 123.6, 50.8, 28.5; IR (KBr) 3137, 1642, 1504, 1415, 1243, 961, 918 
νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for C11H16N4O2: 236.1273; Found: 
237.1349 [M+H]+. 
 
(1Z,2Z)-N-benzyl-N'-hydroxy-2-(hydroxyimino)-2-phenylacetimidamide (28).  
(Z)-N-hydroxybenzimidoyl chloride 250 mg (1.6 mmol), 
benzyl isocyanide 0.197 mL (1.6 mmol), hydroxylamine 1.77 
mL (solution 1M in methanol, 1.9 mmol), sodium bicarbonate 
134 mg (1.6 mmol), DCM dry 3 mL. The crude material was 
purified by column chromatography (eluents: PE/EtOAc 9:1, 
7:3) to give the product as white solid (331.1 mg, yield 77%). 
Signals are referred to the main isomer: 1H-NMR (300 MHz, 
DMSO-d6) δ 11.77 (s, OH), 9.55 (s, OH), 7.53 (m, 2H), 7.32 
(m, 4H), 7.17 (m, 4H), 6.41 (t, NH, J = 6.7 Hz), 4.04 (d, 2H, J= 6.7 Hz); 13C-NMR 
(75 MHz, DMSO-d6) δ 148.1, 147.7, 140.1, 134.4, 129.0, 128.3, 128.0, 127.3, 
126.6, 126.0, 46.2; IR (KBr) 3265, 1658, 1494, 1452, 1093, 944, 902 νmax/cm-1; MS 
(ESI) m/z (M+H)+ Calcd for C15H15N3O2: 269.1164; Found: 270.1240 [M+H]+. 
 
(1Z,2Z)-N-(tert-butyl)-2-(4-fluorophenyl)-N'-hydroxy-2-
(hydroxyimino)acetimidamide (29).  
(Z)-4-fluoro-N-hydroxybenzimidoyl chloride 250 mg (1.4 
mmol), tert-butyl isocyanide 0.158 mL (1.4 mmol), 
hydroxylamine 1.6 mL (solution 1M in methanol, 1.7 
mmol), sodium bicarbonate 118 mg (1.4 mmol), DCM dry 
3 mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 8:2, 7:3) to give the 
product as white solid (248.1 mg, yield 68%). 
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Signals referred to the main isomer: 1H-NMR (300 MHz, DMSO-d6) δ 11.75 (s, 
OH), 9.84 (s, OH), 7.66 (m, 2H), 7.25 (m, 2H), 5.36 (br s, NH), 1.08 (s, 9H); 13C-
NMR (75 MHz, DMSO-d6) δ 163.1 (d, J = 244.5 Hz), 150.2, 146.2, 132.3 (d, J = 
2.8 Hz), 128.8 (d, J = 8 Hz), 116.0 (d, J = 21.2 Hz), 51.2, 31.4; IR (KBr) 3226, 
1643, 1513, 1265, 1224, 953, 834 νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for 
C12H16FN3O2: 253.1227; Found: 276.1114 [M+Na]+. 
 
(1Z,2Z)-N-cyclohexyl-N'-hydroxy-2-(hydroxyimino)-2-(4-
methoxyphenyl)acetimidamide (30).  
(Z)-N-hydroxy-4-methoxybenzimidoyl chloride 250 mg 
(1.3 mmol), cyclohexyl isocyanide 0.161 mL (1.3 
mmol), hydroxylamine 1.5 mL (solution 1M in 
methanol, 1.6 mmol), sodium bicarbonate 109 mg (1.35 
mmol), DCM dry 3 mL. The crude material was 
purified by column chromatography (eluents: 
PE/EtOAc 5:5, 4:6) to give the product as white solid 
(286.2 mg, yield 75%). 
Signals referred to the main isomer: 1H-NMR (300 MHz, DMSO-d6) δ 11.39 (s, 
OH), 9.35 (s, OH), 7.56 (d, J = 8.6 Hz, 2 H, AA′XX′), 6.97 (d, J = 8.6 Hz, 2 H, 
AA′XX′), 5.67 (br d, NH), 3.81 (s, 3H), 2.69 (m, 1H), 1.60 (m, 4H), 1.44 (m, 1H), 
1.21 (m, 2H), 1.01 (br s, 3H); 13C-NMR (75 MHz, DMSO-d6) δ 160.1, 148.0, 
147.2, 127.4, 127.2, 114.0, 55.3, 51.8, 40.2 (peak overlaps with DMSO-d6), 34.6, 
25.0; IR (KBr) 3118, 1643, 1514, 1259, 1247, 1178, 944 νmax/cm-1; MS (ESI) m/z 
(M+H)+ Calcd for C15H21N3O3: 291.1583; Found: 292.1659 [M+H]+. 
 
(1Z,2Z)-2-cyclohexyl-N'-hydroxy-2-(hydroxyimino)-N-pentylacetimidamide 
(31). 
(Z)-N-hydroxycyclohexanecarbimidoyl chloride 350 mg (2.16 
mmol), 1-pentyl isocyanide 0.271 mL (2.16 mmol), 
hydroxylamine 2.4 mL (solution 1M in methanol, 2.59 mmol), 
sodium bicarbonate 181 mg (2.16 mmol), DCM dry 3 mL. 
The crude material was purified by column chromatography 
(eluents: PE/EtOAc 7:3) to give the product as white solid 
(400.1 mg, yield 72%). 
Signals referred to the main isomer: 1H-NMR (300 MHz, 
DMSO-d6) δ 10.83 (s, OH), 9.20 (s, OH), 5.45 (br t, NH), 2.80 
(m, 2H), 2.24 (m, 1H), 1.84 (m, 2H), 1.69 (m, 4H), 1.22 (m, 10H), 0.85 (t, 3H, J = 
6.9 Hz); 13C-NMR (75 MHz, DMSO-d6) δ 153.1, 149.4, 42.7, 42.6, 38.8 (peak 
overlaps with DMSO-d6), 30.1, 30.0, 28.5, 25.7, 21.9, 13.9; IR (KBr) 3105, 1643, 
1467, 1451, 964, 917, 887 νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for C13H25N3O2: 
255.1947; Found: 256.2019 [M+H]+. 
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(1Z,2Z)-N-cyclohexyl-N'-hydroxy-2-(hydroxyimino)-3-
phenylpropanimidamide (32).  
(Z)-N-hydroxy-2-phenylacetimidoyl chloride 350 mg (2.1 
mmol), cyclohexyl isocyanide 0.261 mL (2.1 mmol), 
hydroxylamine 2.3 mL (solution 1M in methanol, 2.5 
mmol), sodium bicarbonate 176 mg (2.1 mmol), DCM dry 
3 mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 7:3, 6:4) to give the 
product as white solid (194.9 mg, yield 34%). 
Signals referred to the main isomer: 1H-NMR (300 MHz, 
DMSO-d6) δ 11.06 (s, OH), 9.35 (s, OH), 7.30-7.18 (m, 5H), 5.22 (br d, NH), 3.57 
(2H, peaks overlap with DMSO-d6), 2.44 (br s, 1H), 1.45 (br s, 3H), 1.15 (br s, 
2H), 0.92 (m, 5H); 13C-NMR (75 MHz, DMSO-d6) δ 149.1, 148.5, 136.5, 129.4, 
128.5, 126.7, 52.2, 40.7, 34.5, 25.3, 25.0; IR (KBr) 3064, 1642, 1424, 997, 941, 
723, 697 νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for C15H21N3O2: 275.1634; 
Found: 276.1707 [M+H]+. 
 
(1Z,2Z)-N-benzyl-N'-hydroxy-2-(hydroxyimino)octanimidamide (33).  
(Z)-N-hydroxyheptanimidoyl chloride 350 mg (2.14 
mmol), benzyl isocyanide 0.261 mL (2.14 mmol), 
hydroxylamine 2.4 mL (solution 1M in methanol, 2.57 
mmol), sodium bicarbonate 180 mg (2.14 mmol), 
DCM dry 3 mL. The crude material was purified by 
column chromatography (eluents: PE/EtOAc 8:2, 6:4) 
to give the product as white solid (195.3 mg, yield 
33%). 
Signals referred to the main isomer: 1H-NMR (300 
MHz, DMSO-d6) δ 10.96 (s, OH), 9.42 (s, OH), 7.35-7.18 (m, 5H), 6.20 (t, NH), 
4.07 (d, 2H, J = 4.9 Hz), 1.98 (t, 2H, J = 7.5 Hz), 1.29 (m, 3H), 1.20-1.09 (m, 5H), 
0.81 (br t, 3H); 13C-NMR (75 MHz, DMSO-d6) δ 149.5, 149.4, 140.9, 128.1, 127.0, 
126.6, 45.9, 33.9, 31.0, 28.2, 25.3, 21.9, 13.9; IR (KBr) 3307, 1695, 1461, 1455, 
1350, 921, 697 νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for C15H23N3O2: 277.1790; 
Found: 278.1856 [M+H]+. 
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(1Z,2Z)-N,2-dicyclohexyl-N'-hydroxy-2-(hydroxyimino)acetimidamide (34).  
(Z)-N-hydroxycyclohexanecarbimidoyl chloride 300 mg (1.86 
mmol), cyclohexyl isocyanide 0.231 mL (1.86 mmol), 
hydroxylamine 2.1 mL (solution 1M in methanol, 2.23 mmol), 
sodium bicarbonate 156 mg (1.86 mmol), DCM dry 3 mL. 
The crude material was purified by column chromatography 
(eluents: PE/EtOAc 9:1, 7:3) to give the product as white solid 
(388.5 mg, yield 78%). 
Signals referred to the main isomer: 1H-NMR (300 MHz, DMSO-d6) δ 10.81 (s, 
OH), 9.19 (s, OH), 5.40 (br d, NH), 2.69 (m, 1H), 2.22 (m, 1H), 1.85-1.08 (m, 
20H); 13C-NMR (75 MHz, DMSO-d6) δ 153.2, 148.4, 51.9, 42.7, 39.5 (peak 
overlaps with DMSO-d6), 34.8, 30.1, 25.9, 25.7, 25.1; IR (KBr) 3208, 1627, 1449, 
1413, 969, 933, 892 νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for C14H25N3O2: 
267.1947; Found: 268.2013 [M+H]+. 
 
(1Z,2Z)-N-(tert-butyl)-2-cyclohexyl-N'-hydroxy-2-
(hydroxyimino)acetimidamide (35).  
(Z)-N-hydroxycyclohexanecarbimidoyl chloride 300 mg (1.86 
mmol), tert-butyl isocyanide 0.210 mL (1.86 mmol), 
hydroxylamine 2.1 mL (solution 1M in methanol, 2.23 
mmol), sodium bicarbonate 156 mg (1.86 mmol), DCM dry 3 
mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 9:1, 7:3) to give the 
product as white solid (161.5 mg, yield 36%). 
Signals referred to the main isomer: 1H-NMR (300 MHz, DMSO-d6) δ 10.84 (s, 
OH), 9.69 (s, OH), 5.01 (s, NH), 2.29 (m, 1H), 1.91 (m, 4H), 1.62 (m, 6H), 1.25 (s, 
9H); 13C-NMR (75 MHz, DMSO-d6) δ 154.8, 147.6, 50.7, 40.4, 30.6, 29.5, 28.7, 
25.8; IR (KBr) 3276, 1647, 1508, 1449, 1364, 969, 953 νmax/cm-1; MS (ESI) m/z 
(M+H)+ Calcd for C12H23N3O2: 241.1790; Found: 264.1684 [M+Na]+. 
 
(1Z,2E)-N'-hydroxy-2-(hydroxyimino)-N-pentyl-2-(thiophen-2-
yl)acetimidamide (36). 
(Z)-N-hydroxythiophene-2-carbimidoyl chloride 300 mg (1.8 
mmol), 1-pentyl isocyanide 0.226 mL (1.8 mmol), 
hydroxylamine 2.0 mL (solution 1M in methanol, 2.16 mmol), 
sodium bicarbonate 151 mg (1.8 mmol), DCM dry 3 mL. The 
crude material was purified by column chromatography 
(eluents: PE/EtOAc 9:1, 6:4) to give the product as white solid 
(157.3 mg, yield 33%). 
Signals referred to the main isomer: 1H-NMR (300 MHz, 
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DMSO-d6) δ 11.63 (s, OH), 9.50 (s, OH), 7.50 (br d, 1H), 7.09 (m, 2H), 5.87 (br t, 
NH), 2.80 (m, 2H), 1.29 (m, 2H), 1.11 (m, 4H), 0.73 (br t, 3H); 13C-NMR (75 
MHz, DMSO-d6) δ 147.8, 145.0, 138.7, 128.1, 127.6 (2C), 42.6, 30.3, 28.4, 21.8, 
13.9; IR (KBr) 3209, 1546, 1438, 1340, 1231, 912, 701 νmax/cm-1; MS (ESI) m/z 
(M+H)+ Calcd for C11H17N3O2S: 255.1041; Found: 256.1111 [M+H]+. 
 
(1Z,2E)-N-cyclohexyl-N'-hydroxy-2-(hydroxyimino)-2-(thiophen-2-
yl)acetimidamide (37).  
(Z)-N-hydroxythiophene-2-carbimidoyl chloride 250 mg (1.5 
mmol), cyclohexyl isocyanide 0.186 mL (1.5 mmol), 
hydroxylamine 1.7 mL (solution 1M in methanol, 1.8 mmol), 
sodium bicarbonate 126 mg (1.5 mmol), DCM dry 3 mL. The 
crude material was purified by column chromatography 
(eluents: PE/EtOAc 9:1, 6:4) to give the product as white solid 
(238.1 mg, yield 57%). 
Signals referred to the main isomer: 1H-NMR (300 MHz, 
DMSO-d6) δ 11.63 (s, OH), 9.54 (s, OH), 7.51 (br d, 1H), 7.09 (m, 2H), 5.64 (br d, 
NH), 2.72 (m, 1H), 1.62 (m, 4H), 1.44 (m, 1H), 1.18 (m, 2H), 1.02 (m, 3H); 13C-
NMR (75 MHz, DMSO-d6) δ 146.8, 145.0, 138.9, 128.0, 127.6 (2C), 52.0, 40.1 
(peak overlaps with DMSO-d6), 34.6, 25.0; IR (KBr) 3275, 1658, 1442, 1008, 919, 
905, 891 νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for C12H17N3O2S: 267.1041; 
Found: 268.1104 [M+H]+. 
 
N-cyclohexyl-3-phenyl-1,2,4-oxadiazol-5-amine (38).  
C-oximinoimidamide 100 mg (0.383 mmol), 
triphenylphosphine 200.9 mg (0.766 mmol), diethyl 
azodicarboxylate 0.120 mL (0.766 mmol), toluene dry 1 
mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 95:5, 9:1) to give the 
product as white solid (69.2 mg, yield 74%). 
1H-NMR (300 MHz, CDCl3) δ 8.0 (d, J = 7.9 Hz, 2H,), 7.44 (m, 3H), 5.65 (br d, 
NH), 3.66 (m, 1H), 2.06 (m, 2H), 1.74 (m, 2H), 1.60 (m, 1H), 1.45-1.28 (m, 5H); 
13C-NMR (75 MHz, CDCl3) δ 170.7, 168.5, 130.8, 128.7, 127.8, 127.3, 53.0, 33.3, 
25.4, 24.7; IR (KBr) 3242, 1647, 1491, 1444, 1390, 1098 νmax/cm-1; m.p. 126.7-
127.7 °C; MS (ESI) m/z (M+H)+ Calcd for C14H17N3O: 243.1372; Found: 244.1444 
[M+H]+. 
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N-pentyl-3-phenyl-1,2,4-oxadiazol-5-amine (41).  
C-oximinoimidamide 70 mg (0.281 mmol), 
triphenylphosphine 81 mg (0.308 mmol), diethyl 
azodicarboxylate 0.048 mL (1.11 mmol), toluene dry 1 
mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 9:1) to give the 
product as white solid (43 mg, yield 66%). 
1H-NMR (300 MHz, CDCl3) δ 7.98 (d, J = 8.0 Hz, 
2H), 7.45 (m, 3H), 6.24 (br s, NH), 3.43 (q, 2H, J = 7.0 Hz), 1.61 (m, 2H), 1.32 (m, 
4H), 0.88 (br t, 3H); 13C-NMR (75 MHz, CDCl3) δ 171.5, 168.5, 130.9, 128.7, 
127.7, 127.3, 43.8, 29.5, 28.8, 22.3, 14.0; IR (KBr) 3244, 1654, 1527, 1462, 1386, 
1301 νmax/cm-1; m.p. 68.1-69.0 °C; MS (ESI) m/z (M+H)+ Calcd for C13H17N3O: 
231.1372; Found: 232.1451 [M+H]+. 
 
N-cyclohexyl-3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-amine (42).   
C-oximinoimidamide 150 mg (0.515 mmol), 
triphenylphosphine 270.2 mg (1.03 mmol), diethyl 
azodicarboxylate 0.162 mL (1.03 mmol), toluene dry 
2 mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 9:1, 85:15) to 
give the product as yellow solid (93 mg, yield 66%). 
1H-NMR (300 MHz, CDCl3) δ 7.90 (d, J = 8.8 Hz, 2 
H, AA′XX′), 6.92 (d, J = 8.8 Hz, 2 H, AA′XX′), 5.82 (br d, NH), 3.81 (s, 3H), 3.62 
(m, 1H), 2.02 (m, 2H), 1.68 (m, 2H), 1.45 (m, 1H), 1.42-1.10 (m, 5H); 13C-NMR 
(75 MHz, CDCl3) δ 170.5, 168.1, 161.6, 128.8, 120.2, 114.0, 55.4, 52.9, 33.2, 25.3, 
24.7; IR (KBr) 3307, 1634, 1390, 1259, 1177, 839 νmax/cm-1; m.p. 110.6-111.0 °C; 
MS (ESI) m/z (M+H)+ Calcd for C15H19N3O2: 273.1477; Found: 296.1360 
[M+Na]+. 
 
3-(4-chlorophenyl)-N-pentyl-1,2,4-oxadiazol-5-amine (43).  
C-oximinoimidamide 144 mg (0.507 mmol), 
triphenylphosphine 266 mg (1.014 mmol), diethyl 
azodicarboxylate 0.159 mL (1.014 mmol), toluene 
dry 2 mL. The crude material was purified by 
column chromatography eluents: PE/EtOAc 95:5, 
9:1) to give the product as white solid (55 mg, 
yield 41%). 
1H-NMR (300 MHz, CDCl3δ 7.92 (d, J = 8.8 Hz, 2 H, AA′XX′), 7.41 (d, J = 8.8 
Hz, 2 H, AA′XX′), 5.81 (br s, NH), 3.43 (q, 2H, J = 7.0 Hz), 1.60 (m, 2H), 1.33 (m, 
4H), 0.89 (br t, 3H); 13C-NMR (75 MHz, CDCl3) δ 171.4, 167.6, 136.9, 129.0, 
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128.6, 126.2, 43.9, 29.5, 28.8, 22.3, 14.0; IR (KBr) 3232, 1637, 1413, 1099, 1013, 
841 νmax/cm-1; m.p. 105.0-106.3 °C; MS (ESI) m/z (M+H)+ Calcd for 
C14H16ClN3O: 265.0982; Found: 266.1642 [M+H]+. 
 
N-(tert-butyl)-3-phenyl-1,2,4-oxadiazol-5-amine (44). 
C-oximinoimidamide 100 mg (0.425 mmol), 
triphenylphosphine 223 mg (0.850 mmol), diethyl 
azodicarboxylate 0.290 mL (0.850 mmol), toluene dry 2 
mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 95:5, 9:1) to give the 
product as white solid (62.7 mg, yield 68%). 
1H-NMR (300 MHz, CDCl3) δ 8.01 (m, 2H), 7.43 (m, 3H), 5.59 (br s, NH), 1.45 (s, 
9H); 13C-NMR (75 MHz, CDCl3) δ 170.5, 168.3, 130.9, 128.8, 128.0, 127.4, 52.9, 
29.2; IR (KBr) 3263, 1622, 1379, 1219, 1141, 751 νmax/cm-1; m.p. 87.1-88.3 °C; 
MS (ESI) m/z (M+H)+ Calcd for C12H15N3O: 217.1215; Found: 218.1279 [M+H]+. 
 
3-(4-methoxyphenyl)-N-pentyl-1,2,4-oxadiazol-5-amine (45).   
C-oximinoimidamide 60 mg (0.215 mmol), 
triphenylphosphine 112.8 mg (0.430 mmol), 
diethyl azodicarboxylate 0.067 mL (0.430 
mmol), toluene dry 2 mL. The crude material 
was purified by column chromatography 
(eluents: PE/EtOAc 95:5, 9:1) to give the 
product as yellow solid (30.7 mg, yield 55%). 
1H-NMR (300 MHz, CDCl3) δ 7.92 (d, J = 8.8 Hz, 2 H, AA′XX′), 6.95 (d, J = 8.8 
Hz, 2 H, AA′XX′), 5.89 (br s, NH), 3.84 (s, 3H), 3.42 (q, J = 6.7 Hz, 2H), 1.62 (m, 
2H), 1.33 (m, 4H), 0.90 (br t, 3H); 13C-NMR (75 MHz, CDCl3) δ 171.3, 168.2, 
161.7, 128.9, 120.2, 114.1, 55.5, 43.9, 29.6, 28.9, 22.4, 14.1; IR (KBr) 3244, 1655, 
1393, 1257, 1175, 846 νmax/cm-1; m.p. 72.6-73.5 °C; MS (ESI) m/z (M+H)+ Calcd 
for C14H19N3O2: 261.1477; Found: 284.1355 [M+Na]+. 
 
N-benzyl-3-phenyl-1,2,4-oxadiazol-5-amine (46).   
C-oximinoimidamide 110 mg (0.408 mmol), 
triphenylphosphine 114.3 mg (0.817 mmol), diethyl 
azodicarboxylate 0.128 mL (0.817 mmol), toluene 
dry 2 mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 95:5, 9:1) to 
give the product as white solid (63.6 mg, yield 62%). 
1H-NMR (300 MHz, CDCl3) δ 7.94 (d, J = 6.8 Hz, 2H), 7.43 (m, 3H), 7.34 (m, 
5H), 6.71 (br s, NH), 4.63 (d, J = 6.1 Hz, 2H); 13C-NMR (75 MHz, CDCl3) δ 171.4, 
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168.5, 137.2, 130.9, 128.9, 128.7, 128.1, 127.6, 127.5, 127.3, 47.7; IR (KBr) 3242, 
1655, 1494, 1446, 1398, 1350 νmax/cm-1; m.p. 115.5-116.0 °C; MS (ESI) m/z 
(M+H)+ Calcd for C15H13N3O: 251.1059; Found: 252.1135 [M+H]+. 
 
N-(tert-butyl)-3-(4-fluorophenyl)-1,2,4-oxadiazol-5-amine (47).  
C-oximinoimidamide 110 mg (0.434 mmol), 
triphenylphosphine 227.8 mg (0.868 mmol), diethyl 
azodicarboxylate 0.136 mL (0.868 mmol), toluene dry 2 
mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 98:2, 95:5) to give 
the product as white solid (74.6 mg, yield 73%). 
1H-NMR (300 MHz, CDCl3) δ 7.98 (m, 2H), 7.10 (m, 2H), 5.58 (br s, NH), 1.44 (s, 
9H); 13C-NMR (75 MHz, CDCl3) δ 170.4, 167.5, 164.0 (d, J = 248.5), 129.4 (d, J = 
8.6), 124.1, 115.8 (d, J = 21.7), 52.8, 29.0 (3C); IR (KBr) 3302, 1632, 1410, 1374, 
1222, 840 νmax/cm-1; m.p. 108.1-109.2 °C; MS (ESI) m/z (M+H)+ Calcd for 
C12H14FN3O: 235.1121; Found: 236.1185 [M+H]+. 
 
N-(tert-butyl)-3-(pyridin-3-yl)-1,2,4-oxadiazol-5-amine (48). 
C-oximinoimidamide 60 mg (0.254 mmol), 
triphenylphosphine 133 mg (0.508 mmol), diethyl 
azodicarboxylate 0.080 mL (0.508 mmol), toluene dry 1 
mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 9:1, 7:3) to give the 
product as white solid (27 mg, yield 49%).  
1H-NMR (300 MHz, CDCl3) δ 9.36 (br s, 1H), 8.70 (br s, 1H), 8.28 (m, 1H), 7.42 
(m, 1H), 5.71 (br s, NH), 1.51 (s, 9H); 13C-NMR (75 MHz, CDCl3) δ 170.8, 166.4, 
151.5, 148.9, 134.7, 124.5, 123.7, 53.0, 29.2; IR (KBr) 3210, 2987, 1750, 1372, 
1276, 1226, 1101 νmax/cm-1; m.p. 140.8-141.7 °C; MS (ESI) m/z (M+H)+ Calcd for 
C11H21N4O: 218.1168; Found: 219.1246 [M+H]+. 
 
3-benzyl-N-cyclohexyl-1,2,4-oxadiazol-5-amine (49). 
C-oximinoimidamide 100 mg (0.383 mmol), 
triphenylphosphine 200 mg (0.765 mmol), diethyl 
azodicarboxylate 0.120 mL (0.765 mmol), toluene dry 
2 mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 95:5, 9:1) to give 
the product as white solid (46.6 mg, yield 47%). 
1H-NMR (300 MHz, CDCl3) δ 7.31 (m, 3H), 7.30 (m, 2H), 5.65 (br d, NH), 3.87 (s, 
2H), 3.52 (m, 1H), 1.98 (m, 2H), 1.74-1.57 (m, 3H), 1.41-1.20 (m, 5H); 13C-NMR 
(75 MHz, CDCl3) δ 170.6, 169.7, 136.0, 129.0, 128.7, 127.0, 52.7, 33.3, 32.7, 25.3, 
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24.7; IR (KBr) 3211, 3088, 1636, 1537, 1397, 718 νmax/cm-1; m.p. 90.9-91.7 °C; 
MS (ESI) m/z (M+H)+ Calcd for C15H19N3O: 257.1528; Found: 258.1601 [M+H]+. 
 
N-pentyl-3-(thiophen-2-yl)-1,2,4-oxadiazol-5-amine (50).  
C-oximinoimidamide 110 mg (0.39 mmol), 
triphenylphosphine 205 mg (0.78 mmol), diethyl 
azodicarboxylate 0.122 mL (0.78 mmol), toluene dry 
2 mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 95:5, 9:1) to give 
the product as yellow solid (68.3 mg, yield 74%). 
1H-NMR (300 MHz, CDCl3) δ 7.67 (dd, 1H, J = 3.8, 1.2 Hz), 7.42 (dd, 1H, J = 4.9, 
1.2 Hz), 7.10 (dd, 1H, J = 4.9, 3.8 Hz), 6.27 (br s, NH), 3.43 (q, 2H, J = 6.7 Hz), 
1.61 (m, 2H), 1.31 (m, 4H), 0.87 (m, 3H); 13C-NMR (75 MHz, CDCl3) δ 171.2, 
164.4, 129.3, 128.8, 128.6, 127.8, 43.8, 29.5, 28.8, 22.3, 14.0; IR (KBr) 3255, 
2951, 1654, 1434, 1389, 1319 νmax/cm-1; m.p. 75.8-76.6 °C; MS (ESI) m/z (M+H)+ 
Calcd for C11H15N3OS: 237.0936; Found: 238.0892 [M+H]+. 
 
N-cyclohexyl-3-(thiophen-2-yl)-1,2,4-oxadiazol-5-amine (51). 
C-oximinoimidamide 120 mg (0.449 mmol), 
triphenylphosphine 235 mg (0.898 mmol), diethyl 
azodicarboxylate 0.141 mL (0.898 mmol), toluene dry 2 
mL. The crude material was purified by column 
chromatography (eluents: PE/EtOAc 95:5, 9:1) to give the 
product as yellow solid (76.7 mg, yield 68%). 
1H-NMR (300 MHz, CDCl3) δ 7.69 (dd, 1H, J = 3.8, 1.2 Hz), 7.42 (dd, 1H, J = 4.9, 
1.2 Hz), 7.11 (dd, 1H, J = 1.2, 3.8 Hz), 5.35 (br d, NH), 3.66 (m, 1H), 2.04 (m, 
2H), 1.72 (m, 2H), 1.60 (m, 2H), 1.46-1.07 (m, 5H); 13C-NMR (75 MHz, CDCl3) δ 
170.5, 164.5, 129.3, 128.8, 128.5, 127.7, 52.9, 33.2, 25.3, 24.6; IR (KBr) 3229, 
2932, 1640, 1554, 1508, 1433, 1389, 1317 νmax/cm-1; m.p. 131.9-132.5 °C; MS 
(ESI) m/z (M+H)+ Calcd for C12H15N3OS: 249.0936; Found: 250.1008 [M+H]+. 
 
 
 
N
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S
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X-Ray data 
 
Crystals of 23 were obtained by slow evaporation of a 1:1 methanol/water solution 
at room temperature, as colourless elongated prisms. 
The preliminary check on the X-ray diffraction quality of the sample showed that 
all selected crystals were twinned crystals characterized by a non-merohedral 
twinning. The twin operation relating the two domains forming the composite 
crystal results a rotation of 180° about the c axis. 
X-ray diffraction data in the θ range 2-25° were collected acquiring 4 sets of 600 
bidimensional CCD frames with the following operative conditions: omega rotation 
axis, scan width 0.3°, acquisition time 30 s, sample-to-detector distance 60 mm, phi 
angle fixed at four different values (0°, 90°, 180°, 270°) for each of the four 
different sets.  
Omega-rotation frames were processed with the SAINT software (Bruker: SAINT 
Software Reference Manual. Version 6, Bruker AXS Inc., Madison, Wisconsin, 
USA, 2003) operating in a “twinning mode” with two components for data 
reduction (including intensity integration, background, twin overlaps, Lorentz and 
polarization corrections) and for determination of accurate unit-cell dimensions, 
obtained by least-squares refinement of the positions of 1557 independent 
reflections with I > 10σ(I) in the θ range 3-20°. Absorption effects were empirically 
evaluated by the TWINABS software (G. M. Sheldrick, TWINABS. University of 
Gottingen, Gottingen, Germany, 1999) and absorption correction was applied to the 
data (0.861 and 0.997 min and max transmission factor). 
The structure was solved by direct methods26 and the refinement was carried out 
with SHELX-97.27 All non-H-atoms were refined anisotropically. Hydrogen atoms 
were detected in a difference Fourier synthesis and refined with isotropic thermal 
factors. CCDC-1037831 contains the supplementary crystallographic data for this 
paper. These data can be obtained free of charge via 
www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge 
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Crystallographic Data Centre, 12, Union Road, Cambridge CB21EZ, UK; fax: 
++44 1223 336 033; or deposit@ccdc.cam.ac.uk). 
Crystal data for 23: C12H17N4O2, Mr = 235.3 g/mol, Monoclinic, Space 
group P21/c, a = 14.624(3) A, b = 6.308(1) A, c = 14.588(3) A, β = 105.522(5)°, V 
= 1296.64(4) A3, Z = 4, Dcalc = 1.21 Mg/m3, R = 0.056 (2307 reflections/1528 
obs), wR2 = 0.135, T = 293(2)K, GOF = 1.078. The reflections were collected in 
the range 1.5° ≤ θ ≤ 25.1° employing a 0.44 x 0.18 x 0.04 crystal. 
The intermolecular hydrogen bonds network is highly effective in forming a 
polymeric chain approximately parallel to the b axis, thereby consolidating the 
crystal structure. In details, the molecules form dimers by centrosymmetric 
hydrogen bonds between O1-H12…N2’ (‘at -x, -y, -z), distance 1.92(4) A, angle 
157(1)°, which are in turns interconnected by O2-H21…O1’’ (’’ at x, y+1, z) 
interactions at distance 1.91(4) A, angle 172(1)° giving rise to molecular chains 
along the b axis (Figure S1). 
 
Figure S1. Intermolecular interactions viewed about down the b axis. 
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8.1 General mechanism  
 
At the beginning of our research with nitrile N-oxide, we hypothesized the 
formation of an α-adduct between the Z-chlorooxime and the isocyanide, ruling out 
the participation of a nitrile N-oxide species, since, in an independent experiment, 
among Z-phenylchlorooxime 1, phenylacetic acid 2, and triethylamine 3, the 
formation of the nitrile N-oxide dimerization products diphenylfuroxan 4 and/or 3,6-
dipheyl-1,4,2,5-dioxadiazine 5 was not detected.1,2 
Later, we realized that the formation of these dimerization products is actually not 
as easy as we thought and cannot be considered as a marker for the involvement of 
nitrile N-oxides. Indeed, when we carried out the reaction in the presence of 
phenylacetylene 6, the corresponding isooxazole 7 was obtained in 40% yields, 
confirming that, even under these buffered conditions (TEA and carboxylic acid), 
the nitrile N-oxides can be generated (Scheme 1).  
 
 
Scheme 1. Experiments to demonstrate the direct involvement of the 
nitrile N-oxide species. 
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When we tried the two component reaction between Z-phenylchloroxime and 
pentyl isocyanide we were not able to isolate the corresponding cyanide and 
isocyanate, as reported by Olofson3 and Vita Finzi,1 but we only observed the 
formation of a complex and inseparable mixture of products. (Scheme 2) 
 
Scheme 2. Reaction between Z-phenylchlorooxime and isocyanide. 
For this reason, initially, we were inclined to hypothesize an α-addition between 
the Z-chloroxime 9 and the isocyanide 10 to give the imidoyl chloride 11, followed 
by the generation of the nitrilium species 12, which can be attacked by the 
nucleophile (Mechanism A).  
 
Anyway, after observing the formation of nitrile N-oxide species even in buffered 
conditions (carboxylic acid and base), we hypothesized the nucleophilic attack of 
isocyanides to the nitrile N-oxides with the formation of the nitrilium ion which can 
be intercepted by a third nucleophile (Mechanism B).  
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Anyway during our research activity, we noted that independently from the 
strength of the nucleophile used as third component: carboxylate4, phenate (Chapter 
6), primary and secondary amines (Chapter 4, 7) and hydroxylamine (Chapter 7) (in 
order of increasing nucleophilicity), we observed that the reaction between 
isocyanides and nitrile N-oxides always overruled the possible attack of the 
nucleophile to the nitrile N-oxide. The unexpected nitrile N-oxide behavior prompted 
us to re-examine the reaction mechanism. Indeed, it should be logic to consider that 
nitrile N-oxides are better electrophilic partners for phenates and amines than 
isocyanides which are usually considered as poor nucleophiles.5 It follows that the 
reaction between nitrile N-oxides and isocyanides cannot be interpreted as a simple 
nucleophilic addition.  
However, if we consider the isocyanides involved in these transformations in their 
carbenic nature and not in their ionic resonance form, a concerted [3+1] 
cycloaddition reaction between isocyanide and nitrile N-oxide could take place to 
give an oxazetidine ring 146. A recent paper corroborates this hypothesis, 
demonstrating that isocyanides exist predominantly in the carbenic form.7 Although 
[3+1] cycloaddition reactions between isocyanides and azomethine imines, nitrile 
ylides, and azomethine ylides have already been reported,6–9 there are no examples 
for a [3+1] cycloaddition reaction between nitrile N-oxides and isocyanides.10 Nitrile 
N-oxides 13, as well as all the 1,3-dipolar species, are ambiphilic dipoles 
characterized by a low energy difference between their HOMO or LUMO frontier 
orbitals1 and they can hence react both with electron-rich or electron-poor 
dipolarophiles, as in this case the isocyanide in its carbenic nature. 
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A four-membered ring should be obtained from the reaction between nitrile N-
oxides and the electron-poor dipolarophiles isocyanides. The so-formed oxazetidine 
ring 14, undergoes ring opening, in order to relieve the ring strain, unveiling the 
ephemeral nitrilium ion 12, which could now be attacked by a third nucleophile and 
finally form the novel product (Mechanism C). 
 
 
In order to verify if Mechanism C was the more plausible, ab initio calculations 
were performed by Dr. Alberto Massarotti, to compare the energies involved in either 
the [3 + 1] cycloaddition or the ionic addition between the isocyanide and the nitrile 
N-oxide and in the reaction between the nucleophile (hydroxylamine) and the nitrile 
N-oxide. 
The model reaction between phenyl nitrile oxide A, pentyl isocyanide B, and 
hydroxylamine C, which generates product P, was chosen for this theoretical 
investigation. The detailed reaction mechanisms were interpreted using density 
functional theory (DFT), which was widely employed to study organic reaction 
mechanisms.11 Two possible reaction pathways were investigated in detail (Scheme 
3).  
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Scheme 3. Possible reaction pathways 1 and 2. 
In reaction path 1, the isocyanide carbon atom behaves as a nucleophile attacking 
the nitrile N-oxide species to generate intermediate M1. In the second step, the 
nitrilium ion is attacked by the nitrogen atom of hydroxylamine. Subsequently, a 
prototropic exchange gives the final compound P. We set the energies of the three 
reactants (A + B + C) as 0.00 kcal/mol as reference in the energy profile. The 
calculated energy barrier for traversing TS1 was 16.88 kcal/mol (depicted in Figure 
1A). In reaction path 2, the isocyanide behaves as carbene giving a [3 + 1] 
cycloaddition with the nitrile N-oxide species in the first step. Subsequently, the 
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resulting oxatedine ring opens due to ring strain via the transition state TS4 to 
generate intermediate M1. The calculated energy barrier for path 2 for traversing 
TS3 was 11.11 kcal/mol, while the rate-limiting step is traversing TS4 that requires 
23.66 kcal/mol (depicted in Figure 1A). 
In addition to paths 1 and 2, we also evaluated the direct attack of hydroxylamine 
C to the phenyl nitrile oxide A (pathway 3, Scheme 4). The energy barrier for 
traversing TS5 was 26.67 kcal/mol (Figure 1B), which indicates that reactant C 
cannot compete with the isocyanide B in the reaction with nitrile N-oxides. 
 
 
 
Scheme 4. The competitive reaction channel investigated (pathway 3). 
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Figure 1. The energy profile of reactions at the M06-2X/6-31G(d, p) level in 
dichloromethane (unit: kcal/mol). The energy reference is the sum of the reactant 
energies computed separately. A) Pathway 1 and 2 are depicted in red and blue 
respectively. B) Pathway 3. 
 
In summary, the energy barriers of pathways 1, 2, and 3 are 16.88, 11.11, and 
26.67 kcal/mol, respectively, indicating that path 2 is the most energetically 
favorable. Moreover, the energy barrier of path 2 is not too high to be accessible 
under room temperature reaction conditions.  
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8.2 Conclusions 
 
In this Chapter, we showed that the presence of the third component is pivotal in 
diverging the course of the two component reaction between the 1,3-dipolar species 
and isocyanides, which is sometimes messy and unable to afford a single main 
product. 
The detailed mechanism of the reaction between nitrile N-oxides and isocyanides 
has been studied indicating a [3+1] cycloaddition between nitrile N-oxide and 
isocyanides as the most energetically favorable step, thus preventing the direct attack 
of the third nucleophile to nitrile N-oxides. 
These quantum mechanical studies further validation the use of such 1,3-dipolar 
species in isocyanide-mediated multicomponent processes. 
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9.1 Introduction 
 
Hydrazonoyl halides are a class of compounds with the general formula -
C(X)NNH-, where X represents a chlorine or bromine group. These compounds are 
the halides of the so-called hydrazonic acids as imidoyl chlorides are the chlorides 
of imidic acids (Scheme 1).1  
 
Scheme 1. General formula of hydrazonoyl halides, hydrazonic acids, 
imidoyl chlorides and imidic acids. 
 
The hydrazonoyl chlorides can be readily synthesized either using 
acylhydrazines or the hydrazones as a starting materials. 
Acylhydrazines can be obtained from phenylhydrazines and acyl chlorides 
(Method A, using dichloromethane as a solvent and pyridine), or from 
phenylhydrazines and carboxylic acids (Method B, using THF as a solvent, 
EDC*HCl, DMAP and triethylamine).2–4 While, hydrazones are prepared by 
reacting aliphatic or aromatic aldehydes with a phenylhydrazines in alcohol at 
room temperature5 (Scheme 2). 
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Scheme 2. General preparation of acylhydrazies and hydrazones. 
 
Then, the acylhydrazines or the hydrazones are transformed in hydrazonoyl 
chloride using different condition methods as exemplified in Table 1.  
Chattaway et al. 
in 19256 
Disadvantage: generally accompanied by halogenation in the N-aryl part of 
the hydrazine in the 2, 4, 6-positions 
 
 
Vukov et al.  
in 19773 
Disadvantage: can only be applied to aromatic hydrazonyl chlorides 
and to specific substrates. 
 
 
Table 1. General preparation of hydrazonoyl chlorides. 
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Appel et al and 
Wolkoff, in 
1973 and 19757,8 
 
Advantage: applicable to aromatic hydrazonyl halides and aliphatich on 
the side of hydrazine. 
Disadvantage: in case ofelectron rich aryl or heteroaryl rings, the 
chlorination can also occur on the ring. 
 
Tewari et al.  
in 19819 
Disadvantage: using only if the aromatic part has two nitro group in 
position 2 and 4. 
 
Ghiglieri-Bertez 
et al. in 198710 
 
Disadvantage: can only be applied substrates. 
 
Sakamoto et al. 
in 198811 
 
Extension of PPh3-CX4 method to N-phenylalkanehydrazonoyl chlorides. 
 
Patel et al. and 
Paulvann et al. 
in 199612, 200013 
 
Advantage: halogen does not enter in the aromatic nucleus  
Disadvantage: the procedure requires a low temperature. 
Table 1. General preparation of hydrazonoyl chlorides (Continued). 
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The most general method appears to us to be the formation of acylhydrazines 
and the the subsequent transformation into hydrazonoyl chlorides using PPh3, CCl4 
in acetonitrile. 
Respect to the reaction with nitrile N-oxides, two important caveats have to be 
highlighted for nitrile imines. The first one is that despite the fact that the reaction 
is stereoselective and generates only the Z isomers, we observed that these 
hydrazonoyl chlorides, as opposed to oximes, were not geometrically stable and, on 
standing, some of them underwent an isomerization process to afford a mixture of 
E and Z isomers. Furthermore hydrazonoyl chlorides have a reduced stability. They 
are not stable on storage, especially the aliphatic ones, with a high predisposition to 
dimerize14 (Scheme 3).  
R1
N NH
Cl
R1 N N Ph
R1 N N Ph
R1
N
N
R1
N
N R1 N N
Ph
R1 N
N
Ph
R1 N
N Ph
R1 N
N
Ph
R1 N
N Ph
R1 N
 
Scheme 3. Dimerization of the corresponding nitrile imine. 
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The use of a bases is able to dehydrohalogenation of the hydrazonoyl halides to 
generate the transient nitrile imines. The latter have been used in 1,3-dipolar 
cycloadditions with a variety of 1,3-dipolarophiles including suitable alkenes and 
alkynes, which afford 4,5-dihydropyrazoles and pyrazoles, respectively (Scheme 
4).15,16 
 
Scheme 4. Generation of nitrile imines from hydrazonoyl halides and 
entrapment with alkynes or alkenes. 
Historically, the first nitrile imine was synthesized by Huisgen and co-workers 
in 1959 by thermal decomposition of 2,5-disubstituted tetrazoles (Scheme 5).17  
 
Scheme 5. Nitrile imines were first observed in the thermal 
decomposition of 2-tetrazoles. 
The dominant structure of nitrilimine is with a C-N triple bond and with a 
formal positive charge on nitrogen and two lone pairs and a formal negative charge 
on the terminal nitrogen. 
 
A survey of the literature showed us the works of Professor Moderack on the 
reaction between nitrile imines and isocyanides.18–23 In these papers it was clearly 
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shown that the two-component reaction could afford several different products 
according to the reaction conditions, the steric and electronic nature of isocyanides 
and the nitrile imines used. This chaotic result can be ascribed to the formation of a 
nitrilium intermediate deriving from the isocyanide attack to the nitrile imine, 
which can follow different pathways, no one being preferred over the others 
(Scheme 6).  
 
Scheme 6. Reaction between nitrile imines and isocyanides reported by Moderack. 
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While the diversity of obtainable products can be considered a bonus of this 
chemistry, the impossibility to limit the course of the reaction to a single product, 
or control the ratio of the various adducts under the conditions and with the 
reagents used, drastically reduces the generality of these transformations.  
Aware the results obtained with nitrile N-oxide,24,25 we reasoned that a third 
component present in the flask might quench the nitrilium ion, obtained from 
isocyanide and nitrile imines, channelling the reaction toward the formation of a 
single product. 
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10.1 Results and discussion 
 
Based on the consideration discussed in the Prologue II (Chapter 9), we carried 
out the reaction between a hydrazonoyl chloride 1, cyclohexylisocyanide 2 and 
benzoic acid 3 as third component, in dichloromethane (0.2 M) at room 
temperature overnight, and with two equivalents of triethylamine (one needed to 
generate the nitrile imine and the other to form the carboxylate). We were pleased 
to observe the formation of the multicomponent adduct α-aminocarbonyl N-
acylhydrazone 4 in 37% yield, along with the adduct 5 in 42% yield deriving from 
a two-component reaction between the hydrazonoyl chloride 1 and the carboxylic 
acid 3 (Scheme 1). 
 
Scheme 1. Three-component reaction between a hydrazonoyl chloride, cyclohexylisocyanide 
and benzoic acid. 
To explain the formation of these two products the following mechanistic 
scenario is proposed. The hydrazonoylchloride 1, under basic conditions, forms the 
ephemeral nitrilimine species 61,2 bearing an electrophilic carbon suitable for the 
isocyanide attack. At this point, the generated nitrilium ion 7 would be ready to 
undergo the transformations reported by Moderack.3–7 Instead the presence of the 
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carboxylate ion prevents the other reaction pathways by generating, in a 
stereoselective way,8 the iminoanhydride intermediate 8, which affords the desired 
product by undergoing a Mumm type rearrangement thanks to the properly 
positioned hydrazine nitrogen atom (Scheme 2).  
Cl
N NH
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Scheme 2. Proposed mechanism. 
Additionally, nitrile imines are highly reactive species which can react directly 
with carboxylic acids9 and undergo an acyl migration to generate the by-product 
compound 5. It is important to highlight that we did not observe any of the 
compounds described by Moderack, proving that the use of the carboxylate as third 
component suppresses all the competing reactions between nitrile imines and 
isocyanides. Stimulated by this early result and with the goal to suppress/reduce the 
formation of the product 5, we decided to screen the reaction conditions in order to 
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improve the 4:5 ratio and increase the yield of α-aminocarbonyl N-acylhydrazones 
(Table 1).  
Entry Solvent Isocyanide (eq) Yield (4) yield (5) 
1 DCM (1 M) 1 44% 54% 
2 Neat 1 52% 18% 
3 DCM (1 M) 1.5 44% 56% 
4 Neat 1.5 54% 41% 
5 Neat 2 56% 19% 
6 DCM (0.2 M) 2 37% 42% 
7 DCM (1 M) 2 38% 23% 
8 Neat 2 52% 42% 
9 Neat 1.5 53% 18% 
10 Neat 2 55% 16% 
11 DCM (1 M) 2 39% 58% 
 
Table 1. Optimization of the reaction conditions. 
To our delight, the solvent-free reaction conditions (Entry 2) with equimolar 
amount of hydrazonoyl chloride, isocyanide and carboxylic acid, and two 
equivalents of TEA gave the α-aminocarbonyl N-acylhydrazone 4 in 52% yield and 
compound 5 in 18% yield, increasing the desired/undesired product ratio.  
With these optimized conditions in hand, we planned to explore the scope and 
the limitations of this novel multi-component process by casually combining one of 
six hydrazonoylchlorides (1, 9-13) with one of five isocyanides (2, 14-17) and one 
of ten carboxylic acids (18-27) (Figure 1). The starting hydrazonoyl chlorides (1, 9-
13) were readily synthesized in two steps with quite good yields (43-77%), starting 
from hydrazines.  
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Hydrazonoyl chlorides
N NH
Cl
N NH
Cl
N NH
Cl
Cl
N NH
Cl
Cl
OMe
N NH
Cl
MeO
N NH
Cl
1 9 10
11 12 13
I
Cl
Carboxylic acids
HO
O
OHO
CF3
OHO
OMe
OHO
Me
OH
O
OHO OHO
NO2
COOH
HO
O
Me
18 19 20 21 22
23 24 25 26 27
Isocyanides
NC
CN
CN
NC
14
15
16
17
NC
2
OHO
I
 
Figure 1. Building blocks used. 
A library of 14 α-aminocarbonyl N-acylhydrazones was thus generated (28-40, 
Figure 2) with yields ranging from 83% to 27%, indicating the generality and the 
versatility of the process. In particular we observed that the reaction proceeded well 
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when the carboxylic acids were solid. When they were liquid (e.g. 
cyclopentancarboxylic acid) the formation of the undesired product was 
preponderant (86% yield). In this case prior salification to afford a solid was used 
with success affording the desired 3-CR product in 67% yield (34).  
 
 
Figure 2. Synthesized α-aminocarbonyl N-acylhydrazones. Yields in parentheses 
refer to the competing reaction between nitrile imines and carboxylic acids. 
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Figure 2. Synthesized α-aminocarbonyl N-acylhydrazones Yields in parentheses 
refer to the competing reaction between nitrile imines and carboxylic acids 
(Continued). 
Although the reaction stereoselectively generates the Z isomer, we observed that 
these acylhydrazones were not always geometrically stable and, on standing, some 
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of them underwent an isomerization process to afford a mix of E and Z isomers. In 
order to provide a detailed structure assignment of the proposed structures, a single 
crystal X-ray diffraction analysis on derivative 4 has been carried out. The 
established solid state structure is represented in Figure 3, together with the relative 
arbitrary atom-numbering scheme. 
 
Figure 3. ORTEP10,11 view of 4 and the relative arbitrary atomnumbering 
scheme (thermal ellipsoids at 40% probability). 
It is noteworthy that we could only find in the literature one example of α-
aminocarbonyl N-acylhydrazone, produced by a two-step reaction involving 
hydrazonoylchloride 1, cyclohexylisocyanide 2 and sodium acetate (Scheme 3).4 
This reaction is however conceptually different from the one we report here, as it 
involves first the attack of isocyanide 2 to the hydrazonoyl chloride 1 to form a 
1,2,3-triazolium salt 41, followed by a challenging purification step consisting of 
several recrystallizations. The purified intermediate then undergoes a ring opening 
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reaction with 3.7 equivalents of sodium acetate at 125-130 °C to give the α-
aminocarbonyl N-acylhydrazones 42 in 33% yields (overall yield after a further 
purification step).  
 
Scheme 3. The only two-step synthesis of α-aminocarbonyl N-
acylhydrazones reported to date. 
Therefore, such two-component reaction is not deemed suitable for the fast and 
efficient synthesis of libraries of α-aminocarbonyl N-acylhydrazone due to the low 
yield of product, the formation of several by-products and the need for several 
purification steps. In order to widen the scope of this novel 3-CR and to further 
explore the reactivity of the nitrilimine nitrogen atom towards a Mumm-type 
rearrangement we decided to react nitrilimine 1, tert-butylisocyanide 14 and 2-
hydroxymethylbenzoic acid 43 (“sacrificial acid”). 
The use of the substituted benzoic acid has been already reported by our 
laboratory12 for the synthesis of unsimmetrical bis (β-aminoamides). The presence 
of a hydroxymethyl function at the orto position of benzoic acid engenders an 
alternative reaction path leading to the formation of phtalide and a formal addition 
of water to the final compound. It should be noted that water itself would not be 
nucleophilic enough to intercept the nascent nitrilium ion. With our satisfaction the 
reaction was clean and we observed a marked increase in yield in the presence of 
solvent. Whereas the desired α-amino-carbonylhydrazone 44 was produced with 
67% yield in the presence of CH2Cl2 (Scheme 4), under neat conditions the yield 
was only 18%.  
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Scheme 4. Multicomponent synthesis of α-amino-carbonylhydrazone 
using the sacrificial acid 43. 
A possible reaction mechanism accounting for the formation of 47 is depicted in 
Scheme 5. Here the α-adduct 45 could in principle follow two different reaction 
pathways: path A, which via a Mumm-type rearrangement gives a 6-membered 
transition state leading to compound 46, and path B, which following the 
intramolecular attack of the hydroxyl function on the iminoanhydride gives the 
adduct 44 (via a five-membered transition state) and phtalide 47. Since only 44 is 
obtained we speculate that the formation of the five-membered intermediate has a 
lower activation energy than in the six-membered case.  
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Scheme 5. Possible paths of 3-CR with “sacrificial acid”.  
It is important to highlight that the “sacrificial acid” 43 is not able to accomplish 
the formal addition of water when an Ugi-type reaction with primary amine is 
attempted, due to the higher nucleophilicity of the secondary amine formed in situ, 
which leads to Mumm rearrangement. 
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To further prove the generality of such mechanism and the selectivity towards 
path B, the synthesis of a small collection of α-aminocarbonylhydrazones was 
attempted. In all cases the α-aminocarbonylhydrazone (48-52) was the only 
reaction product and medium-high yields were obtained (Figure 4). We were 
therefore enthusiastic in discovering the possibility, in our new 3-CR, to tune the 
reactivity of the nitrilimine nitrogen atom. 
 
 
Figure 4. α-Aminocarbonyl N-acylhydrazones synthesized. 
Some of them undergo a rapid isomerization, during the chromatographic 
purification. We were able to isolate the two different isomers, but they both 
underwent a rapid isomerization at room temperature to give a 1:1 E/Z mix.  
In Figure 5 are shown the superimposition of a first spot (green), a second spot 
(red), and the second spot after 20 hours (blue). The second spot shows 
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dichloromethane traces (5.30 ppm), but during the evaporation of the solvent, the 
attempt to dry it at high vacuum pump overnight at room temperature gave the 
spectrum in blue, which clearly shows isomerization (Figure 5).  
 
 
Figure 5. Isomerization of compound 51. 
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10.2 Conclusions 
 
In conclusion, starting from an erratic two component reaction between nitrile 
imines and isocyanides, we discovered a novel 3-CR between nitrile imines, 
isocyanides and carboxylic acids and applied it to the synthesis of the first reported 
library of α-aminocarbonyl N-acylhydrazones and some related α-
aminocarbonylhydrazones. In addition, our novel MCR with “sacrificial acid” 
allows to obtain in the α-aminocarbonylhydrazones, with a NH group that enables 
further derivatization, opening up the way to a variety of post-MCR modifications 
and thus enlarging the scope of the reaction. 
The compounds obtained could also be seen as aza-homologues of the Ugi 
scaffold, in which case the hydrazonoyl chlorides, hence their nitrilimine activated 
form would represent a valuable substitute for the imines.  
In fact, although obtained in a completely different way, the novel 3-CR 
molecular scaffold shows the atom connectivity NCCNNC and an evident 
peptidomimetic nature, similarly to the four-component Ugi scaffold with a 
NCCNC connectivity. Additionally the different chemical functionalities present 
(hydrazone, amide, and acyl groups) enable a potentially large number of post-
trasformation reactions, similarly to the Ugi adducts.13 
Finally, we reckon that other 1,3 dipolar species lay dormant still, since their 
multicomponent reaction with isocyanides has not been investigated so far, and are 
ready to be successfully used for the discovery of novel multicomponent 
reactions.14,15 
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10.3 Experimental section 
 
General Methods. Commercially available reagents and solvents were used 
without further purification. Dichloromethane was dried by distillation from P2O5 
and stored over activated molecular sieves (4 Å). When necessary the reactions 
were performed in oven-dried glassware under a positive pressure of dry nitrogen. 
Melting points were determined in open glass capillaries and are uncorrected. All 
the compounds were characterized by IR. 1H and 13C APT NMR were recorded on 
a 400 MHz. High-resolution ESI-MS spectra were performed on a Thermo LTQ 
Orbitrap XL mass spectrometer. The spectra were recorded by infusion into the ESI 
source using MeOH as the solvent. Chemical shifts (δ) are reported in part per 
million (ppm) relative to the residual solvent peak. Column chromatography was 
performed on silica gel (70–230 mesh ASTM) using the reported eluents. Thin 
layer chromatography (TLC) was carried out on 5 x 20 cm plates with a layer 
thickness of 0.25 mm (Silica gel 60 F254). When necessary they were developed 
with KMnO4.  
 
General preparation of hydrazonoyl chlorides (1, 9-13).16–18  
The hydrazonoyl chlorides were readily synthesized in two steps: 
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Preparation of acylhydrazines. Method A: To a stirred solution of 
phenylhydrazine on 5 mmol scale in dichloromethane (1 M, 5 mL) was slowly 
added pyridine (0.403 mL, 5 mmol, 1 eq.) in an ice bath. Then, to this, well-stirred 
reaction mixture was added dropwise a solution of acyl chloride (5 mmol, 1 eq.) in 
dichloromethane (4 M, 1.25 mL). Upon completion of addition, ice bath was taken 
away, and stirring was continued overnight at the room temperature. The reaction 
was poured in water and the two layers were separated. The organic phase was 
washed with water (x1) and brine (x1), dried over sodium sulfate, concentrated 
under reduced pressure and purified by chromatography. Method B: To a stirred 
solution of acid on a 5 mmol scale in THF (0.2 M, 10 mL) were added EDC HCl 
(1.05 g, 5.5 mmol, 1.1 eq.), DMAP (0.122 g, 1 mmol, 0.2 eq.), triethylamine (1.4 
mL, 10 mmol, 2 eq.) and hydrazine (5 mmol, 1 eq.) at 0 °C. The resulting mixture 
was allowed to warm to room temperature over 24 h. The crude reaction mixture 
was washed with HCl 1M sol. (x2), NaHCO3 sat. sol. (x2) and brine (x1), 
evaporated to dryness and used in the next step without further purification.  
 
Preparation of hydrazonoyl chlorides (1, 9-13).16–18 The 
corresponding acylhydrazine (2.5 mmol) was dissolved in CH3CN (0.5 M, 5 mL) 
and triphenylphosphine (0.787 g, 3 mmol, 1.2 eq.) and carbon tetrachloride (0.289 
mL, 3 mmol, 1.2 eq.) were added. The reaction was stirred at room temperature 
until all the acylhydrazine was consumed as judged by TLC (typically 8-12 hours). 
The reaction was concentrated under reduced pressure and purified by column 
chromatography (n-hexane/EtOAc 30:1) and stored below 0 °C.  
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(Z)-4-methyl-N'-phenylbenzohydrazonoyl chloride (1).  
The crude material was purified by column chromatography 
(n-hexane/ EtOAc 30:1) to give the product as a yellowish 
solid (391 mg, 64% yield). 1H NMR (400 MHz, CDCl3) δ 8.02 
(br s, NH), 7.85 (d, J = 8.2 Hz, 2H), 7.36-7.32 (m, 2H), 7.25-
7.20 (m, 4H), 6.97 (t, J = 7.3 Hz, 1H), 2.42 (s, 3H); 13C NMR 
(100 MHz, CDCl3) δ 143.5, 139.4, 131.8, 129.4, 129.1, 126.3, 
125.0, 121.0, 113.4, 21.3. IR (KBr) 3297, 1586, 1492, 1232, 
1129, 938 νmax/cm-1; Mp 133-134 °C.  
 
(Z)-4-iodo-N'-phenylbenzohydrazonoyl chloride (9).  
The crude material was purified by column chromatography (n-
hexane/ EtOAc 30:1) to give the product as a white solid (570 
mg, 64% yield). 1H NMR (400 MHz, CDCl3) δ 8.04 (br s, NH), 
7.73 (br d, AA’XX’, 2H), 7.64 (br d, AA’XX’, 2H), 7.34-7.30 
(m, 2H), 7.17 (br d, 2H), 6.96 (t, J = 7.1 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 143.0, 137.5, 134.0, 129.4, 127.9, 123.7, 121.4, 
113.5, 95.1. IR (KBr) 3307, 1577, 1503, 1231, 1146, 938 
νmax/cm-1; Mp 160-161 °C.  
 
(Z)-N'-(4-chlorophenyl)-2-phenylacetohydrazonoyl chloride (10).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 30:1) to give the 
product as a white solid (419 mg, 60% yield). 1H NMR 
(400 MHz, CDCl3) δ 7.66 (br s, NH), 7.38-7.31 (m, 5H), 
7.24 (br d, AA’XX’, 2H), 7.00 (br d, AA’XX’, 2H), 3.92 
(s, 2H); 13C NMR (100 MHz, CDCl3) δ 142.4, 135.6, 
129.3, 129.2, 128.8, 127.4, 127.0, 125.5, 114.5, 45.0. IR 
(KBr) 3329, 1593, 1492, 1256, 1185, 1075, 825 νmax/cm-1; Mp 80-81 °C.  
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(Z)-N'-(4-chlorophenyl)benzohydrazonoyl chloride (11).  
The crude material was purified by column chromatography (n-
hexane/ EtOAc 30:1) to give the product as a light yellow solid 
(495 mg, 75% yield). 1H NMR (400 MHz, CDCl3) δ 8.02 (br s, 
NH), 7.93 (br d, AA’XX’, 2H), 7.44-7.39 (m, 3H), 7.28 (br d, 
AA’XX’, 2H), 7.11 (br d, 2H); 13C NMR (100 MHz, CDCl3) δ 
142.0, 134.2, 129.4, 129.3, 128.5, 126.5, 125.8, 125.5, 114.6. IR 
(KBr) 3322, 1592, 1495, 1232, 1129, 1085, 947 νmax/cm-1; Mp 
108-109 °C.  
 
(Z)-4-chloro-N'-(4-methoxyphenyl)benzohydrazonoyl chloride (12).  
The crude material was purified by column chromatography 
(n-hexane/ EtOAc 30:1) to give the product as a light yellow 
solid (457 mg, 62% yield). 1H NMR (400 MHz, CDCl3) δ 
7.91 (br s, NH), 7.83 (br d, AA’XX’, 2H), 7.36 (br d, 
AA’XX’, 2H), 7.11 (br d, AA’XX’, 2H), 6.89 (br d, AA’XX’, 
2H), 3.80 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 154.7, 
137.2, 134.8, 133.1, 128.6, 127.3, 122.6, 114.8, 114.7, 55.6. 
IR (KBr) 3329, 1569, 1396, 1242, 1091, 943 νmax/cm-1; Mp 
108-109 °C.  
 
(Z)-4-methoxy-N'-phenylbenzohydrazonoyl chloride (13). 
Compound 13 characterization data were compared to 
literature reported ones, see: G. Wang, X. Liu, T. Huang, 
Y. Kuang, L. Lin, X. Feng, Org. Lett. 2013, 15, 76–79  
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General preparation of α-aminocarbonyl N-acylhydrazones (4, 
28-40).  
The hydrazonoyl chloride (0.5 mmol, 1 eq.), the isocyanide (0.5 mmol, 1 eq.) 
the carboxylic acid (0.5 mmol, 1 eq.) and TEA (1 mmol, 2 eq.) were one-pot mixed 
in a screw-top vial. The reaction was stirred at room temperature under a nitrogen 
atmosphere overnight. The crude material was purified by column chromatography.  
NB. In order to minimize the cis-trans amide isomerism, which complicates the 
NMR spectra, a simple solvent switch from CDCl3 to DMSO-d6 was employed, 
which was sometimes able to suppress or minimize rotamerism and enable 
assignment of the spectra. Although the reaction stereo-selectively generates the Z 
isomer, we observed that these acylhydrazones are not geometrically stable and on 
standing they undergo an isomerization process to afford equimolar amounts of the 
Z and E isomers. For compounds 30-34, and 37 this process is so rapid that we 
were not able to isolate the Z isomer.  
 
(Z)-2-(2-benzoyl-2-phenylhydrazono)-N-cyclohexyl-2-(p-tolyl)acetamide (4).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc t 9:1) to give the 
product as light yellow solid (114 mg, 52% yield). 1H 
NMR (400 MHz, CDCl3) δ 7.82 (br d, AA’XX’, 2H), 
7.44 (br d, AA’XX’, 2H), 7. 30-7.17 (m, 10H), 6.54 (br 
s, NH), 3.96-3.88 (m, 1H), 2.38 (s, 3H), 1.80-1.77 (m, 
2H), 1.60-1.50 (m, 3H), 1.28-1.22 (m, 2H), 1.09-1.06 
(m, 3H); 13C NMR (100 MHz, CDCl3) δ 168.0, 164.0, 
142.9, 142.0, 134.8, 130.6, 129.4 , 129.2, 129.1, 129.0, 
128.5, 128.0 (2C), 127.9, 127.8, 48.3, 32.6, 25.2, 24.6, 21.6. IR (KBr) 3296, 2923, 
1643, 1552, 1322, 1234, 899 νmax/cm-1; Mp 166-167 °C; MS (ESI) m/z (M+H)+ 
Calcd for C28H29N3O2: 439.2260; Found: 462.2130 [M+Na]+ 
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(Z)-N-(tert-butyl)-2-(4-chlorophenyl)-2-(2-cinnamoyl-2-(4methoxyphenyl) 
hydrazono)acetamide (28).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 9:1) to give the 
product as orange solid (137 mg, 56% yield). Signals 
are referred to the main rotamer: 1H NMR (400 
MHz, CDCl3) δ 7.85 (br d, AA’XX’, 2H), 7.75 (d, J 
= 15.6 Hz, 1H), 7.41-7.33 (m, 9H), 7.05 (br s, NH), 
6.96 (br d, AA’XX’, 2H), 6.48 (br d, 1H), 3.84 (s, 
3H), 1.39 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
163.7 (2C), 159.9, 143.0, 138.2, 134.8, 132.7, 130.0, 
129.8 (2C), 129.6, 128.9, 128.8, 128.0, 117.9, 114.9, 
55.5, 52.0, 28.4. IR (KBr) 3329, 2967, 1670, 1508, 1358, 1251, 836 νmax/cm-1; Mp 
173-174 °C; MS (ESI) m/z (M+H)+ Calcd for C28H28ClN3O3: 489.1819; Found: 
512.1700 [M+Na]+.  
 
(Z)-2-(2-(4-chlorophenyl)-2-(4-(trifluoromethyl)benzoyl)hydrazono)-N-
cyclohexyl-2 phenylacetamide (29).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 9:1) to give the 
product as yellowish solid (208 mg, 79% yield). 1H 
NMR (400 MHz, CDCl3) δ 7.89 (br d, AA’XX’, 2H), 
7. 58-7.53 (m, 5H), 7.45-7.42 (m, 2H), 7.24-7.22 (m, 
4H), 6.28 (br s, NH), 3.93-3.86 (m, 1H), 1.79-1.77 (m, 
2H), 1.63-1.52 (m, 3H), 1.33-1.24 (m, 2H), 1.11-1.03 
(m, 3H); 13C NMR (100 MHz, CDCl3) δ 168.0, 163.5, 
139.8, 138.0, 134.2, 132.5, 132.4 (q, 2JCF = 33 Hz), 
124.8 (q, 1JCF = 270 Hz), 131.6, 129.5, 129.4, 129.3, 
128.8 (2C), 128.4 (2C), 125.1 (q, 3JCF = 3.6 Hz), 48.5, 32.5, 25.1, 24.5. IR (KBr) 
3269, 2928, 1673, 1536, 1333, 1124, 847 νmax/cm-1; Mp 177-178 °C; MS (ESI) 
m/z (M+H)+ Calcd for C28H25ClF3N3O2: 527.1587; Found: 550.1464 [M+Na]+.  
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(Z)-N-(tert-butyl)-2-(2-(4-chlorophenyl)-2-(4-methoxybenzoyl)hydrazono)-3-
phenylpropanamide (30).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 9:1) to give the 
product as a colorless amorphous solid (69 mg, 29% 
yield). Mixture of E/Z isomers, signals are referred to 
the main isomer: 1H NMR (400 MHz, CDCl3) δ 7.40-
7.08 (m, 9H), 6.93 (br s, NH), 6.74 (br d, AA’XX’, 
2H), 6.70 (br d, AA’XX’, 2H), 3.91 (s, 2H), 3.79 (s, 
3H), 1.34 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
162.4, 161.8, 161.4, 141.3, 136.0, 133.2, 133.0, 130.9, 129.8, 129.2, 128.9, 128.6, 
128.4, 126.1, 113.2, 55.3, 51.2, 42.5, 28.5. IR (KBr) 3384, 2928, 1670, 1602, 1511, 
1256, 834 νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for C27H28ClN3O3: 477.1819; 
Found: 500.1719 [M+Na]+.  
 
(Z)-N-(tert-butyl)-2-(2-phenyl-2-(4-(trifluoromethyl)benzoyl)hydrazono)-2-(p-
tolyl)acetamide (31).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 9:1) to give the 
product as yellow solid (171 mg, 71% yield). Mixture of 
E/Z isomers, signals are referred to the main isomer: 1H 
NMR (400 MHz, CDCl3) δ 7.83 (br d, AA’XX’, 2H), 7. 
57 (br d, AA’XX’, 2H), 7. 49 (br d, AA’XX’, 2H), 7.30-
7.22 (m, 5H), 7.13-7.11 (m ,1H), 7.00-6.93 (m, 1H), 
6.34 (br s, NH), 2.40 (s, 3H), 1.34 (s, 9H); 13C NMR 
(100 MHz, CDCl3) δ 164.0, 162.1, 143.0, 141.5, 139.4, 
138.4, 132.6, 132.1 (q, 2JCF = 32.5 Hz), 129.6, 129.5, 129.0, 128.5, 128.2, 128.0, 
125.0 (q, 3JCF = 3.4 Hz), 123.5 (q, 1JCF = 270 Hz), 52.2, 28.6, 21.6. IR (KBr) 
3296, 2961, 1657, 1314, 1015 νmax/cm-1; Mp 176-177 °C; MS (ESI) m/z (M+H)+ 
Calcd for C27H26F3N3O2: 481.1977; Found: 504.1853 [M+Na]+.  
 
N‑Acylhydrazones 
213 
(Z)-N-cyclohexyl-2-(4-methoxyphenyl)-2-(2-(3-methylbenzoyl)-2-
phenylhydrazono)acetamide (32).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 9:1) to give the 
product as sticky solid (94 mg, 40% yield). Mixture of 
E/Z isomers, signals are referred to the main isomer: 
1H NMR (400 MHz, CDCl3) δ 7.88 (br d, AA’XX’, 
2H), 7. 31-7.02 (m, 9H), 6.91 (br d, AA’XX’, 2H), 
6.58 (br d, NH), 3.96-3.91 (m, 1H), 3.82 (s, 3H), 2.23 
(s, 3H), 1.85-1.78 (m, 2H), 1.61-1.49 (m, 3H), 1.34-
1.22 (m, 2H), 1.13-1.09 (m, 3H); 13C NMR (100 MHz, 
CDCl3) δ 168.3, 164.1, 162.9, 142.1 (2C), 137.7, 
134.8, 133.9, 131.3, 130.4, 129.7, 129.0 (2C), 128.0, 127.6, 126.2, 124.1, 114.0, 
55.4, 48.3, 32.6, 25.2, 24.6, 21.2. IR (KBr) 3307, 2928, 1657, 1508, 1253, 735 
νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for C29H31N3O3: 469.2365; Found: 
492.2256 [M+Na]+.  
 
(Z)-2-(2-(4-iodobenzoyl)-2-phenylhydrazono)-N-(naphthalen-2-yl)-2-(p-
tolyl)acetamide (33).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 9:1) to give the 
product as yellow solid (216 mg, 71% yield). 
Mixture of E/Z isomers, signals are referred to the 
main isomer: 1H NMR (400 MHz, CDCl3) δ 8.97 
(br s, NH), 8.20 (s, 1H), 7.92-7.72 (m, 5H), 7.47-
7.39 (m, 4H), 7.27-7.24 (m, 3H), 7.14-6.96 (m, 
7H), 2.25 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
163.1, 161.1, 141.3, 137.5 (2C), 135.0 (2C), 134.8, 
133.9, 133.6, 131.0, 130.7, 129.7, 129.4 (2C), 128.9 (2C), 128.4, 128.0, 126.6, 
125.1, 119.4, 116.0, 97.9, 21.4. IR (KBr) 3346, 3032, 1676, 1536, 1220, 1006 
νmax/cm-1; Mp 202-203 °C; MS (ESI) m/z (M+H)+ Calcd for C32H24IN3O2: 
609.0913; Found: 632.0814 [M+Na]+.  
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(Z)-2-(2-(cyclopentanecarbonyl)-2-phenylhydrazono)-N-pentyl-2-(p-
tolyl)acetamide (34).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 9:1) to give the 
product as sticky solid (140 mg, 67% yield). Mixture of 
E/Z isomers, signals are referred to the main isomer: 1H 
NMR (400 MHz, CDCl3) δ 8.24 (br d, NH), 7.71 (br d, 
2H), 7.41-6.83 (m, 7H), 3.35 (br q, 2H), 2.35 (s, 3H), 
2.24-2.22 (m, 1H), 1.81-1.25 (m, 14H), 0.90-0.88 (m, 
3H); 13C NMR (100 MHz, CDCl3) δ 187.4, 162.0, 
145.5, 131.4, 131.0 (2C), 129.3, 129.2, 128.4, 128.1, 
42.1, 39.2, 29.1, 29.1, 29.0, 26.2, 22.3, 21.5, 13.9. IR (KBr) 3247, 2928, 1684, 
1377, 1185, 694 νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for C26H33N3O2: 
419.2573; Found: 442.2436 [M+Na]+.  
 
(Z)-N-(tert-butyl)-2-(4-iodophenyl)-2-(2-(3-methylbenzoyl)-2-
phenylhydrazono)acetamide (35).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 9:1) to give the 
product as yellow solid (159 mg, 59% yield). Signals are 
referred to the main rotamer: 1H NMR (400 MHz, CDCl3) 
δ 7.78 (br d, AA’XX’, 2H), 7. 65 (br d, AA’XX’, 2H), 
7.33 (s, 1H), 7.26-7.06 (m, 8H), 6.51 (br s, NH), 2.25 (s, 
3H), 1.33 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 167.9, 
163.6, 142.0, 138.0, 137.8, 134.4, 131.5, 129.9 (2C), 
129.1 (2C), 128.0, 128.0, 127.7, 126.4, 99.3, 52.2, 28.5, 21.2. IR (KBr) 3285, 2967, 
1659, 1489, 1215, 735 νmax/cm-1; Mp 142-143 °C; MS (ESI) m/z (M+H)+ Calcd 
for C26H26IN3O2: 539.1070; Found: 562.0911 [M+Na]+.  
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(Z)-N-cyclohexyl-2-(4-iodophenyl)-2-(2-(4-methoxybenzoyl)-2-
phenylhydrazono)acetamide (36).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 9:1) to give the 
product as white solid (215 mg, 74% yield). 1H NMR 
(400 MHz, CDCl3) δ 7.76 (d, J = 8.3 Hz, 2H), 7. 63 (d, J 
= 8.4 Hz, 2H), 7.41 (d, J = 8.5 Hz, 2H), 7.25-7.20 (m, 
5H), 6.71 (d, J = 8.5 Hz, 2H), 6.52 (br d, NH), 3.89-3.84 
(m ,1H), 3.77 (s, 3H), 1.75-1.72 (m, 2H), 1.60-1.51 (m, 
3H), 1.40-1.21 (m, 2H), 1.07-0.99 (m, 3H); 13C NMR 
(100 MHz, CDCl3) δ 167.9, 163.4, 161.5, 142.3, 137.9, 
131.5, 131.4, 129.8, 129.2, 128.0, 127.8 (2C), 126.5, 113.2 (2C), 99.2, 55.2, 48.2, 
32.4, 25.1, 24.6. IR (KBr) 3269, 2928, 1657, 1506, 1251, 1001 νmax/cm-1; Mp 
174-175 °C; MS (ESI) m/z (M+H)+ Calcd for C28H28IN3O3: 581.1175; Found: 
604.1022 [M+Na]+.  
 
(Z)-2-(4-chlorophenyl)-2-(2-(4-methoxyphenyl)-2-(4-nitrobenzoyl)hydrazono)-
N-pentyl-acetamide (37).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 9:1) to give 
the product as a sticky solid (217 mg, 83% yield). 
Mixture of E/Z isomers, signals are referred to the 
main isomer: 1H NMR (400 MHz, DMSO-d6) δ 
8.27-8.21 (m, 4H), 7.87-7.85 (m, 2H), 7.43-7.40 
(m, 2H), 7.26 (br d, AA’XX’, 2H), 7.16 (br s, 
NH), 6.91 (br d, AA’XX’, 2H), 3.75 (s, 3H), 2.83-
2.76 (m, 2H), 1.37-1.04 (m, 6H), 0.81-0.77 (m, 
3H); 13C NMR (100 MHz, DMSO-d6) δ 163.7, 
163.0, 159.6, 148.6, 142.7, 134.1, 131.5, 130.8, 130.3, 129.6 , 129.2 (2C), 123.4 
(2C), 114.3, 55.8, 39.0, 29.1, 28.4, 22.1, 14.1. IR (KBr) 3296, 2934, 1662, 1508, 
1245, 831 νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for C27H27ClN4O5: 522.1670; 
Found: 545.1545 [M+Na]+.  
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(Z)-N-benzyl-2-(4-chlorophenyl)-2-(2-(4-methoxybenzoyl)-2-(4-
methoxyphenyl)hydrazono) acetamide (38).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 9:1) to give 
the product as yellowish solid (155.5 mg, 59% 
yield). 1H NMR (400 MHz, DMSO-d6) δ 8.89 (br 
s, NH), 7.57-7.44 (m, 6H), 7.24-7.14 (m, 7H), 
6.91-6.89 (m, 4H), 3.99 (m, 2H), 3.78 (s, 3H), 
3.76 (s, 3H); 13C NMR (100 MHz, DMSO-d6) δ 
163.5 (2C), 161.5, 159.0, 138.4, 135.7, 133.3, 
132.0, 130.7, 129.2, 129.0, 128.7, 128.1 (2C), 
127.6, 127.5, 114.3, 113.4, 55.8, 55.7, 42.7. IR 
(KBr) 3230, 3054, 2835, 1665, 1294, 1026, 836 
νmax/cm-1; Mp 173-174 °C; MS (ESI) m/z (M+H)+ Calcd for C30H26ClN3O4: 
527.1612; Found: 550.1464 [M+Na]+.  
 
(Z)-2-(2-(4-chlorophenyl)-2-(3-phenylpropanoyl)hydrazono)-N-pentyl-2-
phenylacetamide (39).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 9:1) to give the 
product as yellowish solid (164 mg, 69% yield). 1H 
NMR (400 MHz, DMSO-d6) δ 8.28 (br t, NH), 
7.62 (br d, AA’XX’, 2H), 7.47-7.37 (m, 5H), 7.29-
7.26 (m, 4H), 7.18-7.13 (m, 3H), 3.13-3.05 (m, 
2H), 2.94-2.90 (m, 2H), 2.67-2.59 (m, 2H), 1.25-
1.13 (m, 6H), 0.83 (t, J = 7.1 Hz, 3H); 13C NMR 
(100 MHz, DMSO-d6) δ 191.3, 163.4, 141.7, 
138.2, 134.8, 132.6, 131.0, 130.0, 129.1, 128.8, 128.8, 128.6 (2C), 127.2 (2C), 
126.4, 38.7, 36.2, 30.8, 29.1, 28.3, 22.2, 14.3. IR (KBr) 3263, 2934, 1687, 1624, 
1163, 721 νmax/cm-1; Mp 142-143 °C; MS (ESI) m/z (M+H)+ Calcd for 
C28H30ClN3O2: 475.2027; Found: 498.1873 [M+Na]+.  
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(Z)-2-(2-acetyl-2-(4-chlorophenyl)hydrazono)-N-(tert-butyl)-2-
phenylacetamide (40).  
The crude material was purified by column chromatography (n-
hexane/ EtOAc 9:1) to give the product as a yellow solid (50 
mg, 27% yield). Signals are referred to the main rotamer: 1H 
NMR (400 MHz, DMSO-d6) δ 7.99 (br s, NH), 7.73 ( br d, 
AA’XX’, 2H), 7.51-7.26 (m 7H), 2.31 (s, 3H), 1.07 (s, 9H); 13C 
NMR (100 MHz, DMSO-d6) δ 189.8, 163.0, 143.0, 139.0, 
134.7, 131.9, 129.5, 129.1, 128.8 (2C), 127.7 (2C), 51.6, 28.5, 
23.2. IR (KBr) 3247, 2972, 1695, 1550, 1366, 919, 688 
νmax/cm-1; MP 159-160 °C; MS (ESI) m/z (M+H)+ Calcd for 
C20H22ClN3O2: 371.1401; Found: 394.1299 [M+Na]+.  
 
General preparation of α-aminocarbonylhydrazones (44, 48-52). The 
hydrazonoyl chloride (0.5 mmol, 1 eq.), the isocyanide (0.5 mmol, 1 eq.), the 2-
hydroxymethylbenzoic acid (0.5 mmol, 1 eq.) and TEA (1 mmol, 2 eq.) were one-
pot mixed in DCM (0.5 M, 1 mL). The reaction was stirred at room temperature 
under a nitrogen atmosphere overnight. After evaporation of the solvent, the crude 
material was purified by column chromatography.  
 
(Z)-N-(tert-butyl)-2-(2-phenylhydrazono)-2-(p-tolyl)acetamide (44).  
The crude material was purified by column chromatography 
(n-hexane/ EtOAc 30:1) to give the product as a sticky solid 
(104 mg, 67% yield). Signals are referred to the main 
rotamer: 1H NMR (400 MHz, CDCl3) δ 12.61 (br s, NH), 
7.45 (d, J = 7.9 Hz, 2H), 7.30-7.21 (m, 6H), 6.94-6.90 (m, 
1H), 5.80 (br s, NH), 2.41 (s, 3H), 1.41 (s, 9H); 13C NMR 
(100 MHz, CDCl3) δ 164.2, 144.0, 138.2, 134.2, 132.1, 
129.5, 128.5, 121.1, 113.5, 51.9, 28.8, 21.3. IR (KBr) 3318, 
2972, 1626, 1530, 1245, 1157, 817 νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for 
C19H23N3O: 309.1841; Found: 332.1727 [M+Na]+.  
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(Z)-N-(4-methoxyphenyl)-2-(2-phenylhydrazono)-2-(p-tolyl)acetamide (48).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 30:1) to give 
the product as a sticky solid (72 mg, 40% yield). 
Mixture of E/Z isomers, signals are referred to the 
main isomer: 1H NMR (400 MHz, CDCl3) δ 8.92 
(br s, NH), 8.12 (br s, NH), 7.62 (br d, AA’XX’, 
2H), 7.46-7.27 (m, 6H), 7.09 (br d, AA’XX’, 2H), 
6.98 (br t, 1H), 6.90 (br d, AA’XX’, 2H), 3.80 (s, 
3H), 2.43 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
161.9, 156.0, 142.8, 139.8, 137.6, 131.4, 130.0, 129.4, 129.1, 125.7, 122.0, 121.0, 
114.2, 113.7, 55.6, 21.5. IR (KBr) 3373, 3225, 2923, 1654, 1508, 1242, 823 
νmax/cm-1; MS (ESI) m/z (M+H)+ Calcd for C22H21N3O2: 359.1634; Found: 
382.1512 [M+Na]+.  
 
(Z)-2-(2-(4-chlorophenyl)hydrazono)-N-pentyl-2-phenylacetamide (49).  
The crude material was purified by column chromatography 
(n-hexane/ EtOAc 30:1) to give the product as a sticky solid 
(125 mg, 73% yield). 1H NMR (400 MHz, CDCl3) δ 12.79 
(br s, NH), 7.53 (br d, AA’XX’, 2H), 7.46-7.39 (m, 3H), 7.22 
(br d, AA’XX’, 2H), 7.12 (br d, AA’XX’, 2H), 5.90 (br s, 
NH), 3.35-3.30 (m, 2H), 1.57-1.50 (m, 2H), 1.36-1.26 (m, 
4H), 0.92-0.88 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 
164.2, 142.4, 136.5, 131.7, 129.1, 128.9, 128.7, 128.5, 126.0, 
114.7, 39.3, 29.1, 29.0, 22.3, 14.0. IR (KBr) 3291, 2923, 
1624, 1541, 1245, 820, 688 νmax/cm-1; MS (ESI) m/z 
(M+H)+ Calcd for C19H22ClN3O: 343.1451; Found: 366.1341 
[M+Na]+.  
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(Z)-2-(2-(4-chlorophenyl)hydrazono)-N-(naphthalen-2-yl)-2-phenylacetamide 
(50).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 9:1) to give the product 
as dark yellow solid (114 mg, 57% yield). 1H NMR (400 
MHz, CDCl3) δ 9.10 (br s, NH), 8.40 (br s, NH), 8.08 (s, 
1H), 7.84 (br d, AA’XX’, 1H), 7.80 (br d, AA’XX’, 2H), 
7.63-7.38 (m, 8H), 7.30 (br d, AA’XX’, 2H), 7.06 (br d, 
AA’XX’, 2H); 13C NMR (100 MHz, CDCl3) δ 161.8, 
141.2, 138.1, 135.3, 134.0, 130.5, 130.0, 129.5, 129.2, 
128.8 (2C), 128.4, 127.7, 127.6, 127.0, 126.5, 124.8, 
119.7, 116.0, 114.9. IR (KBr) 3296, 1753, 1651, 1530, 
1489, 1251, 1146, 814 νmax/cm-1; Mp 164-165 °C; MS 
(ESI) m/z (M+H)+ Calcd for C24H18ClN3O: 399.1138; Found: 422.2436 [M+Na]+.  
 
(Z)-N-benzyl-2-(4-chlorophenyl)-2-(2-(4-methoxyphenyl)hydrazono)acetamide 
(51).  
The crude material was purified by column chromatography 
(n-hexane/ EtOAc 9:1) to give the product as dark yellow 
solid (153 mg, 78% yield). Mixture of E/Z isomers, signals 
are referred to the main isomer: 1H NMR (400 MHz, 
CDCl3) δ 7.88 (br s, NH), 7.51-7.26 (m, 10H), 6.97 (br d, 
AA’XX’, 2H), 6.85 (br d, AA’XX’, 2H), 4.60 (br d, 2H), 
3.76 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 164.0, 155.1, 
138.8, 136.5, 135.5, 134.9, 130.8, 129.6, 128.7, 127.7, 
127.6, 127.4, 115.0, 114.8, 55.6, 43.4. IR (KBr) 3412, 3170, 
1632, 1503, 1234, 1078, 823 νmax/cm-1; Mp 123-124 °C; 
MS (ESI) m/z (M+H)+ Calcd for C22H20ClN3O2: 393.1244; 
Found: 416.1122 [M+Na]+. 
  
O
HN
N NH
Cl
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(Z)-2-(4-chlorophenyl)-N-cyclohexyl-2-(2-(4-methoxyphenyl) 
hydrazono)acetamide (52).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 30:1) to give the 
product as a dark yellow solid (108 mg, 56% yield). 1H 
NMR (400 MHz, CDCl3) δ 12.70 (br s, NH), 7.47 (br d, 
AA’XX’, 2H), 7.38 (br d, AA’XX’, 2H), 7.12 (br d, 
AA’XX’, 2H), 6.85 (br d, AA’XX’, 2H), 5.65 (br t, NH), 
3.91-3.84 (m, 1H), 3.77 (s, 3H), 1.95-1.92 (m, 2H), 1.71-
1.60 (m, 3H), 1.44-1.35 (m, 2H), 1.20-1.10 (m, 3H); 13C 
NMR (100 MHz, CDCl3) δ 163.2, 154.9, 137.5, 135.5, 
134.0, 129.8, 129.0, 128.7, 114.7, 114.7, 55.6, 48.2, 32.8, 25.4, 24.8. IR (KBr) 
3401, 3175, 2928, 1626, 1508, 1229, 1039, 820 νmax/cm-1; Mp 170-171 °C; MS 
(ESI) m/z (M+H)+ Calcd for C21H24ClN3O2 : 385.1557; Found: 408.1441 [M+Na]+. 
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Single crystal X-ray diffraction analysis. 
 
ORTEP view of 4 and the relative arbitrary atom-numbering scheme 
(thermal ellipsoids at 40% probability). 
The overall molecular conformation is determined by the Z conformation of the 
C=N double bond. The two carbonyl-O1 and O2 atoms adopt an anti disposition. 
The dihedral angle between the benzene C1-C6 with the ring C8-C13 is 71.6(8)° 
and the equivalent angle with the phenyl C22-C27 is 83.2(7)°. The latter group 
forms a dihedral angle with the phenyl C8-C13 of 66.9(6)°. The cyclohexane 
adopts a half-chair conformation, as shown by the puckering coordinates Q = 
0.564(4) Å, φ2 = -137.8(1)°, θ = 177.6(5)°. The crystal packing is stabilized by 
centrosymmetric hydrogen bonds between N3-H3A…O1’ (‘at -x, -y, -z), distance 
2.11(2) Å, angle 167(1)°, that link the molecules forming dimers. These latter are 
in turns interconnected by C10-H10…O2’’ (’’ at 1-x, 1-y,-z) contacts, distance 
2.62(2) Å, angle 133(1)° giving rise to molecular chains along the c axis. 
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11.1 Results and discussion 
 
Stimulated by our first results with nitrile imines and in connection with our 
studies on the reactivity of α-isocyanoacetamides,1–4 we envisaged a 
multicomponent synthesis of fully substituted furo[2,3-d]pyridazin-4(5H)-ones (4), 
starting from readily available hydrazonoyl chlorides 1 and α- 
methylisocyanoacetamides 2 (Scheme 1). The intermediate α-hydrazono-oxazole 3 
obtained could then be intercepted in situ with dimethylacetylene dicarboxylate 
(DMAD), which should be able to trigger a triple-domino process consisting of a 
Diels−Alder cyclization, a [4 + 2] cycloreversion, and an intramolecular 
lactamization. 
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Scheme 1. General reaction sequence to get furo[2,3-d]pyridazin-4(5H)-ones. 
According to Scheme 2, 2-isocyano-1-morpholino-propan-1-one3 5 and the 
hydrazonoyl chloride 6 were mixed in dichloromethane in the presence of 1 
equivalent of TEA overnight at room temperature. Addition of isocyanide to nitrile 
imine was stereoselective, affording the Z-isomer.5 Due to the low energy barrier 
required for the Z to E isomerism of this class of hydrazones, we detected a Z/E 
mixture of 1,3-oxazole-2-hydrazone 7 obtained in 75% yield after chromatographic 
column. Subsequent reaction of 7 with 1 equivalent of DMAD in toluene at reflux 
overnight afforded a novel fluorescent spot on TLC which, after purification and 
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spectroscopic investigation, was shown to be the desired furo[2,3-d]pyridazin-
4(5H)-one 8 obtained in 51% yield (Scheme 2).  
 
Scheme 2. Synthetic procedure to get furo[2,3-d]pyridazin-4(5H)-ones. 
After demonstrating the feasibility of this novel transformation, in a further 
advancement, we evaluated the possibility to perform the whole transformation in a 
one-pot, two-step domino fashion without isolating the 1,3-oxazole-2- hydrazone 
intermediate 7. Indeed, after monitoring its formation by TLC, the dichloromethane 
was evaporated and the crude reaction mixture was dissolved in toluene: by simply 
adding DMAD the reaction proceeded smoothly toward the formation of the 
furo[2,3-d]pyridazin-4(5H)-one 8. When different DMAD equivalents (1, 1.2, 1.5, 
and 2 equiv) were screened, a satisfactory yield of 45% was obtained when 2 
equivalents was used. 
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The proposed reaction mechanism is reported in Scheme 3. The hydrazonoyl 
chloride formed in situ the dipolar nitrilimine 9 which was then attacked by the 
isocyanide carbon atom of isocyanoacetamide 5. Once the nitrilium ion 10 was 
formed, it was intramolecularly intercepted by the oxygen of the tertiary amide to 
give the 1,3-oxazol-2-hydrazone 7. The latter was then able to attack the DMAD 11 
triple bond to give the unstable oxa-bridged intermediate 12 via Diels-Alder 
reaction, which after acetonitrile loss by means of a [4+2] cycloreversion, and 
simultaneous methanol loss by means of intramolecular lactamization gave the 
desired furo[2,3-d]pyridazin-4(5H)-one 8.  
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Scheme 3. Proposed reaction mechanism for the one-pot domino 
formation of furo[2,3-d]pyridazin-4(5H)-ones 8. 
 
With these optimized one-pot reaction conditions in hand, we started to evaluate 
the scope of this transformation using different hydrazonoyl chlorides (6, 13.19) 
and isocyanoacetamides (5, 20-23) (Figure 1) and randomly combining them in 
order to get a library of furo[2,3-d]pyridazin-4(5H)-ones (24-34) (Figure 2).  
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Figure 1. Building blocks used. 
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Figure 2. Library of synthesized furo[2,3-d]pyridazin-4(5H)-ones. 
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Yields ranged from 22 to 50% and were shown to be unaffected by hydrazonoyl 
chlorides substitution pattern as both electron-withdrawing chlorine or iodine atom 
(14, 17, 19, Figure 2) and electron-donor methoxy or phenoxy groups gave good 
yields (15, 18, 19 Figure 2). Isocyanoacetamides with an additional alkyne 
function, considerable for further derivatizations (21, Figure 2) or a basic amine 
group (22, Figure 2), also worked well, allowing for the generation of widely 
decorated heterocyles. Notably, the yields are referred to a sequence of four 
different reactions (the formation of 1,3-oxazol-2-hydrazone, the Diels-Alder 
cyclization with DMAD, the [4+2] cycloreversion with the extrusion of acetonitrile 
and the intramolecular lactamization with loss of methanol), indicating an average 
yield of 84-67% for each synthetic step.  
It is important to highlight that, to date, the chemistry of isocyanoacetamides 
coupled with domino sequences has been mainly explored using aldehydes, imines, 
and acyl chlorides as electrophilic partners.6–11 In this case, the use of hydrazonoyl 
chlorides allowed for the incorporation of one more nitrogen atom in the forming 
heterocyclic ring, giving access to a furo[2,3-d]pyridazinone scaffold not 
synthesizable with the previous strategies. 
Notwithstanding its vinylogous carbamic nature, the ester function can also be 
easily hydrolyzed without affecting the pyridazinone moiety, providing an acid 
group amenable to further derivatization as reported in Scheme 3 for compound 35. 
 
Scheme 3. Synthesis of the furo[2,3-d]pyridazin-3-carboxylic acid 35. 
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11.2 Conclusions 
 
In conclusion we reported a one-pot synthesis of fully substituted furo[2,3-
d]pyridazin-4(5H)-ones, through a multicomponent, one-pot sequence of four 
different reactions: oxazole formation, Diels-Alder cyclization, [4+2] 
cycloreversion and intramolecular lactamization.  
Furo[2,3-d]pyridazin-4(5H)-one derivatives have shown potential in medicinal 
chemistry as immunomodulator, antiasthmatic, and thromboxane A2 synthase 
inhibitors.12 Despite their pharmaceutical relevance, their synthetic approaches had  
required, until now, at least 5-6 reaction steps with overall yields of 7-20%, 
different purifications and the use of very toxic reagents (e.g. 
trimethylsylildiazomethane), and harsh reaction conditions (e.g. concentrated HCl) 
not always compatible with other functional groups.  
 
The reactivity of 1,3-dipolar species nitrilimines, in situ generated from 
hydrazonoyl chlorides, toward isocyanoacetamides was here explored for the first 
time in a three-center, two components reaction and in combination with a further 
sequence of post-condensation domino processes.  
To our knowledge this is the first report enabling a fast and practical synthesis 
of fully decorated furo[2,3-d]pyridazin-4(5H)-ones starting from cheap and 
available starting materials. The suitability of the developed synthesis to 
combinatorial approaches, and the possibility to get multi-functionalized furo[2,3-
d]pyridazin-4(5H)-ones highlighted how the fused-pyridinazinones chemical space 
could be better explored in order to come up with new bioactive compounds. 
This method constitutes a significant advancement over previously reported 
strategies13,14 and is likely to facilitate deeper medicinal chemistry studies of this 
class of compounds.   
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11.3 Experimental section 
 
General Methods. Commercially available reagents and solvents were used 
without further purification. Dichloromethane was dried by distillation from P2O5 
and stored over activated molecular sieves (4 A). When necessary the reactions 
were performed in oven-dried glassware under a positive pressure of dry nitrogen. 
Melting points were determined in open glass capillaries and are uncorrected. All 
the compounds were characterized by IR. 1H and 13C APT NMR were recorded on 
a 400 MHz. High-resolution ESI-MS spectra were performed on a Thermo LTQ 
Orbitrap XL mass spectrometer. The spectra were recorded by infusion into the ESI 
source using MeOH as the solvent. Chemical shifts (δ) are reported in part per 
million (ppm) relative to the residual solvent peak. Column chromatography was 
performed on silica gel (70–230 mesh ASTM) using the reported eluents. Thin 
layer chromatography (TLC) was carried out on 5 x 20 cm plates with a layer 
thickness of 0.25 mm (Silica gel 60 F254). When necessary they were developed 
with KMnO4. 
 
General preparation of isocyanoacetamides (5, 20-23).3 The α-methyl-α-
isocyanoacetamides where readily synthesized in two steps starting from the 
commercially available methylisocyanoacetate: 
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2-isocyano-1-morpholinopropan-1-one (5). 
 
Compound 1 characterization data were compared to literature 
reported ones.3 
 
 
 
2-isocyano-1-(pyrrolidin-1-yl)propan-1-one (20). 
 
Compound 16 characterization data were compared to literature 
reported ones.3 
 
 
 
2-isocyano-N-methyl-N-(prop-2-yn-1-yl)propanamide (21). 
 
Compound 17 characterization data were compared to 
literature reported ones.1 
 
 
 
2-isocyano-1-(4-methylpiperazin-1-yl)propan-1-one (22).  
 
The crude material was purified by column chromatography 
(dichloromethane/methanol 95:5) to give the product as a 
colorless oil (46% yield). 1H NMR (400 MHz, CDCl3) δ 
4.45 (br q, 1H), 3.62-3.34 (m, 4H), 2.35-2.29 (m, 4H),2.20 
(s, 3H), 1.46 (d, J = 6.7 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 163.9, 158.6, 
54.5, 54.3, 49.5,45.8, 45.6, 42.4, 18.7. IR (KBr) 2939, 2148, 1665, 1451, 1289, 
1144, 998 νmax/cm-1. MS (ESI) m/z Calcd for C9H15N3O: 181,1215; Found: 
182.1290 [M+H]+.  
 
 
N,N-diethyl-2-isocyanopropanamide (23). 
 
Compound 23 characterization data were compared to literature 
reported ones.15 
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General preparation of hydrazonoyl chlorides (6, 13-19).16 The 
hydrazonoyl chlorides were readily synthesized in two steps: 
 
Preparation of acylhydrazines. To a stirred solution of acid on a 5 mmol 
scale in THF (0.2 M) were added EDC HCl (5.5 mmol, 1.1 eq.), DMAP (1 mmol, 
0.2 eq.), triethylamine (10 mmol, 2 eq.) and hydrazine (5 mmol, 1 eq.) at 0 °C. The 
resulting mixture was allowed to warm to room temperature over 24 h. The crude 
reaction mixture was washed with HCl 1M sol. (x2), NaHCO3 at. sol. (x2) and 
brine (x1), evaporated to dryness and used in the next step without further 
purification. 
 
Preparation of hydrazonoyl chlorides (6, 13-19). The corresponding 
acylhydrazine (2.5 mmol) was dissolved in CH3CN (0.5 M) and 
triphenylphosphine (3 mmol, 1.2 eq.) and carbon tetrachloride (3 mmol, 1.2 eq.) 
were added. The reaction was stirred at room temperature until all the 
acylhydrazine was consumed as judged by TLC (typically 8-12 hours). The 
reaction was concentrated under reduced pressure and purified by column 
chromatography (n-hexane/EtOAc 30:1) and stored below 0 °C. Due their delicate 
nature, neither HMRS nor elemental analyses of nitrile imines gave satisfactory 
results. 
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(Z)-4-methyl-N'-phenylbenzohydrazonoyl chloride (6). 
 
Compound 2 characterization data were compared to literature 
reported ones.16 
 
 
 
 
 
 
(Z)-N'-phenylbenzohydrazonoyl chloride (13). 
 
Compound 9 characterization data were compared to literature 
reported ones.17 
 
 
 
 
 
 
(Z)-4-iodo-N'-phenylbenzohydrazonoyl chloride (14). 
 
Compound 10 characterization data were compared to literature 
reported ones.16 
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(Z)-4-phenoxy-N'-phenylbenzohydrazonoyl chloride (15).  
The crude material was purified by column chromatography 
(n-hexane/ EtOAc 30:1) to give the product as an amorphous 
yellowish solid (59% yield). 1H NMR (400 MHz, CDCl3) δ 
8.07 (br s, NH), 7.98 (d, J = 8.7 Hz, 2H), 7.48- 7.39 (m, 4H), 
7.27-7.23 (m, 3H), 7.18 (br d, AA’XX’, 2H), 7.12 (br d, 
AA’XX’, 2H), 7.04 (br t, 1H); 13C NMR (100 MHz, CDCl3) δ 
158.6, 156.6, 143.5, 130.1 (2C), 129.5 (2C), 129.4 (2C), 
128.1, 124.3, 124.0, 121.2, 119.5 (2C), 118.4 (2C), 113.5 
(2C). 
 
 
(Z)-2-(naphthalen-2-yl)-N'-phenylacetohydrazonoyl chloride (16).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 30:1) to give the 
product as a pink oil (59% yield). 1H NMR (400 
MHz, CDCl3) δ 8.26 (d, J = 8.3, 1H), 7.91 (d, J = 
7.8, 1H), 7.86-7.84 (m, 1H), 7.70 (br s, NH), 7.59-
7.47 (m, 4H), 7.33-3.29 (m, 2H), 7.09-7.07 (m, 2H), 6.96-6.93 (m, 1H), 4.42 (s, 
2H). 13C NMR (100 MHz, CDCl3) δ 143.8, 134.0, 132.3, 131.7, 129.5 (2C), 128.9, 
128.4, 128.2, 126.5, 126.0, 125.9, 125.6, 124.0, 120.9, 113.3 (2C), 42.6. 
 
(Z)-N'-(4-chlorophenyl)benzohydrazonoyl chloride (17). 
 
Compound 13 characterization data were compared to literature 
reported ones.16 
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(Z)-N-(3-methoxyphenyl)benzohydrazonoyl chloride (18). 
The crude material was purified by column chromatography 
(PE/EtOAc 95:5) to give the product as a brown solid (55% 
yield). 1H-NMR (300 MHz, CDCl3) δ 8.07 (br s, NH), 7.75 
(br d, 2H), 7.45-7.39 (m, 3H), 7.24 (br t, 1H), 6.85 (br s, 
1H), 6.75 (dd, J = 7.9, 1.86 Hz, 1H), 6.54 (dd, J = 8.1, 2.4 
Hz, 1H), 3.84 (s, 3H); 13C-NMR (75 MHz, CDCl3) δ 160.9, 
144.8, 134.5, 130.3, 129.3, 128.5 (2C), 126.5 (2C), 124.8, 
106.6, 106.2, 99.6, 55.3. 
 
(Z)-4-chloro-N-(3-methoxyphenyl)benzohydrazonoyl chloride (19). 
The crude material was purified by column 
chromatography (PE/EtOAc 95:5) to give the product as 
a brown solid (47% yield). 1H-NMR (300 MHz, 
CDCl3+CD3OD) δ 7.79 (d, AA’XX, J = 8.2 Hz, 2H), 
7.33 (d, AA’XX, J = 8.2 Hz, 2H), 7.19-7.15 (m, 1H), 
6.75 (br s, 1H), 6.69 (dd, J = 7.9, 1.8 Hz, 1H), 6.47 (dd, 
J = 8.1, 2.4 Hz, 1H), 3.82 (s, 3H); 13C-NMR (75 MHz, 
CDCl3+CD3OD) δ 160.8, 144.4, 135.1, 132.9, 130.1, 
128.6, 127.5, 123.5, 106.6, 106.2, 99.6, 55.3. 
 
 
Synthesis of 4-(4-methyl-2-((2-phenylhydrazono)(p-tolyl)methyl)oxazol-5-
yl)morpholine (7). 
The hydrazonoyl chloride (0.8 mmol, 1 eq.), the 
isocyanoacetamide (0.8 mmol, 1 eq.) and TEA (0.8 
mmol, 1 eq.) were one-pot mixed in DCM (0.8 M, 1 
mL) and stirred at room temperature under a 
nitrogen atmosphere overnight. After evaporation of 
the solvent, the crude material was purified by 
column chromatograph (n-hexane/ EtOAc 8:2) to 
give the product as yellow solid (226 mg, 75% 
yield). Data are referred to the main isomer. 1H NMR (400 MHz, CDCl3) δ 12.77 
(br s, NH), 7.68 (br d, AA’XX’, 2H), 7.31-7.22 (m, 7H), 3.81-3.79 (m, 4H), 3.12-
3.10 (m, 4H), 2.40 (s, 3H), 2.26 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 170.3, 
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163.4, 143.8, 138.4, 133.4, 130.8, 129.6 (2C), 129.2 (2C), 128.4 (2C), 126.0, 121.4, 
113.6 (2C), 66.7, 66.5, 45.9, 42.5, 21.3, 18.8. IR (KBr) 3219, 2945, 2846, 1947, 
1909, 1665, 1596, 1495, 1251 νmax/cm-1; Mp 137-138 °C; MS (ESI) m/z Calcd for 
C22H24N4O2: 376.1899; Found: 377.1963 [M+H]+. 
 
General one-pot preparation of furo[2,3-d]pyridazin-4(5H)-ones 
(8, 24-34). The hydrazonoyl chloride (0.8 mmol, 1 eq.), the isocyanoacetamide 
(0.8 mmol, 1 eq.) and TEA (0.8 mmol, 1 eq.) were one-pot mixed in DCM (0.8 M, 
1 mL) and stirred at room temperature under a nitrogen atmosphere overnight. The 
formation of the intermediate oxazole was monitored by TLC, and after 
evaporation of the solvent, toluene (0.2M, 4 mL) and DMAD (dimethyl 
acetylenedicarboxylate) (1.6 mmol, 2 equiv.) were added to the crude mixture and 
the reaction was stirred at reflux temperature overnight. After evaporation of the 
solvent, the crude material was purified by column chromatography. 
 
Methyl 2-morpholino-4-oxo-5-phenyl-7-(p-tolyl)-4,5-dihydrofuro[2,3-
d]pyridazine-3-carboxylate (8).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 7:3) to give the 
product as yellow solid (160 mg, 45% yield). 1H 
NMR (400 MHz, CDCl3) δ 7.85 (br d, AA’XX’, 2H), 
7.61 (br d, AA’XX’, 2H), 7.50-7.46 (m, 2H), 7.40-
7.36 (m, 1H), 7.29 (br d, 2H), 3.91 (s, 3H), 3.89-3.87 
(m, 4H), 3.67-3.64 (m, 4H), 2.41 (s, 3H); 13C NMR 
(100 MHz, CDCl3) δ 163.8, 161.5, 156.8, 143.6, 
142.3, 139.9, 134.8, 129.5 (2C), 129.4, 128.7 (2C), 
127.9, 127.4 (2C), 126.4 (2C), 123.5, 90.5, 66.3 (2C), 52.2, 48.2 (2C), 21.4. IR 
(KBr) 2956, 2846, 1695, 1585, 1448, 1294, 1072 νmax/cm-1; Mp 211-212 °C; MS 
(ESI) m/z Calcd for C25H23N3O5: 445.1638; Found: 446.1693 [M+H]+. 
 
Furo[2,3‑d]pyridazin-4(5H)‑ones 
241 
Methyl 5-(4-chlorophenyl)-2-(methyl(prop-2-yn-1-yl)amino)-4-oxo-7-phenyl-
4,5-dihydrofuro [2,3-d]pyridazine-3-carboxylate (24).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 7:3) to give 
the product as yellow solid (118 mg, 33% yield). 
1H NMR (400 MHz,CDCl3) δ 8.01 (br d, 
AA’XX’, 2H), 7.60 (br d, AA’XX’, 2H), 7.50-
7.43 (m, 5H), 4.36 (s, 2H), 3.93 (s, 3H), 3.27 (s, 
3H), 2.37 (s, 1H); 13C NMR (100 MHz, CDCl3) 
δ 163.6, 160.9, 156.6, 143.5, 140.8, 134.9, 133.6, 132.1, 129.7, 128.7 (4C), 127.6 
(2C), 127.5 (2C), 123.8, 90.6, 77.5, 73.6, 52.2, 42.3, 38.1. IR (KBr) 3214, 2945, 
1673, 1591, 1489, 1286, 1067 νmax/cm-1; Mp 86-87 °C; MS (ESI) m/z Calcd for 
C24H18ClN3O4: 447.0986; Found: 448.1036 [M+H]+. 
 
Methyl 7-(4-iodophenyl)-2-(4-methylpiperazin-1-yl)-4-oxo-5-phenyl-4,5-
dihydrofuro[2,3-d]pyridazine-3-carboxylate (25).  
The crude material was purified by column 
chromatography (dichloromethane/methanol 
95:5) to give the product as yellow solid (141 
mg, 31% yield). 1H NMR (400 MHz, CDCl3) δ 
7.83 (br d, AA’XX’, 2H), 7.71 (br d, AA’XX’, 
2H), 7.59 (br d, 2H), 7.50-7.46 (m, 2H), 7.41-
7.37 (m, 1H), 3.90 (s, 3H), 3.72-3.69 (m, 4H), 
2.66-2.62 (m, 4H), 2.40 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 163.8, 161.5, 156.7, 143.1, 
142.2, 138.0, 133.7, 131.8, 129.1, 128.8, 128.1, 126.4, 123.8, 96.0, 90.2, 54.3 (2C), 
52.3, 47.9 (2C), 46.0. IR (KBr) 2939, 2802, 1681, 1575, 1451, 1275, 1072 
νmax/cm-1; Mp 236-237 °C; MS (ESI) m/z Calcd for C25H23IN4O4: 570.0764; 
Found: 571.0777 [M+H]+. 
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Methyl 2-(4-methylpiperazin-1-yl)-4-oxo-7-(4-phenoxyphenyl)-5-phenyl-4,5-
dihydrofuro[2,3-d]pyridazine-3-carboxylate (26).  
The crude material was purified by column 
chromatography (dichloromethane/methanol 
95:5) to give the product as yellow solid (167 
mg, 39% yield). 1H NMR (400 MHz, CDCl3) δ 
7.94 (br d, AA’XX’, 2H), 7.60 (br d, AA’XX’, 
2H), 7.49-7.45 (m, 2H), 7.39- 7.35 (m, 3H), 7.16 
(br t, 1H), 7.09-7.05 (m, 4H), 3.90 (s, 3H), 3.75-
3.71 (m, 4H), 2.71-2.66 (m, 4H), 2.43 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 163.8, 161.3, 
158.9, 156.7, 156.4, 143.4, 142.4, 134.1, 129.9 
(2C), 129.0 (2C), 128.6 (2C), 127.8, 127.0, 126.3 
(2C), 124.0, 123.6, 119.6 (2C), 118.5 (2C),94.1, 54.2 (2C), 52.1, 47.8 (2C), 45.7. 
IR (KBr) 2945, 2796, 1681, 1585, 1486, 1237, 1155, 1067 νmax/cm-1; Mp 193-194 
°C; MS (ESI) m/z Calcd for C31H28N4O5: 536.2060; Found: 537.2079 [M+H]+. 
 
Methyl 2-(4-methylpiperazin-1-yl)-7-(naphthalen-2-ylmethyl)-4-oxo-5-phenyl-
4,5-dihydrofuro[2,3-d]pyridazine-3-carboxylate (27).  
The crude material was purified by column 
chromatography (dichloromethane/methanol 
98:2) to give the product as light yellow solid 
(89.5 mg, 22% yield). 1H NMR (400 MHz, 
CDCl3) δ 8.31 (d, J = 8.0 Hz, 1H), 7.87 (d, J = 
8.1 Hz, 1H), 7.78 (d, J = 8.1 Hz, 1H), 7.58-7.47 
(m, 7H), 7.43-7.37 (m, 2H), 4.61 (s, 2H), 3.83 (s, 
3H), 3.40-3.38 (m, 4H), 2.41-2.39 (m, 4H), 2.30 
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 163.8, 
161.6, 156.9, 144.3, 142.3, 136.0, 134.0, 132.6, 132.1, 128.8 (3C), 128.0, 127.9, 
127.6, 126.5 (2C), 126.3, 125.8, 125.2, 124.0, 123.3, 89.5, 54.3 (2C), 52.0, 48.0 
(2C), 46.0, 35.1. IR (KBr) 2939, 2796, 1670, 1583, 1448, 1253, 1144, 1061 
νmax/cm-1; Mp 202-203 °C; MS (ESI) m/z Calcd for C30H28N4O4: 508.2111; 
Found: 509.2176 [M+H]+. 
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Methyl 2-(methyl(prop-2-yn-1-yl)amino)-4-oxo-5,7-diphenyl-4,5-
dihydrofuro[2,3-d]pyridazine-3-carboxylate (28).  
The crude material was purified by column 
chromatography (n-hexane/ EtOAc 7:3) to give the 
product as yellowish solid (106 mg, 32% yield). 1H 
NMR (400 MHz, CDCl3) δ 8.03 (br d, AA’ XX’, 
2H), 7.62 (br d, AA’ XX’, 2H), 7.52-7.46 (m, 5H), 
7.41-7.37 (m, 1H), 4.37 (br d, 2H), 3.93 (s, 3H), 
3.27 (s, 3H), 2.36 (br t, 1H); 13C NMR (100 MHz, 
CDCl3) δ 163.7, 161.0, 156.8, 143.6, 142.3, 134.7, 132.2, 129.7, 128.8 (2C), 128.7 
(2C), 127.9, 127.5 (2C), 126.4 (2C), 123.7, 90.5, 73.6, 52.4, 42.3 (2C), 38.2. IR 
(KBr) 3252, 1703, 1668, 1610, 1215, 1070 νmax/cm-1; Mp 146-147 °C; MS (ESI) 
m/z Calcd for C24H19N3O4: 413.1376; Found: 414.1458 [M+H]+. 
 
Methyl 7-(4-chlorophenyl)-5-(3-methoxyphenyl)-4-oxo-2-(pyrrolidin-1-yl)-4,5-
dihydrofuro[2,3-d]pyridazine-3-carboxylate (29).  
The crude material was purified by column 
chromatography (PE/EtOAc 7:3) to give the 
product as yellowish solid (169 mg, 44% yield). 
1H-NMR (300 MHz, CDCl3) δ 7.95 (d, AA’XX’, 
J = 8.2 Hz, 2H), 7.43 (d, AA’XX’, J = 8.2 Hz, 
2H), 7.40-7.45 (m, 1H), 7.18-7.13 (m, 2H), 6.93 
(dd, J = 8.2, 2.1 Hz, 1H), 3.89 (s, 3H), 3.83 (s, 
3H), 3.67 (br t, 4H), 2.05 (br t , 4H); 13C-NMR 
(75 MHz, CDCl3) δ 163.7, 160.0, 159.9, 156.9, 143.5, 142.6, 135.6, 133.2, 131.0, 
129.5, 129.0, 128.8, 124.4, 119.0, 114.1, 112.4, 86.8, 55.6, 52.1, 49.8, 25.6; IR 
(KBr) 2952, 2873, 1738, 1683, 1589, 1489, 1271, 1089, 835 νmax/cm-1; Mp 162.2-
163.1  °C; MS (ESI) m/z Calcd for C25H22ClN3O5: 479.1248; Found: 480.1327 
[M+H]+. 
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Methyl 5-(3-methoxyphenyl)-2-morpholino-4-oxo-7-phenyl-4,5-
dihydrofuro[2,3-d]pyridazine-3-carboxylate (30).  
The crude material was purified by column 
chromatography (PE/EtOAc 6:4) to give the 
product as white solid (185 mg, 50% yield). 
1H-NMR (300 MHz, CDCl3) δ 7.99 (br d, 2H), 
7.47-7.33 (m, 4H), 7.21-7.15 (m, 2H), 6.92 
(dd, J = 8.1, 2.1 Hz, 1H), 3.91 (s, 3H), 3.82 (s, 
3H), 3.66 (br t, 4H), 2.02 (br t, 4H); 13C-NMR 
(75 MHz, CDCl3) δ 163.8, 160.0, 159.9, 156.9, 
143.6, 142.9, 134.4, 132.5, 129.5, 129.4, 128.7, 127.5, 124.2, 119.0, 114.0, 112.4, 
86.7, 55.5, 52.0, 49.7, 25.5; IR (KBr) 2955, 2877, 1687, 1601, 1580, 1491, 1270, 
1087, 767 νmax/cm-1; Mp 194.7-195.8 °C; MS (ESI) m/z Calcd for C25H23N3O6: 
461.1587; Found: 462.1664 [M+H]+. 
 
Methyl 5-(3-methoxyphenyl)-4-oxo-7-phenyl-2-(pyrrolidin-1-yl)-4,5-
dihydrofuro[2,3-d]pyridazine-3-carboxylate (31).  
The crude material was purified by column 
chromatography (PE/EtOAc 6:4) to give the 
product as white solid (89 mg, 25% yield). 1H-
NMR (300 MHz, CDCl3) δ 7.96 (d, J = 7.6 Hz, 
2H), 7.48-7.35 (m, 4H), 7.20-7.14 (m, 2H), 6.94 
(br d, 1H), 3.91 (s, 3H), 3.89-3.86 (m, 4H), 3.83 
(s, 3H), 3.67-3.34 (m, 4H); 13C-NMR (75 MHz, 
CDCl3) δ 163.9, 161.6, 160.0, 156.8, 143.6, 143.5, 134.7, 132.3, 129.8, 129.6, 
128.9, 127.6, 123.7, 119.0, 114.2, 112.5, 90.7, 66.4, 55.6, 52.4, 48.4; IR (KBr) 
2952, 2857, 1687, 1673, 1577, 1492, 1288, 1070, 1031, 773 νmax/cm-1; Mp 184.2-
184.8 °C; MS (ESI) m/z Calcd for C25H23N3O5: 445.1638; Found: 446.1676 
[M+H]+. 
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Methyl 4-oxo-5,7-diphenyl-2-(pyrrolidin-1-yl)-4,5-dihydrofuro[2,3-
d]pyridazine-3-carboxylate (32).  
The crude material was purified by column 
chromatography (PE/EtOAc 7:3) to give the product 
as white solid (103 mg, 31% yield). 1H-NMR (300 
MHz, CDCl3) δ 8.01 (d, J = 7.6 Hz, 2H), 7.62 (d, J = 
7.6 Hz, 2H), 7.50-7.42 (m, 5H), 7.39-7.35 (m, 1H), 
3.90 (s, 3H), 3.70-3.66 (m, 4H), 2.06-2.02 (m, 4H); 
13C-NMR (75 MHz, CDCl3) δ 163.9, 160.1, 157.2, 
143.0, 142.6, 134.6, 132.6, 129.6, 128.8, 127.9, 127.6, 127.3, 126.6, 124.2, 86.8, 
52.1, 49.8, 25.6; IR (KBr) 2972, 2875, 1709, 1670, 1613, 1585, 1496, 1263, 1080, 
912, 773 νmax/cm-1; Mp 231.1-231.6 °C; MS (ESI) m/z Calcd for C24H21N3O4: 
415.1532; Found: 416.1614 [M+H]+. 
 
Methyl 4-oxo-5-phenyl-2-(pyrrolidin-1-yl)-7-(p-tolyl)-4,5-dihydrofuro[2,3-
d]pyridazine-3- carboxylate (33).  
The crude material was purified by column 
chromatography (PE/EtOAc 7:3) to give the product as 
white solid (120 mg, 35% yield). 1H-NMR (300 MHz, 
CDCl3) δ 7.88 (d, AA’XX’, J = 8.2 Hz, 2H), 7.63 (d, 
AA’XX’, J = 8.2 Hz, 2H), 7.50-7.46 (m, 2H), 7.43-
7.33 (m, 1H), 7.27-7.25 (m, 2H), 3.92 (s, 3H), 3.68-
3.67 (m, 4H), 2.40 (br s, 3H), 2.05-2.03 (m,4H); 
13CNMR (75 MHz, CDCl3) δ 163.8, 160.0, 157.0, 
142.9, 142.6, 139.6, 134.5, 129.7, 129.4, 128.6, 127.8, 
126.5, 124.1, 86.7, 52.0, 49.6, 25.5, 21.4; IR (KBr) 2968, 2862, 1680, 1565, 1442, 
1078, 988 νmax/cm-1; Mp 220.2-220.9 °C; MS (ESI) m/z  Calcd for C25H23N3O4: 
429.1689; Found: 430.1735 [M+H]+. 
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Methyl 2-(diethylamino)-4-oxo-5,7-diphenyl-4,5-dihydrofuro[2,3-d]pyridazine-
3-carboxylate (34).  
The crude material was purified by column 
chromatography (PE/EtOAc 7:3) to give the product 
as white solid (104 mg, 31% yield). 1H-NMR (300 
MHz, CDCl3) δ 8.03 (d, J = 7.8 Hz, 2H), 7.67 (d, J = 
7.8 Hz, 2H), 7.53-7.39 (m, 6H), 3.96 (s, 3H), 3.65 (q, 
J = 7.0 Hz, 4H), 1.31 (t, J = 7.0 Hz, 6H); 13C-NMR 
(75 MHz, CDCl3) δ 164.4, 160.3, 157.1, 142.8, 142.6, 
134.6, 132.7, 129.6, 128.8, 128.0, 127.6, 126.6, 124.7, 
87.9, 52.5, 45.3, 13.5; IR (KBr) 2865, 1698, 1667, 1611, 1572, 1487, 1315, 891, 
801 νmax/cm-1; Mp 225.2-226.1 °C; MS (ESI) m/z Calcd for C24H23N3O4: 
417.1689; Found: 418.1769 [M+H]+. 
 
Preparation of: Lithium 7-(4-iodophenyl)-2-(4-methylpiperazin-1-yl)-4-oxo-5-
phenyl-4,5-dihydrofuro[2,3-d]pyridazine-3-carboxylate (35).  
The furo[2,3-d]pyridazin-4(5H)-one 25 (0.05 
mmol, 1 eq.) was dissolved in THF/H2O 3:1 
(0.2M), lithium hydroxide (0.05 mmol, 1 eq.) 
was added and the rection mixture was stirred at 
100 °C overnight. The hydrolysis of the ester 
function was monitored by TLC (95:5 
DCM/MeOH). The conversion as revealed by 
NMR of the crude reaction mixture was 
quantitative. 1H-NMR (400 MHz, D2O-DMSO-
d6) δ 7.86 (br d, AA’XX’, 2H), 7.71 (br d, AA’XX’, 2H), 7.52-7.37 (m, 5H), 3.51-
3.48 (m, 4H), 2.43-2.39 (m, 4H), 2.16 (s, 3H); 13C-NMR (100 MHz, D2O-DMSO-
d6) δ 167.7, 166.4, 158.6, 158.4, 142.6, 141.9, 138.2 (2C), 134.1, 132.0, 129.8 
(2C), 129.1 (2C), 128.4, 126.8 (2C), 124.9, 96.7, 54.2 (2C), 47.2 (2C), 45.9; IR 
(KBr) 2934, 2780, 17111, 1569, 1489, 1358, 1144, 998 νmax/cm-1; Mp 204-205 
°C; MS (ESI) m/z Calcd for C24H21IN4O4: 556.0607; Found: 557.0647 [M+H]+. 
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12.1 Results and discussion 
 
Continuing to use the chemistry developed in Chapters 10 and 11, we 
recognized that α-aminocarbonyl hydrazones 1,1 thanks to their atom connectivity 
and the presence of the hydrazone functional group could be exploited in a post-
condensation modification using a Buchwald–Hartwing intramolecular amination 
to generate the substituted indazole ring 5 in two operationally simple reaction 
steps (Scheme 1). 
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Scheme 1. General structure of α-aminocarbonyl hydrazones and 
cyclic indazole derivatives. 
In order to test our hypothesis, we reacted 2-iodo-N'-phenylbenzohydrazonoyl 
chloride 8, cyclohexylisocyanide 9 and 2-hydroxymethylbenzoic acid (“sacrificial 
acid”) 3 in DCM at room temperature overnight to obtain α-aminocarbonyl 
hydrazone 10 in 65%. The multicomponent reaction is triggered by the in situ 
generation of nitrile imine by a base-induced dehydrochlorination of hydrazonoyl 
chloride. The 2-hydroxymethylbenzoic acid behaves like a pseudo water molecule 
in order to overpass the poor reactivity of water on the nitrilium ion.2 Subsequently, 
this linear intermediate was then reacted in classic Buchwald-Hartwing conditions 
to evaluate indazole 11 formation (Scheme 2).  
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Scheme 2. 3-CR affording α-aminocarbonyl hydrazones and test reaction for 
the formation of indazole derivatives. 
It is important to highlight that a priori both the hydrazone and the amide 
function could cyclize to give either the indazole or the indolone derivatives,3 both 
being at a suitable distance (5 centers) from the aromatic iodine atom of 
intermediate 10. Refluxing 10 in toluene, and in the presence of palladium acetate, 
Xantphos and cesium carbonate gave indeed the desired indazole 11 in 66% yield 
(Entry 1, Table 1), and 12.5 % of indolone derivative 12 coming from 
intramolecular amidation.  
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Entry Solvent Catalyst Ligand 
Yield of 11 
(yield of 12) 
1 Toluene Pd(OAc)2 Xantphos 66% (12,5%) 
2 Toluene Pd(dppf)Cl2 Xantphos 48% (4%) 
3 Toluene CuI N,N’-dimehtylethylene diamine 22% (10%) 
4 Toluene Pd(dppf)Cl2 XPhos 38% (20%) 
5 Toluene Pd(PPh3)2Cl2 Tri-o-tolyl-phosphine 78% (traces) 
6 1,4-dioxan Pd(PPh3)2Cl2 Tri-o-tolyl-phosphine 97% (traces) 
Table 1. Optimization of indazole cyclization conditions. 
In order to optimize indazole formation we screened different palladium sources 
(Entries 2, 4-6), ligands (Entries 3-6), and solvents (Entry 6), and we also tried 
copper catalyst in place of palladium (Entry 3). With palladium catalysts (Entries 1, 
2 and 4–6) 1 equivalent of cesium carbonate was used as base. With our 
satisfaction, we were able to obtain indazole 12 in 97% yields, which means a 
highly regioselective formation of indazole derivatives over indolone one, when 
intermediate 10 was refluxed in 1,4-dioxan in the presence of tri-o-tolylphosphine 
(0.1 equiv.), cesium carbonate (1 equiv.) and bis(triphenylphosphine)palladium(II) 
dichloride (0.07 equiv.). 
Despite the reported examples of both intermolecular4 and intramolecular5 
hydrazone N-arylation (Scheme 3), to our knowledge this is the first example of a 
regioselective hydrazone palladium catalyzed cyclization in the presence of an 
amide bond.  
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Scheme 3. Examples of inter- and intra-molecular hydrazine  
N-arylation reported in literature. 
 
To evaluate the scope of this cyclization, we synthesized five different 
hydrazonoyl chlorides (8, 13-16) and we selected six isocyanides (9, 17-21) as 
starting inputs (Figure 1).  
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Figure 1. Starting materials for the synthesis of α-aminocarbonyl hydrazones. 
 
A library of α-aminocarbonyl hydrazones (31-74% yields) was obtained (Figure 
2). Aliphatic hydrazonoyl chlorides are much less stable than aromatic ones and did 
not react successfully in this reaction (poor yield, byproducts formation and 
difficult purification procedure). 
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Figure 2. Synthesized library of linear α-aminocarbonyl hydrazones. 
We then reacted the intermediate hydrazones using the optimized conditions to 
get eleven different substituted 1-arylindazole-3-carboxamides in excellent yields 
(48-98%) (Figure 3).  
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Figure 3. Synthesized library of indazole cyclic derivatives. 
The reaction proved to be quite general in scope as the presence of both 
aliphatic (33-36, 38-40, 42 and 43) and aromatic (37, 41) carboxamides gave good 
yields. Only electron-withdrawing nitrile group on the hydrazone aromatic ring in 
derivatives 39, 40 and 41 showed to decrease yields to 65, 64 and 48%, 
respectively (Figure 3). 
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A working hypothesis for the formation of hydrazone derivatives is depicted in 
Scheme 4. The hydrazonoyl chlorides 44 readily form the nitrilimine, which is the 
active 1,3-dipolar species and is attacked by the isocyanide carbon atom to form a 
nitrilium ion. The latter is then attacked by the carboxylate function of sacrificial 
acid 3 to give an unstable imidate: the hydroxy-function cyclize into the C=O 
carbonyl to give the N-arylhydrazono-acetamides 50 and phthalide. In this reaction 
sacrificial acid 3 enables to overcome the poor nucleophilicity of water towards the 
nitrilium ion. 3 behaves indeed like a pseudo water molecule, as it traps the 
nitrilium ion and then undergoes an intramolecular cyclization to deliver one 
oxygen atom to the product, as water would, and the aromatic lactone phthalide.   
TE
A
 
Scheme 4. Proposed mechanism for the synthesis of hydrazono-
acetamide derivate 50. 
In order to further expand the scope of the reaction we tried a direct conversion 
of N-arylindazole-3-carboxamides to N-arylindazole-3-carbonitriles. The synthesis 
of such derivatives is usually accomplished in two or more synthetic steps, with 
overall yields of 26 to 44% and the use of harsh reaction conditions, with Zn- or 
Cu-containing waste6,7 or promoted by tri-n-butyltin chloride and palladium.8,9 An 
alternative two-step route, based on a primary amide formation and subsequent 
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dehydration to nitrile (overall yield 63%) has been reported for the synthesis of p38 
kinase inhibitors.10 Dealing with their biological activities, N-arylindazole-3-
carbonitrile derivatives have been described also as xanthine oxidase inhibitors6,7 
and as low nanomolar bradykinin receptor antagonists.8,9 We speculated indeed that 
a one-step conversion of the reported N-arylindazole-3-carboxamides to N-
arylindazole-3-carbonitrile could be useful to further enlarge the size and the 
variability of the synthesizable libraries. So, reacting N-arylindazole-3-
carboxamide 36 in POCl3 at 150 °C in a sealed tube for 4h we were able to get N-
arylindazole-3-carbonitrile 52 in 96% yield (Scheme 5).  
To our knowledge, this transformation accounts for the first application of 
benzylisocyanide as a convertible isocyanide.  
 
 
Scheme 5. Conversion of N-arylindazole-3-carboxamides to N-
arylindazole-3-carbonitriles. 
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12.2 Conclusions 
 
In conclusion we developed a novel, concise two-step synthesis for the 
construction of 1-aryl-indazoles-3-carboxamides performing a three component 
reaction between isocyanides, 2-iodo-N-arylbenzohydrazonoyl chlorides and 2-
hydroxymethylbenzoic and a Buchwald-Hartwig cyclization.  
A regioselective intramolecular hydrazone palladium catalyzed cyclization in 
the presence of aliphatic amide functional groups was reported for the first time 
with high yields and broad substrate scope. Furthermore benzyl-isocyanide was 
unconventionally employed as a convertible isocyanide for the synthesis of 
biologically interesting N-arylindazole-3-carbonitriles.  
 
It is important highlight that the classic methods of preparations reported in 
literature depend on the pattern of substitution of the indazole ring.5,11–14 In 
particular 1-arylindazole-3-carboxamides 56 are prepared starting from the 
corresponding 1H-indazole-carboxylic acids 54 which are coupled with amines and 
then subjected to a Pd or Cu N-arylation. One disadvantage of this synthetic plan is 
that aryl substituted 1H-indazole-carboxylic acids require a multistep synthesis 
with poor overall efficiency (Scheme 6).15,16 Our novel strategy provides an 
additional indazole synthesis to those already reported in literature both in the type 
of substrate as well as the substitution pattern obtainable in the products.  
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Scheme 6. Conventional synthesis of N-arylindazoles-3-carboxamides. 
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12.3 Experimental section 
 
General Method. Commercially available reagents and solvents were used 
without further purification. Dichloromethane was dried by distillation from P2O5 
and stored over activated molecular sieves (4 Å). When necessary the reactions 
were performed in oven-dried glassware under a positive pressure of dry nitrogen. 
Melting points were determined in open glass capillaries and are uncorrected. All 
the compounds were characterized by IR. 1H and 13C APT NMR were recorded on 
a 400 MHz. High-resolution ESI-MS spectra were performed on a Thermo LTQ 
Orbitrap XL mass spectrometer. The spectra were recorded by infusion into the ESI 
source using MeOH as the solvent. Chemical shifts (d) are reported in part per 
million (ppm) relative to the residual solvent peak. Column chromatography was 
performed on silica gel (70–230 mesh ASTM) using the reported eluents. Thin 
layer chromatography (TLC) was carried out on 5 x 20 cm plates with a layer 
thickness of 0.25 mm (silica gel 60 F254). When necessary they were developed 
with KMnO4. 
 
General preparation of hydrazonoyl chlorides (8, 13-16).11a 
The hydrazonoyl chlorides were readily synthesized in two steps: 
Preparation of acylhydrazines. To a stirred solution of 2- iodobenzoic acids on a 5 
mmol scale in THF (0.2 M, 10 mL) were added EDC HCl (1.05 g, 5.50 mmol, 1.1 
eq.), DMAP (0.12 g, 1 mmol, 0.2 eq.), triethylamine (1.40 mL, 10 mmol, 2 eq.) and 
hydrazine (5 mmol, 1 eq.) at 0 °C. The resulting mixture was allowed to warm to 
room temperature over 24 h. The crude reaction mixture was washed with HCl 1 M 
sol. (x2), sat. NaHCO3 (x2) and brine (x1), evaporated to dryness and used in the 
next step without further purification. 
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Preparation of hydrazonoyl chlorides. The corresponding acylhydrazine (2.50 
mmol) was dissolved in CH3CN (0.5 M, 5 mL) and triphenylphosphine (0.79 g, 3 
mmol, 1.2 eq.) and carbon tetrachloride (0.29 mL, 3 mmol, 1.2 eq.) were added. 
The reaction was stirred at room temperature until all the acylhydrazine was 
consumed as Judged by TLC (typically 8–12 hours). The reaction was concentrated 
under reduced pressure and purified by column chromatography (n-hexane/EtOAc) 
and stored below 0 °C. 
 
(Z)-2-Iodo-N’-phenylbenzohydrazonoyl chloride (8). 
The crude material was purified by column chromatography (n-
hexane/EtOAc 30:1) to give the product as a white solid (0.41 g, 
46% yield). 1H NMR (400 MHz, CDCl3) δ 8.16 (br s, NH), 8.05 (d, 
J = 7.8 Hz, 1H), 7.64 (br d, 1H), 7.48–7.41 (m, 3H), 7.35–7.33 (m, 
2H), 7.14–7.07 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 143.3, 
140.5, 139.9, 130.9, 130.7, 129.6, 128.3, 123.0, 121.6, 113.7, 96.8. 
 
 
 
(Z)-2-Iodo-N’-(4-methoxyphenyl)benzohydrazonoyl chloride (13).  
The crude material was purified by column chromatography (n-
hexane/EtOAc 30:1) to give the product as a yellowish solid (0.43 
g, 44% yield). 1H NMR (400 MHz, CDCl3) δ 7.96 (d, J = 7.9 Hz, 
1H), 7.90 (br s, NH), 7.54 (d, J = 7.7 Hz, 1H), 7.40 (t, J = 7.5 Hz, 
1H), 7.15 (d, J = 8.8 Hz, 2H), 7.06 (t, J = 7.5 Hz, 1H), 6.87 (d, J = 
8.9 Hz, 1H), 3.79 (s, 3H); 13C NMR (100 MHz, CDCl3) d 154.7, 
140.5, 139.9, 137.2, 130.8, 130.5, 128.2, 122.0, 114.8 (4C), 96.6, 
55.7. 
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(Z)-4-Chloro-2-iodo-N’-phenylbenzohydrazonoyl chloride (14). 
The crude material was purified by column chromatography (n-
hexane/EtOAc 30:1) to give the product as a light yellow solid 
(0.69 g, 71% yield). 1H NMR (400 MHz, CDCl3) δ 8.04 (s, 
NH), 7.97 (s, 1H), 7.47 (br d, 1H), 7.39 (br d, AA’XX’, 1H), 
7.33–7.29 (m, 2H), 7.22–7.20 (m, 2H), 6.96 (t, J = 7.2 Hz, 1H). 
13C NMR (100 MHz, CDCl3) δ 142.9, 139.8, 138.2, 135.5, 
131.2, 129.4, 128.4, 121.6, 121.5, 113.5, 96.3. 
 
 
 
(Z)-N’-(4-Chlorophenyl)-2-iodobenzohydrazonoyl chloride (15). 
The crude material was purified by column chromatography (n-
hexane/EtOAc 30:1) to give the product as a light yellow solid (0.33 
g, 34% yield). 1H NMR (400 MHz, CDCl3) δ 8.03 (br s, NH), 7.71 
(br d, AA’XX’, 2H), 7.41 (br t, 1H), 7.26 (br d, AA’XX’, 2H), 7.15 
(br d, AA’XX’, 2H), 7.08 (br t, 1H); 13C NMR (100 MHz, CDCl3) δ 
141.8, 140.4, 139.6, 130.8, 130.7, 129.3, 128.2, 126.1, 123.7, 114.8, 
96.5. 
 
 
 
(Z)-N’-(4-Cyanophenyl)-2-iodobenzohydrazonoyl chloride (16). 
The crude material was purified by column chromatography (n-
hexane/ EtOAc 9:1) to give the product as a light orange solid (0.84 
g, 88% yield). 1H NMR (400 MHz, CDCl3) δ 10.44 (br s, NH), 7.98 
(br d, 1H), 7.65 (br d, AA’XX’, 2H), 7.59 (br d, 1H), 7.49 (br t, 
1H), 7.40 (br d, AA’XX’, 2H), 7.19 (br t, 1H); 13C NMR (100 
MHz, CDCl3) δ 148.1, 140.3, 140.2, 134.0, 131.8, 131.0, 129.0, 
125.0, 120.0, 114.2, 102.2, 97.5. 
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Synthesis of 2-hydroxymethyl benzoic acid (3) 
 
To a solution of NaOH (4.5 g, 111.9 mmol, 1.5 eq) in H2O (100 ml), 
phtalide (10 g, 74.6 mmol, 1eq) was added and the mixture was 
refluxed for 3 h. The solution was let to reach room tempereture, and 
then HCl conc. was added. A white solid precipitate was formed, 
which was purified by filtration (90%). 1H-NMR (300 MHz, 
CD3OD) δ 7.96 (d, J = 6.6 Hz, 1H), 7.63 (d, J =7.9 Hz, 1H), 7.53 (t, J =7.7 Hz, 1H), 
7.33 (t, J = 7.1 Hz, 1H), 4.92 (s, 2H); 13C-NMR (75 MHz, CD3OD) δ 169.5, 143.3, 
132.2, 130.7, 128.6, 127.6, 126.8, 62.6; MS (ESI) m/z 153.4 (M+H)+.  
 
 
General preparation of a-aminocarbonylhydrazones (10, 22-32).  
The hydrazonoyl chloride (0.5 mmol, 1 eq.), the isocyanide (0.5 mmol, 1 eq.), 2-
hydroxymethylbenzoic acid (0.5 mmol, 1 eq.) and TEA (1 mmol, 2 eq.) were one-
pot mixed in DCM (0.5 M, 1 mL) and stirred at room temperature under a nitrogen 
atmosphere overnight. After evaporation of the solvent, the crude material was 
purified by column chromatography. 
 
(Z)-N-Cyclohexyl-2-(2-iodophenyl)-2-(2-phenylhydrazono)acetamide (10).  
The crude material was purified by column chromatography 
(n-hexane/EtOAc 30:1) to give the product as yellow solid 
(0.15 g, 66% yield). 1H NMR (400 MHz, CDCl3) δ 13.25 (br 
s, NH), 7.93 (br d, 1H), 7.46–7.45 (m, 2H), 7.29–7.10 (m, 
5H), 6.93 (br t, 1H), 5.17 (br d, NH), 3.89–3.82 (m, 1H), 1.94–
1.92 (m, 2H), 1.68–1.58 (m, 3H), 1.42–1.33 (m, 2H), 1.16–
1.04 (m, 3H). 13C NMR (100 MHz, CDCl3) δ 162.6, 143.5, 
140.7, 140.0, 132.8, 131.8, 130.4, 129.2, 128.9, 121.7, 113.8, 
100.6, 48.2, 32.7, 25.4, 24.8. IR (KBr) 3390, 2923, 2846, 
1632, 1497, 1171, 760 νmax/cm-1; mp 121.1–122.3 °C; MS 
(ESI) m/z (M+H)+ calcd for C20H23IN3O: 448.0886; found: 448.0895 (100%) 
[M+H]+. 
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(Z)-N-(tert-Butyl)-2-(2-iodophenyl)-2-(2-(4-methoxyphenyl)-
hydrazono)acetamide (22).  
The crude material was purified by column chromatography (n-
hexane/EtOAc 30:1) to give the product as sticky reddish solid 
(0.10 g, 44% yield). 1H NMR (400 MHz, CDCl3) δ 13.20 (bs, 
NH), 7.92 (d, J = 7.9 Hz, 1H), 7.45–7.44 (m, 2H), 7.14 (br d, 
AA’XX’, 2H), 7.12–7.07 (m, 1H), 6.83 (d, J = 8.9 Hz, 2H), 5.05 
(br s, NH), 3.76 (s, 3H), 1.35 (s, 9H); 13C NMR (100 MHz, CDCl3) 
δ 163.5, 154.9, 141.2, 139.6, 137.6, 132.3, 131.8, 130.1, 128.9, 
115.0, 114.6, 100.7, 55.6, 51.6, 28.6. IR (KBr) 3406, 2956, 1635, 
1530, 1500, 1229, 1157 νmax/cm-1; MS (ESI) m/z (M+H)+ calcd for 
C19H23IN3O2: 452.0835; found: 452.0774 (100%) [M+H]+. 
 
(Z)-2-(2-Iodophenyl)-2-(2-(4-methoxyphenyl)hydrazono)-N-pentylacetamide 
(23).  
 The crude material was purified by column chromatography (n-
hexane/EtOAc 95:5) to give the product as reddish oil (0.11 g, 
46% yield). 1H NMR (400 MHz, CDCl3) δ 13.19 (br s, NH), 7.94 
(d, J = 7.9 Hz, 1H), 7.47–7.42 (m, 2H), 7.13 (br d, AA’XX’, 
2H), 7.11–7.08 (m, 1H), 6.83 (d, J = 8.8 Hz, 2H), 5.27 (br t, 
NH), 3.76 (s, 3H), 3.26 (q, J = 6.5 Hz, 2H), 1.53–1.46 (m, 2H), 
1.33–1.25 (m, 4H), 0.89–0.86 (m, 3H); 13C NMR (100 MHz, 
CDCl3) δ 163.7, 155.0, 140.9, 140.0, 139.7, 137.5, 131.7, 130.2, 
128.8, 115.0 (2C), 114.6 (2C), 101.0, 55.6, 39.2, 29.1, 29.0, 22.3, 
14.0. IR (KBr) 3417, 2950, 2923, 1635, 1506, 1220, 1168, 823 
νmax/cm-1; MS (ESI) m/z (M+H)+ calcd for C20H25IN3O2: 466.0991; found: 
466.0956 (100%) [M+H]+. 
 
(Z)-2-(4-Chloro-2-iodophenyl)-N-cyclohexyl-2-(2-phenylhydrazono) acetamide 
(24).  
 The crude material was purified by column 
chromatography (n-hexane/EtOAc 30 : 1) to give the 
product as yellow solid (0.18 g, 74% yield). 1H NMR (400 
MHz, CDCl3) δ 13.20 (br s, NH), 7.45 (br d, AA’XX’, 
1H), 7.37 (br d, AA’XX’, 1H), 7.28–7.24 (m, 2H), 7.17 
(br d, AA’XX’, 2H), 6.94 (br t, 1H), 5.07 (br d, NH), 
3.88–3.80 (m, 1H), 1.95–1.92 (m, 2H), 1.69–1.59 (m, 
3H), 1.42–1.32 (m, 2H), 1.17–1.06 (m, 3H); 13C NMR 
(100 MHz, CDCl3) δ 162.3, 143.3, 139.4, 139.0, 135.2, 
132.3, 131.5, 129.2, 129.1, 122.0, 113.9, 100.6, 48.2, 
32.8, 25.4, 24.8. IR (KBr) 3395, 2928, 2851, 1635, 1495, 1245, 1168, 990, 740 
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νmax/cm-1; mp 132.6–133.2 °C; MS (ESI) m/z (M+H)+ calcd for C20-H22ClIN3O: 
482.0496; found: 482.0482 (100%) [M+H]+. 
 
(Z)-N-Benzyl-2-(2-(4-chlorophenyl)hydrazono)-2-(2-iodophenyl)-acetamide 
(25).  
The crude material was purified by column chromatography 
(n-hexane/EtOAc 99:1) to give the product as yellowish solid 
(0.10 g, 41% yield). 1H NMR (400 MHz, CDCl3) δ 13.24 (br 
s, NH), 7.92 (br d, 1H), 7.45–7.10 (m, 12H), 5.63 (br s, NH), 
4.50 (d, J = 5.9 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 
163.4, 142.15, 140.4, 139.8, 137.3, 132.9, 131.5, 130.5, 129.2, 
128.9, 128.7, 126.7, 115.2, 100.6, 43.3. IR (KBr) 3390, 1629, 
1533, 1495, 1160, 823, 754 νmax/cm-1; mp 110.4–111.7 °C; 
MS (ESI) m/z (M+H)+ calcd for C21H18ClIN3O: 490.0183; 
found: 490.0152 (100%) [M+H]+. 
 
(Z)-2-(2-Iodophenyl)-N-(4-methoxyphenyl)-2-(2-phenylhydrazono)acetamide 
(26).  
The crude material was purified by column 
chromatography (n-hexane/EtOAc 95:5) to give the 
product as yellow solid (0.07 g, 31% yield). 1H NMR 
(400 MHz, CDCl3) δ 13.22 (br s, NH), 7.99 (br d, 1H), 
7.57–7.50 (m, 2H), 7.34–7.15 (m, 7H), 6.96 (br t, 1H), 
6.88 (br d, AA’XX’, 2H), 6.83 (br s, NH), 3.80 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 161.1, 157.2, 143.4, 
140.5, 139.9, 132.4, 132.0, 130.6, 129.5, 129.1, 123.1, 
122.2, 114.3, 114.1, 100.9, 55.5. IR (KBr) 3351, 1601, 
1506, 1484, 1234, 1146, 998 νmax/cm-1; mp 119.3–120.6 °C; MS (ESI) m/z (M+H)+ 
calcd for C21H19IN3O2: 472.0522; found: 472.0556 (100%) [M+H]+. 
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(Z)-2-(2-(4-Chlorophenyl)hydrazono)-2-(2-iodophenyl)-N-(4-
methoxybenzyl)acetamide (27). 
The crude material was purified by column 
chromatography (n-hexane/EtOAc 99:1) to 
give the product as white solid (0.11 g, 43% 
yield). 1H NMR (400 MHz, CDCl3) δ 13.24 (br 
s, NH), 7.91 (br d, 1H), 7.44–7.42 (m, 2H), 
7.23–7.10 (m, 7H), 6.85 (br d, AA’XX’, 2H), 
5.60–5.57 (m, 1H), 4.42 (br d, 2H), 3.78 (s, 
3H). 13C NMR (100 MHz, CDCl3) δ 160.3, 
159.1, 142.1, 140.3, 139.8, 132.9, 131.6, 
130.5, 129.3, 129.2, 129.1, 128.9, 126.6, 115.1, 114.1, 100.6, 55.3, 42.8. IR (KBr) 
3324, 3208, 1626, 1517, 1489, 1242, 1160, 1004, 825 νmax/cm-1; mp 143.3–144.4 
°C; MS (ESI) m/z (M+H)+ calcd for C22H20ClIN3O2: 520.0289; found: 520.0292 
(100%) [M+H]+. 
 
(Z)-N-(tert-Butyl)-2-(2-(4-cyanophenyl)hydrazono)-2-(2-iodophenyl)acetamide 
(28).  
The crude material was purified by column chromatography (n-
hexane/EtOAc 95:5) to give the product as white solid (0.11 g, 
47% yield). 1H NMR (400 MHz, CDCl3) δ 13.45 (br s, NH), 
7.94 (br d, 1H), 7.53–7.41 (m, 4H), 7.21–7.16 (m, 3H), 5.18 (br 
s, NH), 1.35 (s, 9H). 13C NMR (100 MHz, CDCl3) δ 162.7, 
147.0, 140.2, 139.7, 136.7, 133.5, 131.5, 130.8, 129.0, 119.7, 
113.8, 103.5, 99.6, 52.1, 28.4. IR (KBr) 3390, 3164, 2961, 2214, 
1637, 1508, 1149, 990 νmax/cm-1; mp 167.8– 168.8 °C; MS (ESI) 
m/z (M+H)+ calcd for C19H20IN4O: 447.0682; found: 447.0646 
(100%) [M+H]+. 
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(Z)-2-(2-(4-Cyanophenyl)hydrazono)-2-(2-iodophenyl)-N-pentylacetamide 
(29).  
The crude material was purified by column chromatography 
(n-hexane/EtOAc 9:1) to give the product as yellowish solid 
(0.12 g, 52% yield). 1H NMR (400 MHz, CDCl3) δ 13.43 (br s, 
NH), 7.96 (br d, 1H), 7.54–7.41 (m, 4H), 7.22–7.15 (m, 3H), 
5.42 (br s, NH), 3.30–3.25 (m, 1H), 1.55–1.48 (m, 2H), 1.33–
1.25 (m, 4H), 0.88 (br t, 3H). 13C NMR (100 MHz, CDCl3) δ 
163.1, 146.9, 139.9, 139.8, 135.9, 133.6, 131.4, 130.8, 129.0, 
119.7, 113.9, 103.8, 99.9, 39.5, 29.1, 28.8, 22.3, 13.9. IR (KBr) 
3329, 2923, 2214, 1646, 1508, 1149, 828 νmax/cm-1; mp 91.0–
92.4 °C; MS (ESI) m/z (M+H)+ calcd for C20H22IN4O: 
461.0838; found: 461.0852 (100%) [M+H]+. 
 
 
 
(Z)-2-(2-(4-Cyanophenyl)hydrazono)-2-(2-iodophenyl)-N-(4-
methoxyphenyl)acetamide (30).  
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as reddish solid (0.08 g, 34% yield). 1H NMR 
(400 MHz, CDCl3) δ 13.40 (br s, NH), 8.00 (br d, 1H), 
7.56–7.54 (m, 5H), 7.34–7.21 (m, 4H), 6.92 (br s, NH), 
6.89 (br s, AA’XX’, 2H). 13C NMR (100 MHz, CDCl3) 
δ 161.2, 157.6, 146.7, 140.0, 139.7, 135.7, 133.6, 
131.8, 131.1, 129.2, 128.9, 123.1, 119.6, 114.3, 114.1, 
104.2, 100.0, 55.5. IR (KBr) 3395, 2208, 1607, 1506, 
1229, 1141, 825 νmax/cm-1; mp 111.2–112.3 °C; MS 
(ESI) m/z (M+H)+ calcd for C22H18IN4O2: 497.0474; 
found: 497.0482 (100%) [M+H]+. 
 
O
NI
N N
CN
Chapter 12 
270 
(Z)-N-(tert-Butyl)-2-(2-(4-chlorophenyl)hydrazono)-2-(2-
iodophenyl)acetamide (31).  
The crude material was purified by column chromatography (n-
hexane/EtOAc 97:3) to give the product as yellow solid (0.11 g, 
46% yield). 1H NMR (400 MHz, CDCl3) δ 13.26 (br s, NH), 7.93 
(br d, 1H), 7.46–7.42 (m, 2H), 7.22–7.10 (m, 5H), 5.11 (br s, 
NH), 1.35 (s, 9H). 13C NMR (100 MHz, CDCl3) δ 163.2, 142.3, 
140.8, 139.7, 134.0, 131.7, 130.4, 129.1, 128.9, 126.2, 114.9, 
100.2, 51.8, 28.5. IR (KBr) 3406, 2956, 1643, 1489, 1231, 1157, 
987, 823 νmax/cm-1; mp 139.4–140.6 °C; MS (ESI) m/z (M+H)+ 
calcd for C18H20ClIN3O: 456.0340; found: 456.0304 (100%) 
[M+H]+. 
 
 
(Z)-2-(2-(4-Chlorophenyl)hydrazono)-N-cyclohexyl-2-(2-iodophenyl)acetamide 
(32).  
The crude material was purified by column chromatography 
(n-hexane/EtOAc 97:3) to give the product as orange solid 
(0.08 g, 34% yield). 1H NMR (400 MHz, CDCl3) δ 13.25 (br 
s, NH), 7.93 (br d, 1H), 7.46–7.41 (m, 2H), 7.20 (br d, 
AA’XX’, 2H), 7.14–7.09 (m, 4H), 5.16 (br d, NH), 3.87–3.79 
(m, 1H), 1.92–1.89 (m, 2H), 1.67–1.63 (m, 3H), 1.38–1.31 
(m, 2H), 1.12–1.05 (m, 3H). 13C NMR (100 MHz, CDCl3) δ 
162.5, 142.2, 140.5, 139.7, 133.5, 131.7, 130.4, 129.2, 128.9, 
126.3, 114.9, 100.4, 48.2, 32.7, 25.4, 24.7. IR (KBr) 3390, 
2923, 2846, 1635, 1492, 1160, 993 νmax/cm-1; mp 134.8–
135.4 °C; MS (ESI) m/z (M+H)+ calcd for C20H22ClIN3O: 
482.0496; found: 482.0472(100%) [M+H]+. 
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General preparation of N-arylindazole-3-carboxamides (11, 33-43).  
The α-aminocarbonylhydrazone (0.1 mmol, 1 eq.) is dissolved in dry 1,4-dioxan 
(0.3 M) and cesium carbonate (0.1 mmol, 1 eq.), tri-o-tolylphosphine (0.01 mmol, 
0.1 eq.) and bis(triphenylphosphine)palladium(II) dichloride (0.007 mmol, 0.07 
eq.) were added. The reaction mixture was stirred at reflux temperature overnight, 
evaporated and purified by chromatographic column (n-hexane/ EtOAc). 
 
N-Cyclohexyl-1-phenyl-1H-indazole-3-carboxamide (11).  
The crude material was purified by column chromatography 
(n-hexane/EtOAc 95:5) to give the product as yellow solid 
(0.03 g, 97% yield). 1H NMR (400 MHz, CDCl3) δ 8.49 (d, J 
= 8.1 Hz, 1H), 7.73–7.66 (m, 3H), 7.58–7.54 (m, 2H), 7.46–
7.40 (m, 2H), 7.35–7.32 (m, 1H), 7.04 (br d, NH), 4.10–4.00 
(m, 1H), 2.08–2.03 (m, 2H), 1.80–1.64 (m, 3H), 1.50–1.20 
(m, 5H); 13C NMR (100 MHz, CDCl3) δ 161.6, 140.4, 139.7, 
139.5, 129.6 (2C), 127.6 (2C), 123.9, 123.4 (2C), 123.3, 
123.2, 110.4, 48.0, 33.3 (2C), 25.6, 25.0 (2C). IR (KBr) 2923, 2851, 1662, 1555, 
1363, 1245, 1171, 1056 νmax/cm-1; mp 104.3–105.5 °C; MS (ESI) m/z (M+H)+ 
calcd for C20H22N3O: 320.1763; found: 320.1730 (100%) [M+H]+. 
 
N-(tert-Butyl)-1-(4-methoxyphenyl)-1H-indazole-3-carboxamide (33).  
The crude material was purified by column chromatography (n-
hexane/EtOAc 9:1) to give the product as reddish oil (0.03 g, 
90% yield). 1H NMR (400 MHz, CDCl3) δ 8.48 (d, J = 8.1 Hz, 
1H), 7.60–7.56 (m, 3H), 7.42 (br t, 1H), 7.31 (br t, 1H), 7.08–
7.04 (m, 3H), 3.89 (s, 3H), 1.53 (s, 9H); 13C NMR (100 MHz, 
CDCl3) δ 162.0, 159.0, 140.7, 139.6, 132.4, 127.4, 125.2 (2C), 
123.4, 123.3, 123.0, 114.7 (2C), 110.3, 55.7, 51.3, 29.1. IR 
(KBr) 3406, 2956, 1668, 1533, 1508, 1196, 1028, 751 νmax/cm-
1; MS (ESI) m/z (M+H)+ calcd for C19H22N3O2: 324.1712; 
found: 324.1728 (100%) [M+H]+. 
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1-(4-Methoxyphenyl)-N-pentyl-1H-indazole-3-carboxamide (34). 
The crude material was purified by column chromatography (n-
hexane/EtOAc 9:1) to give the product as an off-white solid 
(0.03 g, 92% yield). 1H NMR (400 MHz, CDCl3) δ 8.47 (d, J = 
8.1 Hz, 1H), 7.59–7.56 (m, 3H), 7.41 (br t, 1H), 7.31 (br t, 1H), 
7.14 (br t, NH), 7.06 (br d, AA’XX’, 2H), 3.87 (s, 3H), 3.52–
3.47 (m, 2H), 1.66–1.61 (m, 2H), 1.39–1.35 (m, 4H), 0.92–0.88 
(m, 3H); 13C NMR (100 MHz, CDCl3) δ 162.5, 159.1, 140.6, 
139.0, 132.5, 127.4, 125.1 (2C), 123.5, 123.2, 123.1, 114.7 
(2C), 110.3, 55.6, 39.1, 29.5, 29.2, 22.4, 14.0. IR (KBr) 3291, 
2956, 1640, 1544, 1245, 1201, 1026 νmax/cm-1; mp 58.7–59.8 °C; MS (ESI) m/z 
(M+H)+ calcd for C20H24N3O2: 338.1869; found: 338.1843 (100%) [M+H]+. 
 
6-Chloro-N-cyclohexyl-1-phenyl-1H-indazole-3-carboxamide (35).  
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as an off-white solid (0.03 mg, 98% yield). 1H 
NMR (400 MHz, CDCl3) δ 8.41 (d, J = 8.6 Hz, 1H), 
7.69–7.67 (m, 3H), 7.60–7.57 (m, 2H), 7.48–7.44 (m, 
1H), 7.30 (d, J = 8.6 Hz, 1H), 6.99 (br d, NH), 4.08–4.00 
(m, 1H), 2.08–2.05 (m, 2H), 1.80–1.66 (m, 4H), 1.49–
1.17 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 161.1, 
140.7, 139.8, 139.0, 134.2, 129.7 (2C), 128.0, 124.4 (2C), 123.5 (2C), 122.2, 110.2, 
48.0, 33.2 (2C), 25.6, 25.0 (2C). IR (KBr) 3324, 2934, 2851, 1637, 1536, 1495, 
1251, 751 νmax/cm-1; mp 146.1–147.2 °C; MS (ESI) m/z (M+H)+ calcd for 
C20H21ClN3O: 354.1373; found: 354.1349 (100%) [M+H]+. 
 
N-Benzyl-1-(4-chlorophenyl)-1H-indazole-3-carboxamide (36). 
The crude material was purified by column chromatography 
(n-hexane/EtOAc 95:5) to give the product as white solid 
(0.03 g, 92% yield). 1H NMR (400 MHz, CDCl3) δ 8.52 (d, J 
= 8.1 Hz, 1H), 7.68–7.65 (m, 3H), 7.53–7.29 (m, 10H), 4.73 
(br d, 2H); 13C NMR (100 MHz, CDCl3) δ 162.1, 140.2, 
139.5, 138.2, 138.0, 133.2, 129.7 (2C), 128.7 (2C), 128.0, 
127.9 (2C), 127.5, 124.4 (2C), 124.0, 123.6, 123.3, 110.3, 
43.1. IR (KBr) 3302, 1648, 1539, 1492, 1196, 1086, 976 
νmax/cm-1; mp 101.3–102.6 °C; MS (ESI) m/z (M+H)+ calcd 
for C21H17ClN3O: 362.1060; found: 362.1030 (100%) 
[M+H]+. 
N-(4-Methoxyphenyl)-1-phenyl-1H-indazole-3-carboxamide (37). 
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The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as red solid (0.03 g, 75% yield). 1H NMR (400 
MHz, CDCl3) δ 8.88 (br s, NH), 8.53 (d, J = 7.0 Hz, 
1H), 7.73–7.66 (m, 5H), 7.57–7.54 (m, 2H), 7.46–7.41 
(m, 2H), 7.34 (br t, 1H), 6.91 (d, J = 8.6 Hz, 2H), 3.78 
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 160.1, 156.3, 
140.5, 139.4, 139.3, 131.0, 129.6, 127.8 (2C), 123.9, 
123.5, 123.4, 123.2, 121.5, 114.2, 110.6, 55.5. IR (KBr) 3318, 2956, 1668, 1530, 
1240, 1020, 823 νmax/cm-1; mp 116.6–117.3 °C; MS (ESI) m/z (M+H)+ calcd for 
C21H18N3O2: 344.1399; found: 344.1407 (100%) [M+H]+. 
 
1-(4-Chlorophenyl)-N-(4-methoxybenzyl)-1H-indazole-3-carboxamide (38).  
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as orange solid (0.03 g, 85% yield). 1H 
NMR (400 MHz, CDCl3) δ 8.52 (br d, 1H), 7.64–
7.61 (m, 3H), 7.49–7.46 (m, 4H), 7.37–7.31 (m, 
3H), 6.86 (br d, AA’XX’, 2H), 4.64 (br d, 2H), 3.77 
(s, 3H). 13C NMR (100 MHz, CDCl3) δ 162.0, 
159.0, 140.2, 139.7, 138.0, 133.1, 130.4, 129.7, 
129.3, 128.0, 124.3, 124.0, 123.5, 123.4, 114.1, 
110.3, 55.3, 42.6. IR (KBr) 3313, 1646, 1541, 1492, 
1086, 828 νmax/cm-1; mp 135.0–136.1 °C; MS (ESI) 
m/z (M+H)+ calcd for C22H19ClN3O2: 392.1166; found: 392.1133 (100%) [M+H]+. 
 
N-(tert-Butyl)-1-(4-cyanophenyl)-1H-indazole-3-carboxamide (39).  
The crude material was purified by column chromatography (n-
hexane/EtOAc 95:5) to give the product as yellowish solid 
(0.02 g, 65% yield). 1H NMR (400 MHz, CDCl3) δ 8.50 (br d, 
1H), 6.91 (br d, AA’XX’, 2H), 7.84 (br d, AA’XX’, 2H), 7.73 
(br d, 1H), 7.49 (br t, 1H), 7.35 (br t, 1H), 6.99 (br s, NH), 1.53 
(s, 9H). 13C NMR (100 MHz, CDCl3) δ 161.3, 143.0, 141.7, 
140.0, 133.6, 128.5, 124.4, 123.9 (2C), 122.7, 118.2, 110.3, 
110.3, 51.5, 29.0. IR (KBr) 3340, 2967, 2230, 1651, 1541, 
1363, 850 νmax/cm-1; mp 131.7–133.0 °C; MS (ESI) m/z 
(M+H)+ calcd for C19H19N4O: 319.1559; found: 319.1525 
(100%) [M+H]+. 
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1-(4-Cyanophenyl)-N-pentyl-1H-indazole-3-carboxamide (40). 
The crude material was purified by column chromatography (n-
hexane/EtOAc 95:5) to give the product as light pink solid 
(0.02 g, 64% yield). 1H NMR (400 MHz, CDCl3) δ 8.51 (br d, 
1H), 7.91 (br d, AA’XX’, 2H), 7.84 (br d, AA’XX’, 2H), 7.75 
(br d, 1H), 7.51 (br t, 1H), 7.37 (br t, 1H), 7.12 (br t, NH), 
3.53–3.48 (m, 2H), 1.76–1.65 (m, 2H), 1.39–1.38 (m, 4H), 
0.92–0.89 (m, 3H). 13C NMR (100 MHz, CDCl3) δ 161.8, 
143.1, 141.1, 140.0, 133.6, 128.5, 124.5, 124.0, 123.8, 122.7, 
118.2, 110.4, 110.3, 39.2, 29.5, 29.1, 22.4, 14.0. IR (KBr) 3285, 
2934, 2225, 1646, 1555, 1421, 1179, 842 νmax/cm-1; mp 144.2–
145.5 °C; MS (ESI) m/z (M+H)+ calcd for C20H21N4O: 333.1715; found: 333.1728 
(100%) [M+H]+. 
 
1-(4-Cyanophenyl)-N-(4-methoxyphenyl)-1H-indazole-3-carboxamide (41).  
The crude material was purified by column 
chromatography (n-hexane/EtOAc 9:1) to give the 
product as pink solid (0.02 g, 48% yield). 1H NMR 
(400 MHz, CDCl3) δ 8.78 (br s, NH), 8.56 (br d, 1H), 
7.96 (br d, AA’XX’, 2H), 7.88 (br d, AA’XX’, 2H), 
7.78 (br d, 1H), 7.66 (br d, AA’XX’, 2H), 7.56 (br t, 
1H), 7.43 (br t, 1H), 6.93 (br d, AA’XX’, 2H), 3.82 (s, 
3H). 13C NMR (100 MHz, CDCl3) δ 159.5, 156.5, 
142.9, 141.0, 140.2, 133.7, 130.6, 128.7, 124.5, 124.3, 
123.8, 122.9, 121.6, 118.1, 114.3, 110.7, 110.4, 55.5. 
IR (KBr) 3302, 2225, 1648, 1599, 1506, 1237, 1168, 836 νmax/cm-1; mp 191.5–
192.4 °C; MS (ESI) m/z (M+H)+ calcd for C22H17N4O2: 369.1352; found: 369.1341 
(100%) [M+H]+. 
 
N-(tert-Butyl)-1-(4-chlorophenyl)-1H-indazole-3-carboxamide (42).  
 
The crude material was purified by column chromatography (n-
hexane/EtOAc 98:2) to give the product as yellow solid (0.02 g, 
59% yield). 1H NMR (400 MHz, CDCl3) δ 8.49 (br d, 1H), 7.67–
7.61 (m, 3H), 7.52 (br d, AA’XX’, 2H), 7.45 (br t, 1H), 7.33 (br t, 
1H), 7.01 (br s, NH), 1.53 (s, 9H). 13C NMR (100 MHz, CDCl3) δ 
161.7, 140.5, 140.3, 138.0, 133.1, 129.7, 127.9, 124.5, 123.8, 
123.6, 123.4, 110.1, 51.3, 29.1. IR (KBr) 3401, 3060, 2961, 1662, 
1530, 1497, 1193, 1091 νmax/cm-1; mp 47.1–48.7 °C; MS (ESI) 
N
N
NH
O
Cl
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m/z (M+H)+ calcd for C18H19ClN3O: 328.1217; found: 328.1224 (100%) [M+H]+. 
 
1-(4-Chlorophenyl)-N-cyclohexyl-1H-indazole-3-carboxamide (43).  
The crude material was purified by column chromatography 
(n-hexane/EtOAc 98:2) to give the product as yellow solid 
(0.03 g, 83% yield). 1H NMR (400 MHz, CDCl3) δ 8.49 (br 
d, 1H), 7.67 (br d, AA’XX’, 2H), 7.63 (br d, 1H), 7.52 (br d, 
AA’XX’, 2H), 7.45 (br t, 1H), 7.34 (br t, 1H), 7.00 (br s, 
NH), 4.10–4.01 (m, 1H), 2.08–2.03 (m, 2H), 1.83–1.76 (m, 
3H), 1.49–1.20 (m, 5H). 13C NMR (100 MHz, CDCl3) δ 
161.3, 140.2, 140.0, 138.0, 133.1, 129.7, 127.9, 124.4, 
124.0, 123.5, 123.4, 110.1, 48.0, 33.3, 25.6, 25.0. IR (KBr) 
3401, 2923, 2846, 1657, 1528, 1492, 1196, 1086, 831 νmax/cm-1; mp 58.9–60.8 °C; 
MS (ESI) m/z (M+H)+ calcd for C20H21ClN3O: 354.1373; found: 354.1384 (100%) 
[M+H]+. 
 
 
General preparation of N-arylindazole-3-carbonitriles (52). 
N-Benzyl-1-(4-chlorophenyl)-1H-indazole-3-carboxamide 37 (0.07 mmol, 1 
equiv.) is dissolved in phosphorous oxychloride (0.03 M) stirred at 150 °C for 4 
hours. The reaction mixture is cooled at room temperature and poured into 
ice/ammonium hydroxide. The product is then extracted with EtOAc (x3); the 
organic phase is washed with brine, dried over Na2SO4 and evaporated. The 
product is then purified by chromatographic column (n-hexane/ EtOAc). 
 
1-(4-Chlorophenyl)-1H-indazole-3-carbonitrile (52).  
The crude material was purified by column chromatography (n-
hexane/EtOAc 98:2) to give the product as yellowish solid (0.02 g, 
96% yield). 1H NMR (400 MHz, CDCl3) δ 7.93 (br d, 1H), 7.75 (br 
d, 1H), 7.68 (br d, AA’XX’, 2H), 7.57–7.55 (m, 3H), 7.44 (br t, 
1H). 13C NMR (100 MHz, CDCl3) δ 130.0, 137.4, 134.3, 130.0, 
128.9, 126.1, 124.6, 124.4, 120.6, 120.1, 113.1, 111.2. IR (KBr) 
2236, 1495, 1355, 1218, 1089, 834 νmax/cm-1; mp 164.4–165.6 °C; 
MS (ESI) m/z (M+H)+ calcd for C14H9ClN3: 254.0485; found: 
254.0467 (100%) [M+H]+. 
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In this Ph.D. thesis period (2013-2016), we developed seven novel 
multicomponent reactions between the 1,3-dipolar species nitrile N-oxides and 
nitrile imines, generated from Z-chlooximes or hydrazonoyl chloride respectly, 
with isocyanides in the presence of a nucleophilic component. 
The presence of a third component is pivotal in diverging the course of the two-
component reaction between the 1,3-dipolar species and isocyanides, which is 
sometimes messy and unable to afford a single main product.  
We have established straightforward synthetic routes which with only one or 
two synthetic steps allow to synthesize several important scaffolds for medicinal 
chemists. In particular starting from nitrile N-oxide we obtained C-
oximinoamidines, aryl α-ketoamide amides, aryloxyimino amides, and 5-amino-
1,2,4-oxadiazoles (Figure 1).  
 
Figure 1. Scaffolds synthesized by a novel MCRs starting from Z-
chlorooximes. 
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While starting from nitrile imines we synthesized aminocarbonyl N-
acylhydrazones, furo[2,3-d]pyridazin-4(5H)-ones and 1-arylindazole-3-
carboxamides (Figure 2). 
 
Figure 2. Scaffolds synthesized by a novel MCRs starting from 
hydrazonoyl chlorides. 
 
It is important to highlight that the entire sequence of reactions is realized under 
mild reaction conditions avoiding the use of expensive coupling agents and using 
simple and easily available starting materials. 
The detailed mechanism of the reaction between nitrile N-oxides and 
isocyanides has been studied indicating a [3+1] cycloaddition as the most 
energetically favorable step, thus preventing the direct attack of the third 
nucleophile to nitrile N-oxides. The mechanism with nitrile imines has been less 
well investigated leaving the possibility of a direct nucleophilic attack of 
isocyanide to nitrile imine or a 1,3-dipolar cycloaddition to form the strained 1,2-
diazet-3(2H)-imine.  
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As several nucleophiles showed an ability to intercept the nitrilium ion 
generated by reacting nitrile N-oxide or nitrile imine with isocyanide, is it plausible 
that other nucleophiles besides those reported by us, can intercept the nitrilium ion 
in a productive manner without directly competing with the isocyanide in the 
reaction with the 1,3-dipolar species.  
This will create novel opportunities for the synthesis of molecular scaffolds not 
easily accessible through conventional multistep synthesis.  
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Nitrile N-oxides and nitrile imines as electrophilic partners for the 
discovery of novel isocyanides multicomponent reactions: an 
innovative strategy for the synthesis of molecular scaffolds useful in 
medicinal chemistry 
 
1. Introduction 
Multicomponent reactions (MCRs) are reactions in which three or more 
different starting materials are combined, in one step, to give a product that 
incorporates substantial portions of all the components, reducing the number of 
synthetic steps necessary to form the desired molecules.  
Special subclasses of the MCRs are those isocyanides based. Isocyanides have a 
unique reactivity; indeed, no other functional group reacts with nucleophiles and 
electrophiles at the same carbon atom, leading to the so-called α-adduct.  
Nowadays, most MCR chemistry performed with isocyanides relates to the 
classical reactions of Passerini and Ugi, followed by post transformation reactions 
(Scheme 1).  
 
Scheme 1. Passerini reaction (P-3CR) and Ugi reaction (U-4CR). 
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2. Outline of the thesis 
The major objective of this thesis was related to the ambitious goal of 
discovering new multicomponent reactions. This could be lead to the synthesis of 
important scaffolds in medicinal chemistry either not easily accessible via the 
classical two-component chemistry or never reported in literature. 
The aim of this Ph.D. thesis was the search for neglected electrophilic groups 
that could replace the carbonyl component in the Passerini reaction. In particular, 
we have investigated, the role of Z-chlorooximes and hydrazonoyl chlorides. These 
two starting materials are, indeed, able to generate, under very mild reaction 
conditions, 1,3-dipolar species, respectively, nitrile N-oxides and nitrile imines 
which can be attacked by the isocyanide. The ephemeral nitrilium ion created can 
then be intercepted by a third component (Scheme 2).  
 
 
Scheme 2. Reaction between nitrile N-oxides or nitrile imines, isocyanides and a third 
nucleophile. 
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3. Nitrile N-oxides and nitrile imines as electrophilic partners in 
isocyanides based multicomponent reactions (IMCRs) 
Over last decades was shown as the two components reactions between 
isocyanides and nitrile N-oxides or nitrile imines were inefficient forming several 
products. In this thesis we demonstrated that this erratic situation changes abruptly 
when a third component was present in the flask to driving the reaction towards the 
formation of a single novel product. 
In detail, the multicomponent reaction between N-oxides, isocyanides and 
amine, has allowed to obtain C-oximinoamidines, a so far elusive class of 
compounds (Schema 3). A library of thirteen C-oximinoamidines was synthesized 
in order to demonstrated the generality of this synthetic procedure. 
 
Scheme 3. General reaction between Z-chlorooximes, isocyanides 
and amine.  
 
In the search of new different nucleophiles able to intercept the nitrilium 
intermediate, generated from the reaction between nitrile N-oxides and isocyanides, 
we reasoned that the nitrilium ion could also be intramolecularly intercepted by an 
internal nucleophile. To prove this hypothesis, we reacted Z-arylchlorooximes and 
α-isocyanoacetamides producing 1,3-oxazol-2-oxime derivatives in good yields. 
Opening of the oxazole ring and deoximation reaction gave a facile access to aryl-
α-ketoamide amides, a class of privileged scaffolds in medicinal chemistry and 
important synthetic intermediates in organic chemistry. A library of eighteen α-keto 
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amide amides was synthesized in order to demonstrated the generality of this 
synthetic procedure (Scheme 4).  
 
 
Scheme 4. Synthesis of 1,3-oxazol-2-oxime and subsequently of aryl-
α-ketoamide amides.  
 
As a continuation of our studies, we reported the discovery of a novel 
multicomponent reaction in which electron-deficient phenols were the third 
component in a reaction with Z-chlorooximes and isocyanides. In this case, after 
the formation of the imidate, the hydroxyl group of the oxime, which was properly 
positioned, thanks to the stereoselective addition of isocyanide to the nitrile N-
oxide, triggered a Smiles rearrangement, to form aryloxyiminoamides. To 
demonstrate the versatility of this novel transformation a solution-phase 
combinatorial library of 41 aryloxyiminoamides has been produced (Scheme 5).  
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Scheme 5. Three-component synthesis of aryloximinoamides.  
 
We then envisaged a novel multicomponent reaction using a hyper-nucleophile 
like hydroxylamine as the third component to prepare aminodioximes. 
Furthermore, the one-pot conversion of aminodioximes to 1,2,3-oxadiazole-5-
amines via Mitsunobu-Beckmann rearrangement was reported for the first time 
(Scheme 6).  
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Scheme 6. Three-component synthesis of aminodioximes 
aminodioximes and subsequently of 1,2,3-oxadiazole-5-amines.  
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Subsequently, we used nitrile imines as electrophilic input in a novel three-
component reaction from readily available hydrazonoyl chlorides, isocyanides, and 
carboxylic acids to obtain α-aminocarbonyl N-acylhydrazones. The strategy 
exploited the ability of the carboxylic acid as third component to suppress all the 
competing reactions between nitrile imines and isocyanides (Scheme 7).  
 
 
Scheme 7. Three-component reaction between hydrazonoyl chloride, 
isocyanide and carboxylic acid.  
 
The reactivity of the 1,3-dipolar species nitrilimines was also exploited in 
combination with α-isocyanoacetamides allowing the one-pot synthesis of 
tetrasubstituted furo[2,3-d]pyridazin-4(5H)-ones. In brief, hydrazonoyl chlorides 
react with isocyanoacetamides, in the presence of TEA, to give 1,3-oxazol-2-
hydrazones which, without being isolated, can react with dimethylacetylene 
dicarboxylate to afford furo[2,3-d]pyridazin-4(5H)-ones with an unprecedented 
level of complexity in a triple domino Diels-Alder/retro-Diels-Alder/lactamization 
reaction sequence (Scheme 8).  
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Scheme 8. Synthesis of furo[2,3-d]pyridazin-4(5H)-ones.  
Continuing our interest for hydrazonoyl chlorides in isocyan 
ide-mediated multicomponent reactions, we have disclosed a convergent and 
efficient two-step synthesis of pharmaceutically relevant 1-arylindazole-3-
carboxamides. The process exploited a strategic three-component reaction between 
isocyanides, 2-iodo-N-arylbenzohydrazonoyl chlorides and 2-
hydroxymethylbenzoic acid followed by a chemoselective Buchwald-Hartwig 
intramolecular cyclization (Scheme 9).  
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Scheme 9. Synthesis of 1-arylindazole-3-carboxamides. 
 
 
4. Conclusions 
In conclusion, we developed seven novel multicomponent reactions between the 
1,3-dipolar species nitrile N-oxides or nitrile imines, generated from Z-
chlorooximes or hydrazonoyl chloride respectly, with isocyanides in the presence 
of a nucleophilic component. 
It is important to highlight that the entire sequence of reactions is realized under 
mild reaction conditions avoiding the use of expensive reagents and using simple 
and easily available starting materials. 
The detailed mechanism of the reaction between nitrile N-oxides and 
isocyanides was also investigated indicating a [3+1] cycloaddition between 1,3-
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dipolar species and isocyanides as the most energetically favorable step, thus 
preventing the direct attack of the third nucleophile to nitrile N-oxides. 
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